10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 1, 2023

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                    .

Commission File No.: 0-121

KULICKE AND SOFFA INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

Pennsylvania	23-1498399
(State or other jurisdiction of incorporation)	(IRS Employer
	Identification No.)

23A Serangoon North Avenue 5, #01-01, Singapore 554369

1005 Virginia Dr., Fort Washington, PA 19034

(Address of principal executive offices and Zip Code)

(215) 784-6000

(Registrant's telephone number, including area code) 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, Without Par Value	KLIC	The Nasdaq Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ 

As of August 4, 2023, there were 56,473,297 shares of the Registrant’s Common Stock, no par value, outstanding.

KULICKE AND SOFFA INDUSTRIES, INC.

FORM 10 – Q

July 1, 2023

 Index

		Page Number
PART I - FINANCIAL INFORMATION
Item 1.	FINANCIAL STATEMENTS (Unaudited)
	Consolidated Condensed Balance Sheets as of July 1, 2023 and October 1, 2022	1
	Consolidated Condensed Statements of Operations for the three and nine months ended July 1, 2023 and July 2, 2022	2
	Consolidated Condensed Statements of Comprehensive Income for the three and nine months ended July 1, 2023 and July 2, 2022	3
	Consolidated Condensed Statements of Changes in Shareholders’ Equity for the three and nine months ended July 1, 2023 and July 2, 2022	4
	Consolidated Condensed Statements of Cash Flows for the nine months ended July 1, 2023 and July 2, 2022	6
	Notes to Consolidated Condensed Financial Statements	7
Item 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	27
Item 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	40
Item 4.	CONTROLS AND PROCEDURES	41
PART II - OTHER INFORMATION
Item 1.	LEGAL PROCEEDINGS	42
Item 1A.	RISK FACTORS	42
Item 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	45
Item 3.	DEFAULTS UPON SENIOR SECURITIES	45
Item 4.	MINE SAFETY DISCLOSURES	45
Item 5.	OTHER INFORMATION	45
Item 6.	EXHIBITS	46
	SIGNATURES	47

PART I. - FINANCIAL INFORMATION

Item 1. – FINANCIAL STATEMENTS

KULICKE AND SOFFA INDUSTRIES, INC.

CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited)

(in thousands)

	As of
	July 1, 2023		October 1, 2022
ASSETS
Current assets:
Cash and cash equivalents	$	401,806	$	555,537
Short-term investments	310,000		220,000
Accounts and other receivable, net of allowance for doubtful accounts of $49 and $0, respectively	198,107		309,323
Inventories, net	227,991		184,986
Prepaid expenses and other current assets	45,144		62,200
Total current assets	1,183,048		1,332,046
Property, plant and equipment, net	113,567		80,908
Operating right-of-use assets	46,351		41,767
Goodwill	89,291		68,096
Intangible assets, net	31,418		31,939
Deferred tax assets	40,926		25,572
Equity investments	433		5,397
Other assets	3,088		2,874
TOTAL ASSETS	$	1,508,122	$	1,588,599
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	52,857		67,311
Operating lease liabilities	6,569		6,766
Income taxes payable	16,844		40,063
Accrued expenses and other current liabilities	120,506		134,541
Total current liabilities	196,776		248,681
Deferred tax liabilities	36,735		34,037
Income taxes payable	50,673		64,634
Operating lease liabilities	41,390		34,927
Other liabilities	12,836		11,670
TOTAL LIABILITIES	$	338,410	$	393,949
Commitments and contingent liabilities (Note 16)
Shareholders’ equity:
Preferred stock, without par value: Authorized 5,000 shares; issued - none	$	—	$	—
Common stock, without par value: Authorized 200,000 shares; issued 85,364 and 85,364, respectively; outstanding 56,488 and 57,128 shares, respectively	572,338		561,684
Treasury stock, at cost, 28,875 and 28,237 shares, respectively	(728,064)		(675,800)
Retained earnings	1,343,163		1,341,666
Accumulated other comprehensive loss	(17,725)		(32,900)
TOTAL SHAREHOLDERS’ EQUITY	$	1,169,712	$	1,194,650
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,508,122	$	1,588,599

The accompanying notes are an integral part of these consolidated condensed financial statements.

1

KULICKE AND SOFFA INDUSTRIES, INC.

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (Unaudited)

(in thousands, except per share data)

	Three months ended				Nine months ended
	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Net revenue	$	190,917	$	372,137	$	540,171	$	1,217,307
Cost of sales	100,899		181,452		277,355		601,674
Gross profit	90,018		190,685		262,816		615,633
Selling, general and administrative	36,393		33,216		114,233		107,263
Research and development	36,578		34,046		107,085		104,496
Impairment charges	21,535		1,346		21,535		1,346
Operating expenses	94,506		68,608		242,853		213,105
(Loss)/income from operations	(4,488)		122,077		19,963		402,528
Interest income	8,847		2,158		23,406		3,099
Interest expense	(50)		(36)		(116)		(173)
Income before income taxes	4,309		124,199		43,253		405,454
Provision for income taxes	148		5,165		9,462		36,813
Net income	$	4,161	$	119,034	$	33,791	$	368,641
Net income per share:
Basic	$	0.07	$	2.02	$	0.60	$	6.05
Diluted	$	0.07	$	1.99	$	0.59	$	5.95
Weighted average shares outstanding:
Basic	56,553		58,985		56,763		60,951
Diluted	57,519		59,955		57,684		61,940

 The accompanying notes are an integral part of these consolidated condensed financial statements.

2

KULICKE AND SOFFA INDUSTRIES, INC.

CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(in thousands)

	Three months ended				Nine months ended
	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Net income	$	4,161	$	119,034	$	33,791	$	368,641
Other comprehensive income:
Foreign currency translation adjustment	(2,459)		(12,009)		13,514		(18,025)
Unrecognized actuarial (gain)/loss on pension plan, net of tax	(17)		122		(73)		103
	(2,476)		(11,887)		13,441		(17,922)
Derivatives designated as hedging instruments:
Unrealized (loss)/gain on derivative instruments, net of tax	(1,280)		(1,233)		2,550		(1,168)
Reclassification adjustment for (gain)/loss on derivative instruments recognized, net of tax	(518)		170		(816)		793
Net (decrease)/increase from derivatives designated as hedging instruments, net of tax	(1,798)		(1,063)		1,734		(375)
Total other comprehensive (loss)/income	(4,274)		(12,950)		15,175		(18,297)
Comprehensive (loss)/income	$	(113)	$	106,084	$	48,966	$	350,344

The accompanying notes are an integral part of these consolidated condensed financial statements.

3

KULICKE AND SOFFA INDUSTRIES, INC.

CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited)

(in thousands)

	Common Stock			Treasury Stock		Retained Earnings		Accumulated Other Comprehensive (Loss)/Income		Shareholders' Equity
	Shares	Amount
Balances as of October 1, 2022	57,128	$	561,684	$	(675,800)	$	1,341,666	$	(32,900)	$	1,194,650
Issuance of stock for services rendered	6	180		57		—		—		237
Repurchase of common stock	(1,054)	—		(45,382)		—		—		(45,382)
Issuance of shares for equity-based compensation	667	(6,412)		6,412		—		—		—
Equity-based compensation	—	6,284		—		—		—		6,284
Cash dividend declared	—	—		—		(10,794)		—		(10,794)
Components of comprehensive income:
Net income	—	—		—		14,589		—		14,589
Other comprehensive income	—	—		—		—		17,645		17,645
Total comprehensive income	—	—		—		14,589		17,645		32,234
Balances as of December 31, 2022	56,747	$	561,736	$	(714,713)	$	1,345,461	$	(15,255)	$	1,177,229
Issuance of stock for services rendered	5	184		53		—		—		237
Repurchase of common stock	(102)	—		(4,990)		—		—		(4,990)
Issuance of shares for equity-based compensation	3	(31)		31		—		—		—
Equity-based compensation	—	5,142		—		—		—		5,142
Cash dividend declared	—	—		—		(10,766)		—		(10,766)
Components of comprehensive income:
Net income	—	—		—		15,041		—		15,041
Other comprehensive income	—	—		—		—		1,804		1,804
Total comprehensive income	—	—		—		15,041		1,804		16,845
Balances as of April 1, 2023	56,653	$	567,031	$	(719,619)	$	1,349,736	$	(13,451)	$	1,183,697
Issuance of stock for services rendered	5	194		43		—		—		237
Repurchase of common stock	(175)	—		(8,541)		—		—		(8,541)
Issuance of shares for equity-based compensation	5	(53)		53		—		—		—
Equity-based compensation	—	5,166		—		—		—		5,166
Cash dividend declared	—	—		—		(10,734)		—		(10,734)
Components of comprehensive income/(loss):
Net income	—	—		—		4,161		—		4,161
Other comprehensive loss	—	—		—		—		(4,274)		(4,274)
Total comprehensive income/(loss)	—	—		—		4,161		(4,274)		(113)
Balances as of July 1, 2023	56,488	$	572,338	$	(728,064)	$	1,343,163	$	(17,725)	$	1,169,712

4

	Common Stock			Treasury Stock		Retained Earnings		Accumulated Other Comprehensive Loss		Shareholders' Equity
	Shares	Amount
Balances as of October 2, 2021	61,931	$	550,117	$	(400,412)	$	948,554	$	(3,022)	$	1,095,237
Issuance of stock for services rendered	4	197		41		—		—		238
Repurchase of common stock	(276)	—		(15,380)		—		—		(15,380)
Issuance of shares for equity-based compensation	725	(6,963)		6,963		—		—		—
Equity-based compensation	—	5,074		—		—		—		5,074
Cash dividend declared	—	—		—		(10,610)		—		(10,610)
Components of comprehensive income/(loss):
Net income	—	—		—		133,606		—		133,606
Other comprehensive loss	—	—		—		—		(989)		(989)
Total comprehensive income/(loss)	—	—		—		133,606		(989)		132,617
Balances as of January 1, 2022	62,384	$	548,425	$	(408,788)	$	1,071,550	$	(4,011)	$	1,207,176
Issuance of stock for services rendered	4	202		35		—		—		237
Repurchase of common stock	(2,944)	(30,000)		(146,153)		—		—		(176,153)
Issuance of shares for equity-based compensation	24	(222)		222		—		—		—
Equity-based compensation	—	4,459		—		—		—		4,459
Cash dividend declared	—	—		—		(10,110)		—		(10,110)
Components of comprehensive income/(loss):
Net income	—	—		—		116,001		—		116,001
Other comprehensive loss	—	—		—		—		(4,358)		(4,358)
Total comprehensive income/(loss)	—	—		—		116,001		(4,358)		111,643
Balances as of April 2, 2022	59,468	$	522,864	$	(554,684)	$	1,177,441	$	(8,369)	$	1,137,252
Issuance of stock for services rendered	4	196		41		—		—		237
Repurchase of common stock	(997)	30,000		(61,098)		—		—		(31,098)
Issuance of shares for equity-based compensation	5	(52)		52		—		—		—
Equity-based compensation	—	4,228		—		—		—		4,228
Cash dividend declared	—	—		—		(9,970)		—		(9,970)
Components of comprehensive income/(loss):
Net income	—	—		—		119,034		—		119,034
Other comprehensive loss	—	—		—		—		(12,950)		(12,950)
Total comprehensive income/(loss)	—	—		—		119,034		(12,950)		106,084
Balances as of July 2, 2022	58,480	$	557,236	$	(615,689)	$	1,286,505	$	(21,319)	$	1,206,733

 The accompanying notes are an integral part of these consolidated condensed financial statements.

5

KULICKE AND SOFFA INDUSTRIES, INC.

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited)

(in thousands)

	Nine months ended
	July 1, 2023		July 2, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	33,791	$	368,641
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	20,746		15,773
Impairment charges	21,535		1,346
Equity-based compensation and employee benefits	17,303		14,473
Adjustment for doubtful accounts	49		(245)
Adjustment for inventory valuation	2,598		1,110
Deferred taxes	(14,441)		(3,675)
Gain on disposal of property, plant and equipment	(539)		(129)
Unrealized foreign currency translation	2,610		(3,806)
Changes in operating assets and liabilities, net of assets and liabilities assumed in businesses combinations:
Accounts and other receivable	112,881		71,825
Inventories	(44,106)		(49,230)
Prepaid expenses and other current assets	17,165		(50,725)
Accounts payable, accrued expenses and other current liabilities	(35,461)		(84,017)
Income taxes payable	(37,028)		(6,663)
Other, net	(1,191)		(1,053)
Net cash provided by operating activities	95,912		273,625
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of business, net of cash acquired	(36,881)		—
Purchases of property, plant and equipment	(35,125)		(10,380)
Proceeds from sales of property, plant and equipment	318		119
Investment in private equity fund	(36)		(397)
Purchase of short-term investments	(465,000)		(389,000)
Maturity of short-term investments	375,000		466,000
Net cash (used in)/provided by investing activities	(161,724)		66,342
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment on short-term debt	—		(54,500)
Proceeds from short-term debt	—		54,500
Payment for finance lease	(447)		(373)
Repurchase of common stock/treasury stock	(60,608)		(221,139)
Common stock cash dividends paid	(31,303)		(29,393)
Net cash used in financing activities	(92,358)		(250,905)
Effect of exchange rate changes on cash and cash equivalents	4,439		(6,069)
Changes in cash and cash equivalents	(153,731)		82,993
Cash and cash equivalents at beginning of period	555,537		362,788
Cash and cash equivalents at end of period	$	401,806	$	445,781
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:
Property, plant and equipment included in accounts payable and accrued expenses	$	8,098	$	660
CASH PAID FOR:
Interest	$	116	$	173
Income taxes, net of refunds	$	55,998	$	50,059

The accompanying notes are an integral part of these consolidated condensed financial statements. 

6

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited

NOTE 1. BASIS OF PRESENTATION

These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“we,” “us,” “our,” or the “Company”), with appropriate elimination of intercompany balances and transactions.

The interim consolidated condensed financial statements are unaudited and, in management’s opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K/A for the fiscal year ended October 1, 2022 (the “2022 Annual Report”) filed with the Securities and Exchange Commission on August 8, 2023, which includes the Consolidated Balance Sheets as of October 1, 2022 and October 2, 2021, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders’ Equity and Cash Flows for each of the years in the three-year period ended October 1, 2022. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.

Fiscal Year    

Each of the Company’s first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2023 quarters end on December 31, 2022, April 1, 2023, July 1, 2023 and September 30, 2023. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2022 quarters ended on January 1, 2022, April 2, 2022, July 2, 2022 and October 1, 2022.

Nature of Business

The Company designs, develops, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company’s operating results depend upon the capital and operating expenditures of integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), foundry service providers, and other electronics manufacturers and automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry’s demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, solutions and services, including those sold or provided by the Company. These downturns and slowdowns have in the past adversely affected the Company’s operating results. The Company believes such volatility will continue to characterize the industry and the Company’s operations in the future.

Use of Estimates

The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.

Due to the persistent macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of July 1, 2023. While there was no material impact to our consolidated condensed financial statements as of and for the quarter ended July 1, 2023, these estimates may change, as new events occur and additional information is obtained, including macroeconomic headwinds that could materially impact our consolidated condensed financial statements in future reporting periods.

7

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

Significant Accounting Policies

There have been no material changes to our significant accounting policies summarized in Note 1: Basis of Presentation to our Consolidated Financial Statements included in our 2022 Annual Report.

Revision of Segment-Related Disclosures within the Previously Issued Consolidated Financial Statements

During the third quarter of fiscal year 2023, in response to comment letters from and ongoing discussions with the staff of the SEC, the Company reconsidered the guidance under ASC 280, Segment Reporting, and determined that certain prior period conclusions about the Company’s operating and reportable segments were erroneous. As a result, the Company had incorrectly presented certain segment-related disclosures in the notes to our previously issued consolidated financial statements, included in our Annual Report on Form 10-K for the year ended October 1, 2022, originally filed with the SEC on November 17, 2022 (the “Original Form 10-K”).

The Company has evaluated the materiality of the incorrect presentation of its segment-related disclosures in the notes to its consolidated financial statements and has concluded that it did not result in a material misstatement of the Company’s previously issued consolidated financial statements.

In light of the changes to the Company’s operating and reportable segments, the Company has revised, in this Quarterly Report on Form 10-Q, the segment-related disclosures in Note 4: Goodwill and Intangible Assets and Note 15: Segment Information to update the prior period presentation. The effect of this revision has been reflected in all footnotes impacted by this revision.

Recent Accounting Pronouncements

Government Assistance

In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosure by Business Entities about Government Assistance which aims at increasing the transparency of government assistance received by most business entities. The standard requires business entities to make annual disclosures about the nature of the transactions and the related accounting policy used to account for the transactions, the line items and applicable amounts on the balance sheet and income statement that are affected by the transactions, and significant terms and conditions of the transactions, including commitments and contingencies. If an entity omits any required disclosures because it is legally prohibited, it must describe the general nature of the information and indicate that the omitted disclosures are legally prohibited from being disclosed. This ASU is effective for fiscal years beginning after December 15, 2021, which for the Company is in fiscal 2023. The Company will include disclosures for material items with the filing of its Annual Report on Form 10-K for the year ending on September 30, 2023.

Business Combinations

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination in accordance with Topic 606: Revenue from Contracts with Customers. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments with early adoption permitted. We elected for an early adoption of this ASU in fiscal year 2023. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.

8

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

NOTE 2. BALANCE SHEET COMPONENTS

The following tables reflect the components of significant balance sheet accounts as of July 1, 2023 and October 1, 2022:

	As of
(in thousands)	July 1, 2023		October 1, 2022
Short-term investments, available-for-sale (1)	$	310,000	$	220,000
Inventories, net:
Raw materials and supplies	$	127,216	$	118,833
Work in process	71,052		40,114
Finished goods	49,155		45,277
	247,423		204,224
Inventory reserves	(19,432)		(19,238)
	$	227,991	$	184,986
Property, plant and equipment, net:
Land	$	2,182	$	2,182
Buildings and building improvements	22,929		22,783
Leasehold improvements	83,785		32,400
Data processing equipment and software	37,483		38,223
Machinery, equipment, furniture and fixtures	93,192		90,151
Construction in progress	11,910		25,004
	251,481		210,743
Accumulated depreciation	(137,914)		(129,835)
	$	113,567	$	80,908
Accrued expenses and other current liabilities:
Accrued customer obligations (2)	$	52,268	$	58,916
Wages and benefits	31,735		50,279
Dividends payable	10,734		9,743
Commissions and professional fees	3,825		5,019
Accrued leasehold renovations	13,378		—
Severance	—		19
Other	8,566		10,565
	$	120,506	$	134,541

(1)All short-term investments were classified as available-for-sale and the fair value approximates cost basis. The Company did not recognize any realized gains or losses on the sale of investments during the three and nine months ended July 1, 2023 and July 2, 2022.

(2)Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.

9

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

NOTE 3. BUSINESS COMBINATION

Acquisition of Advanced Jet Automation Co., Ltd. (“AJA”)

On September 8, 2022, the Company through one of its subsidiaries, Kulicke and Soffa Luxembourg S.À R.L, entered into a definitive agreement (the “Definitive Agreement”) for the acquisition of Advanced Jet Automation Co., Ltd. (“AJA”), a technology company headquartered in Taiwan. Subsequent to the acquisition, AJA has been renamed to Kulicke and Soffa Hi-Tech Co., Ltd.

On February 22, 2023 (the “Closing Date”), pursuant to the Definitive Agreement, the Company completed its acquisition of AJA, including the material business and assets formerly owned by AJA’s affiliate, Samurai Spirit Inc., a leading developer and manufacturer of high-precision micro-dispensing equipment and solutions in Taiwan. AJA became a wholly-owned subsidiary of the Company and will operate as a business unit (the “dispensing business unit”), deemed a separate operating segment (advanced dispensing) which is reported under the "All Others" category. The acquisition broadens the Company’s existing semiconductor, electronic assembly and advanced display portfolio, increasing opportunities across several exciting growth areas including mini and micro LED, which support both backlighting and direct-emissive approaches.

The purchase price consisted of $38.1 million in cash paid at closing (the “Purchase Price”) and additional potential earn-out payments based on certain revenue and earnings before interest, tax, depreciation and amortization (“EBITDA”) benchmarks established for the dispensing business unit. As at July 1, 2023, the Company held $4.0 million in escrow and will continue to hold such sums for a period of twenty-four (24) months from the Closing Date, as security pending the completion of Ruo Chuan Inc.’s obligations as the seller under the Definitive Agreement.

The Company has estimated the preliminary fair value of acquired assets and liabilities as of the date of acquisition based on current information available. The valuation of these tangible and identifiable intangible assets and liabilities is subject to further management review and may change materially between the preliminary allocation and end of the purchase price allocation period of February 21, 2024. Any changes in these estimates may have a material impact on our Consolidated Condensed Statements of Operations or Consolidated Condensed Balance Sheets.

The acquisition of AJA was accounted for in accordance with ASC No. 805, Business Combinations, using the acquisition method.

The following table summarizes the allocation of the assets acquired and liabilities assumed based on the fair values as of the Closing Date:

(in thousands)	February 22, 2023
Cash and cash equivalents	$	1,238
Account and other receivables, net	1,156
Inventory	1,581
Property, plant and equipment, net	1,462
Right-of-use assets	989
Other assets	127
Goodwill	27,975
Intangible assets	7,768
Accounts and other payables	(965)
Accrued expenses and other liabilities	(251)
Contract liabilities	(187)
Lease liability	(989)
Deferred tax liabilities	(1,785)
Total purchase price	$	38,119

Excluding inventory and property, plant and equipment, all other tangible net assets (liabilities) were valued at their respective carrying amounts, which the Company believes approximate their current fair values at the Closing Date. In connection with the acquisition of AJA, the Company recorded deferred tax liabilities primarily relating to the acquired intangible assets.

10

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired and includes the value of expected future cash flows of AJA from expected synergies with our other affiliates and other unidentifiable intangible assets. None of the goodwill recorded as part of the acquisition will be deductible for income tax purposes.

The following table summarizes the fair value, useful life and valuation methodology of each identifiable intangible asset.

(in thousands)	Fair Value		Useful Lives
Developed technology(1)	$	4,261	8
Customer relationships(2)	2,131		8
In-process research and development (“IPR&D”)(3)	459		N.A.
Patents(3)	524		8
Order Backlog(4)	393		1
Total identifiable intangible assets	$	7,768

(1)The fair value of developed technology was determined using the Relief-from-Royalty Method under the income approach.

(2)Customer relationships represent the fair value of the existing relationships using the Multi-Period Excess Earnings Method under the income approach.

(3)The fair value of IPR&D and Patents were determined using the Replacement Cost Method, a form of the cost approach.

(4)Order backlog represents primarily the fair value of purchase arrangements with customers using the Multi-Period Excess Earnings Method under the income approach.

IPR&D is recorded as an indefinite-lived intangible asset and not amortized, but rather is reviewed for impairment on an annual basis or more frequently if indicators of impairment are present, until the project is completed, abandoned, or transferred to a third party. Developed technology, customer relationships, patents and order backlog are amortized using a straight-line method, representing the Company’s best estimate of the distribution of the economic value of the identifiable intangible assets.

For the three and nine months ended July 1, 2023, the acquired dispensing business unit contributed to a net loss of $0.9 million and $1.3 million respectively.

For the three and nine months ended July 1, 2023, the Company incurred $0.1 million and $0.5 million of expenses related to the acquisition, respectively, which is included within selling, general and administrative expense in the Consolidated Condensed Statements of Operations.

The acquisition did not result in material contributions to revenue and net income in the consolidated financial statements for the three and nine months ended July 1, 2023. Additionally, pro forma financial information is not provided for consolidated revenue and net income as such amounts attributable to AJA were insignificant to the Company’s consolidated financial statements taken as a whole.

NOTE 4. GOODWILL AND INTANGIBLE ASSETS

Goodwill

Intangible assets classified as goodwill are not amortized. The goodwill established in connection with our acquisitions represents the estimated future economic benefits arising from the assets we acquired that did not qualify to be identified and recognized individually. The goodwill also includes the value of expected future cash flows from the acquisitions, expected synergies with our other affiliates and other unidentifiable intangible assets.

The Company performs an annual impairment test of its goodwill during the fourth quarter of each fiscal year, which coincides with the completion of its annual forecasting and refreshing of business outlook process.

The Company performed its annual impairment test in the fourth quarter of fiscal 2022 and concluded that no impairment charge was required. Any future adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment in the future.

In each interim period, the Company reviewed qualitative factors to ascertain if a "triggering" event may have taken place that may have the effect of reducing the fair value of the reporting unit below its carrying value. During the three months ended July 1, 2023, the Company concluded that a triggering event had occurred in connection with the Lithography reporting unit. The triggering event occurred based on the long-term financial and business outlook for the Lithography reporting unit updated as part of the Company’s annual strategic planning process performed during the third quarter. This updated outlook projected that the near-term projected cash flows are expected to be lower than previously forecasted due to a shift in market penetration timeline and increase in cost of materials being purchased. Under ASC 350, the Company is required to test its goodwill and

11

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

other intangible assets for impairment annually or when a triggering event has occurred that would indicate it is more likely than not that the fair value of the reporting unit is less than the carrying value including goodwill and other intangible assets. Accordingly, the Company has performed the goodwill impairment test for the Lithography reporting unit with reference to the guidance under ASC 350.

The Company used a discounted cash flow model to determine the fair value of the Lithography reporting unit. The cash flow projections used within the discounted cash flow model were prepared using the forecasted financial results of the reporting unit, which was based upon underlying estimates of the total market size using independent third party industry reports, and market share data developed using the combination of independent third-party data and our internal data. Significant assumptions used to determine the fair value of the Lithography reporting unit include revenue forecasts, terminal growth rate of 2.5%, working capital, tax rate and a weighted average cost of capital (discount rate) of 11.7%.

In accordance with the guidance under ASC 350, the Company’s impairment test is performed by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount by which the carrying amount of the reporting unit exceeds its fair value. Based on the calculation, the Company determined that the carrying value exceeded the fair value of this reporting unit which resulted in a goodwill impairment charge of $9.8 million, representing the entire goodwill assigned to this reporting unit. This goodwill impairment charge, which is a non-cash charge, has been reflected in the Company’s Consolidated Condensed Statements of Operations for the three and nine months ended July 1, 2023.

While we have concluded that a triggering event for the other reporting units did not occur during the quarter ended July 1, 2023, the persistent macroeconomic headwinds could impact the results of operations due to changes to assumptions utilized in the determination of the estimated fair values of the reporting units that could be significant enough to trigger an impairment.

Net sales and earnings growth rates could be negatively impacted by reductions or changes in demand for our products. The discount rate utilized in our valuation model could also be impacted by changes in the underlying interest rates and risk premiums included in the determination of the cost of capital.

As discussed in Note 1, during the third quarter of fiscal year 2023, the Company reconsidered its reportable segments and has revised the related prior period presentation in its 2022 Annual Report. As a result, its four reportable segments are (1) Ball Bonding Equipment, (2) Wedge Bonding Equipment, (3) Advanced Solutions, and (4) Aftermarket Products and Services (“APS”). All other operating segments that do not meet the quantitative threshold to be disclosed as a separate reportable segment have been grouped within an “All Others” category. Please refer to Note 15 for further information on the revision of the reportable and operating segments.

Accordingly, the Company’s goodwill as previously reported under “Capital Equipment” in prior periods has been disaggregated and presented separately into the Wedge Bonding Equipment reportable segment and the “All Others” category. There are no changes to the goodwill reported under the APS reportable segment. While there were no changes in the methodology and level at which the Company provides its goodwill impairment tests, and no resulting amendments to the total carrying amount of the goodwill, the following table shows the allocation of goodwill based on these revised segments.

The following table summarizes the Company’s recorded goodwill, where applicable, by reportable segments and the “All Others” category (refer to Note 15 for further information) as of July 1, 2023 and October 1, 2022:

(in thousands)	Wedge Bonding Equipment		APS		All Others	Total
Balance at October 1, 2022(1)	$	18,280	$	25,907	23,909	$	68,096
Acquired in business combination	—		—		27,975	$	27,975
Goodwill impairment	—		—		(9,794)	$	(9,794)
Other	—		294		2,720	$	3,014
Balance at July 1, 2023	$	18,280	$	26,201	44,810	$	89,291

(1) Cumulative goodwill impairment pertaining to the “All Others” category as of October 1, 2022 was $35.2 million.

During the quarter ended April 1, 2023, the Company recorded goodwill relating to the acquisition of AJA. For further information on the acquisition of AJA, please refer to Note 3.

12

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

Intangible Assets

Intangible assets with determinable lives are amortized over their estimated useful lives. The Company’s intangible assets consist primarily of developed technology, customer relationships, in-process research and development, and trade and brand names.

In connection with the evaluation of the goodwill impairment in the Lithography reporting unit, the Company assessed tangible and intangible assets for impairment prior to performing the first step of the goodwill impairment test. The Company used a discounted cash flow model to determine the fair value of the asset group for the Lithography reporting unit, where significant assumptions include revenue forecasts, terminal growth rate of 2.5%, working capital, tax rate and a weighted average cost of capital (discount rate) of 11.7%.

As a result of the analysis, the Company determined an impairment charge of $6.9 million on the developed technology reported within the “All Others” category for the three and nine months ended July 1, 2023. The impairment of intangible assets is a non-cash charge which has been reflected in the Company’s Consolidated Condensed Statements of Operations for the three and nine months ended July 1, 2023.

The following table reflects net intangible assets as of July 1, 2023 and October 1, 2022: 

	As of				Average estimated
(dollar amounts in thousands)	July 1, 2023		October 1, 2022		useful lives (in years)
Developed technology	$	99,614	$	89,017	6.0 to 15.0
Accumulated amortization	(65,861)		(58,636)
Impairment charges	$	(6,900)	$	—
Net developed technology	$	26,853	$	30,381
Customer relationships	$	37,259	$	33,515	5.0 to 8.0
Accumulated amortization	(35,217)		(33,515)
Net customer relationships	$	2,042	$	—
In-process research and development	$	459	$	—	N.A
Net in-process research and development	$	459	$	—
Trade and brand name	$	7,212	$	6,945	7.0 to 8.0
Accumulated amortization	(7,212)		(6,945)
Net trade and brand name	—		—
Other intangible assets	$	5,634	$	4,700	1.0 to 8.0
Accumulated amortization	(3,570)		(3,142)
Net other intangible assets	$	2,064	$	1,558
	$	31,418	$	31,939

13

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

The following table reflects estimated annual amortization expense related to intangible assets as of July 1, 2023:

	As of
(in thousands)	July 1, 2023
Remaining fiscal 2023	$	1,378
Fiscal 2024	5,274
Fiscal 2025	5,110
Fiscal 2026	5,110
Fiscal 2027	4,835
Thereafter	9,711
Total amortization expense	$	31,418

NOTE 5. CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS

Cash equivalents consist of instruments with remaining maturities of three months or less at the date of purchase. In general, these investments are free of trading restrictions.

Cash, cash equivalents, and short-term investments consisted of the following as of July 1, 2023:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	31,696	$	—	$	—	$	31,696
Cash equivalents:
Money market funds (1)	215,114		—		(13)		215,101
Time deposits (2)	155,009		—		—		155,009
Total cash and cash equivalents	$	401,819	$	—	$	(13)	$	401,806
Short-term investments:
Time deposits (2)	310,000		—		—		310,000
Total short-term investments	$	310,000	$	—	$	—	$	310,000
Total cash, cash equivalents and short-term investments	$	711,819	$	—	$	(13)	$	711,806

(1)The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2)Fair value approximates cost basis.

Cash, cash equivalents and short-term investments consisted of the following as of October 1, 2022:

14

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	173,402	$	—	$	—	$	173,402
Cash equivalents:
Money market funds (1)	157,145		—		(20)		157,125
Time deposits (2)	225,010		—		—		225,010
Total cash and cash equivalents	$	555,557	$	—	$	(20)	$	555,537
Short-term investments:
Time deposits (2)	220,000		—		—		220,000
Total short-term investments	$	220,000	$	—	$	—	$	220,000
Total cash, cash equivalents and short-term investments	$	775,557	$	—	$	(20)	$	775,537

(1)The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2)Fair value approximates cost basis.

NOTE 6. EQUITY INVESTMENTS

Equity investments consisted of the following as of July 1, 2023 and October 1, 2022:

	As of
(in thousands)	July 1, 2023		October 1, 2022
Non-marketable equity securities	$	433	$	5,397

During the three and nine months ended July 1, 2023, the Company recorded an impairment of $5.0 million on a non-marketable equity security without a readily determinable fair value. The entire amount of the investment in the non-marketable equity security was impaired due to a significant deterioration in the earnings performance of the equity investee. The impairment amount is recorded in the Company’s Consolidated Condensed Statements of Operations.

NOTE 7. FAIR VALUE MEASUREMENTS

Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3).

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis 

We measure certain financial assets and liabilities at fair value on a recurring basis. There were no transfers between fair value measurement levels during the three and nine months ended July 1, 2023.

Fair Value Measurements on a Nonrecurring Basis

Our non-financial assets such as intangible assets and property, plant and equipment are carried at cost unless impairment is deemed to have occurred.

Fair Value of Financial Instruments

Amounts reported as accounts receivables, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value.

15

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

NOTE 8. DERIVATIVE FINANCIAL INSTRUMENTS

The Company’s international operations are exposed to changes in foreign exchange rates due to transactions denominated in currencies other than U.S. dollars. Most of the Company’s revenue and cost of materials are transacted in U.S. dollars. However, a significant amount of the Company’s operating expenses is denominated in local currencies, primarily in Singapore.

The foreign currency exposure of our operating expenses is generally hedged with foreign exchange forward contracts. The Company’s foreign exchange risk management programs include using foreign exchange forward contracts with cash flow hedge accounting designation to hedge exposures to the variability in the U.S. dollar equivalent of forecasted non-U.S. dollar-denominated operating expenses. These instruments generally mature within twelve months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and in the same line item on the Consolidated Condensed Statements of Operations as the impact of the hedged transaction.

The fair value of derivative instruments on our Consolidated Condensed Balance Sheets as of July 1, 2023 and October 1, 2022 were as follows:

	As of
	July 1, 2023				October 1, 2022
(in thousands)	Notional Amount		Fair Value Liability Derivatives(1)		Notional Amount		Fair Value Liability Derivatives(1)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts (2)	$	58,288	$	(500)	$	57,570	$	(2,234)
Total derivatives	$	58,288	$	(500)	$	57,570	$	(2,234)

(1)The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Condensed Balance Sheets.

(2)Hedged amounts expected to be recognized to income within the next twelve months.

The effects of derivative instruments designated as cash flow hedges in our Consolidated Condensed Statements of Comprehensive Income for the three and nine months ended July 1, 2023 and July 2, 2022 were as follows:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Foreign exchange forward contract in cash flow hedging relationships:
Net (loss)/gain recognized in OCI, net of tax (1)	$	(1,280)	$	(1,233)	$	2,550	$	(1,168)
Net gain/(loss) reclassified from accumulated OCI into income, net of tax (2)	$	518	$	(170)	$	816	$	(793)

(1)Net change in the fair value of the effective portion classified in OCI.

(2)Effective portion classified as selling, general and administrative expense.

NOTE 9. LEASES

We have entered into various non-cancellable operating and finance lease agreements for certain of our offices, manufacturing, technology, sales support and service centers, equipment, and vehicles. We determine if an arrangement is a lease, or contains a lease, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor. Our lease terms may include one or more options to extend the lease terms, for periods from one year to 20 years, when it is reasonably certain that we will exercise that option. As of July 1, 2023, there were four options to extend the lease which was recognized as a right-of-use (“ROU”) asset, or a lease liability. We have lease agreements with lease and non-lease components, and non-lease components are accounted for separately and not included in our leased assets and corresponding liabilities. We have elected not to present short-term leases on the Consolidated Condensed Balance Sheets as these leases have a lease term of 12 months or less at lease inception.

16

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

Operating leases are included in operating ROU assets, current operating lease liabilities and non-current operating lease liabilities, and finance leases are included in property, plant and equipment, accrued expenses and other current liabilities, and other liabilities on the Consolidated Condensed Balance Sheets. As of July 1, 2023 and October 1, 2022, our finance leases are not material.

The following table shows the components of lease expense:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Operating lease expense (1)	$	2,846	$	2,173	$	8,119	$	6,217

(1)Operating lease expense includes short-term lease expense, which is immaterial for the three and nine months ended July 1, 2023 and July 2, 2022.

The following table shows the cash flows arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below:

	Nine months ended
(in thousands)	July 1, 2023		July 2, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	6,913	$	5,715

The following table shows the weighted-average lease terms and discount rates for operating leases:

	As of
	July 1, 2023		October 1, 2022
Operating leases:
Weighted-average remaining lease term (in years):	7.7		8.0
Weighted-average discount rate:	6.4	%	5.8	%

Future lease payments, excluding short-term leases are detailed as follows:

	As of
(in thousands)	July 1, 2023
Remaining fiscal 2023	$	2,453
Fiscal 2024	9,088
Fiscal 2025	8,817
Fiscal 2026	8,382
Fiscal 2027	6,462
Thereafter	26,168
Total minimum lease payments	$	61,370
Less: Interest	$	13,411
Present value of lease obligations	$	47,959
Less: Current portion	$	6,569
Long-term portion of lease obligations	$	41,390

17

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

NOTE 10. DEBT AND OTHER OBLIGATIONS

Bank Guarantees

On November 22, 2013, the Company obtained a $5.0 million credit facility with Citibank in connection with the issuance of bank guarantees for operational purposes. As of July 1, 2023, the outstanding amount under this facility was $3.2 million.

Credit Facilities

On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company and one of its subsidiaries with an overdraft facility of up to $150.0 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the Secured Overnight Financing Rate (“SOFR”) plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of two of its subsidiaries (the “Subsidiaries”), or encumber its assets with material security interests (including any pledge of monies in the Subsidiaries' cash deposit account with the Bank). The Facility Agreements also contain typical events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other material indebtedness of the Company and any breach of a representation or warranty under the Facility Agreements. As of July 1, 2023, there were no outstanding amounts under the Overdraft Facility.

NOTE 11. SHAREHOLDERS’ EQUITY AND EMPLOYEE BENEFIT PLANS

401(k) Retirement Income Plans

The Company has a 401(k) retirement plan (the “401(k) Plan”) for eligible U.S. employees. The 401(k) Plan allows for employee contributions and matching Company contributions from 4% to 6% based upon terms and conditions of the 401(k) Plan.

The following table reflects the Company’s contributions to the 401(k) Plan during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Cash	$	463	$	419	$	1,477	$	1,423

Share Repurchase Program

On August 15, 2017, the Company’s Board of Directors authorized a program (the “Program”) to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018, 2019 and 2020, the Board of Directors increased the share repurchase authorization under the Program to $200 million, $300 million, and $400 million, respectively. On March 3, 2022, the Board of Directors further increased the share repurchase authorization under the Program by an additional $400 million to $800 million, and extended its duration through August 1, 2025. On May 7, 2022, the Company entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. This trading plan was most recently modified on May 29, 2023. The Program may be suspended or discontinued at any time and is funded using the Company’s available cash, cash equivalents and short-term investments. Under the Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations.

During the three and nine months ended July 1, 2023, the Company repurchased a total of approximately 174.9 thousand and 1,331.1 thousand shares of common stock under the Program at a cost of approximately $8.5 million and $58.9 million, respectively. The stock repurchases were recorded in the periods they were delivered and accounted for as treasury stock in the Company’s Consolidated Condensed Balance Sheets. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon re-issuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital.

18

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

If the Company reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings.

As of July 1, 2023, our remaining stock repurchase authorization under the Program was approximately $190.2 million.

Dividends

On November 16, 2022, the Board of Directors declared a quarterly dividend of $0.19 per share of common stock. Dividends paid during the three and nine months ended July 1, 2023 totaled $10.8 million and $31.3 million, respectively. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company’s financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company’s shareholders.

Accumulated Other Comprehensive Loss

The following table reflects accumulated other comprehensive loss reflected on the Consolidated Condensed Balance Sheets as of July 1, 2023 and October 1, 2022: 

	As of
(in thousands)	July 1, 2023		October 1, 2022
Loss from foreign currency translation adjustments	$	(16,341)	$	(29,854)
Unrecognized actuarial loss on pension plan, net of tax	(884)		(812)
Unrealized loss on hedging	(500)		(2,234)
Accumulated other comprehensive loss	$	(17,725)	$	(32,900)

Equity-Based Compensation

The Company has a stockholder-approved equity-based compensation plan, the 2021 Omnibus Incentive Plan (the “Plan”) from which employees and directors receive grants. As of July 1, 2023, 2.5 million shares of common stock are available for grant to the Company’s employees and directors under the Plan.

•Relative Total Shareholder Return Performance Share Units (“Relative TSR PSUs”) entitle the employee to receive common stock of the Company on the award vesting date, typically the third anniversary of the grant date (or as soon as administratively practicable if later), if market performance objectives which measure the relative TSR are attained. Relative TSR is calculated based upon the 90-calendar day average price at the end of the performance period of the Company’s stock as compared to specific peer companies that comprise the GICS (45301020) Semiconductor Index. TSR is measured for the Company and each peer company over a performance period, which is generally three years. Vesting percentages range from 0% to 200% of awards granted. The provisions of the Relative TSR PSUs are reflected in the grant date fair value of the award; therefore, compensation expense is recognized regardless of whether the market condition is ultimately satisfied. Compensation expense is reversed if the award is forfeited prior to the vesting date.

•Revenue Growth Performance Share Units (“Growth PSUs”) entitle the employee to receive common stock of the Company on the award vesting date, typically the third anniversary of the grant date (or as soon as administratively practicable if later), based on organic revenue growth objectives and relative growth performance against named competitors as set by the Management Development and Compensation Committee (“MDCC”) of the Company’s Board of Directors. Organic revenue growth is calculated by averaging revenue growth (net of revenues from acquisitions) over a performance period, which is generally three years. Revenues from acquisitions will be included in the calculation after four fiscal quarters after acquisition. Any portion of the grant that does not meet the revenue growth objectives and relative growth performance is forfeited. Vesting percentages range from 0% to 200% of awards granted.

•In general, Time-based Restricted Share Units (“Time-based RSUs”) awarded to employees vest ratably over a three-year period on the anniversary of the grant date provided the employee remains employed by the Company.

Equity-based compensation expense recognized in the Consolidated Condensed Statements of Operations for the three and nine months ended July 1, 2023 and July 2, 2022 was based upon awards ultimately expected to vest, with forfeiture accounted for when they occur.

19

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

The following table reflects Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock granted during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended		Nine months ended
(shares in thousands)	July 1, 2023	July 2, 2022	July 1, 2023	July 2, 2022
Time-based RSUs	—	1	512	303
Relative TSR PSUs	—	—	186	154
Growth PSUs	—	—	92	77
Common stock	5	4	17	12
Equity-based compensation in shares	5	5	807	546

The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Cost of sales	$	272	$	193	$	903	$	727
Selling, general and administrative	3,800		3,233		12,398		10,485
Research and development	1,331		1,039		4,002		3,261
Total equity-based compensation expense	$	5,403	$	4,465	$	17,303	$	14,473

The following table reflects equity-based compensation expense, by type of award, for the three and nine months ended July 1, 2023 and July 2, 2022:  

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Time-based RSUs	$	3,560	$	2,845	$	10,758	$	8,763
Relative TSR PSUs	1,252		1,073		3,697		3,060
Growth PSUs	354		310		2,137		1,938
Common stock	237		237		711		712
Total equity-based compensation expense	$	5,403	$	4,465	$	17,303	$	14,473

NOTE 12. REVENUE AND CONTRACT BALANCES

The Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay. Service revenue is generally recognized over time as the services are performed. For the three and nine months ended July 1, 2023, and July 2, 2022, the service revenue was not material.

The Company reports revenue based on its reportable segments. The Company believes that reporting revenue on this basis provides information about how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Please refer to Note 15: Segment Information, for disclosure of revenue by segment.

Contract Balances

Our contract assets relate to our rights to consideration for revenue with collection dependent on events other than the passage of time, such as the achievement of specified payment milestones. The contract assets will be transferred to net account receivables as our right to consideration for these contract assets become unconditional. Contracts assets are reported in the accompanying Consolidated Condensed Balance Sheets within prepaid expenses and other current assets.

Our contract liabilities are primarily related to payments received in advance of satisfying performance obligations, and are reported in the accompanying Consolidated Condensed Balance Sheets within accrued expenses and other current liabilities.

20

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

Contract liabilities increase as a result of receiving new advance payments from customers and decrease as revenue is recognized from product sales under advance payment arrangements upon satisfying the performance obligations.

The following table shows the changes in contract asset balances during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Contract assets, beginning of period	$	29,210	$	26,721	$	26,317	$	—
Additions	1,337		18,563		4,230		45,284
Transferred to accounts receivable or collected	(20,365)		—		(20,365)		—
Contract assets, end of period	$	10,182	$	45,284	$	10,182	$	45,284

The following table shows the changes in contract liability balances during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Contract liabilities, beginning of period	$	6,556	$	17,300	$	3,160	$	15,596
Revenue recognized	(12,404)		(29,612)		(28,950)		(104,796)
Additions	11,832		17,996		31,774		94,884
Contract liabilities, end of period	$	5,984	$	5,684	$	5,984	$	5,684

NOTE 13. EARNINGS PER SHARE

Basic income per share is calculated using the weighted average number of shares of common stock outstanding during the period. Restricted stock are included in the calculation of diluted earnings per share, except when their effect would be anti-dilutive.

The following table reflects a reconciliation of the shares used in the basic and diluted net income per share computation for the three and nine months ended July 1, 2023 and July 2, 2022:

21

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

	Three months ended
(in thousands, except per share data)	July 1, 2023				July 2, 2022
	Basic		Diluted		Basic		Diluted
NUMERATOR:
Net income	$	4,161	$	4,161	$	119,034	$	119,034
DENOMINATOR:
Weighted average shares outstanding - Basic	56,553		56,553		58,985		58,985
Dilutive effect of Equity Plans			966				970
Weighted average shares outstanding - Diluted			57,519				59,955
EPS:
Net income per share - Basic	$	0.07	$	0.07	$	2.02	$	2.02
Effect of dilutive shares			—				(0.03)
Net income per share - Diluted			$	0.07			$	1.99
Anti-dilutive shares(1)			0				19

	Nine months ended
(in thousands, except per share data)	July 1, 2023				July 2, 2022
	Basic		Diluted		Basic		Diluted
NUMERATOR:
Net income	$	33,791	$	33,791	$	368,641	$	368,641
DENOMINATOR:
Weighted average shares outstanding - Basic	56,763		56,763		60,951		60,951
Dilutive effect of Equity Plans			921				989
Weighted average shares outstanding - Diluted			57,684				61,940
EPS:
Net income per share - Basic	$	0.60	$	0.60	$	6.05	$	6.05
Effect of dilutive shares			(0.01)				(0.10)
Net income per share - Diluted			$	0.59			$	5.95
Anti-dilutive shares(1)			1				1

(1) Represents the Relative TSR PSUs and Growth PSUs that are excluded from the calculation of diluted earnings per share for the three and nine months ended July 1, 2023 and July 2, 2022 as the effect would have been anti-dilutive.

NOTE 14. INCOME TAXES

The following table reflects the provision for income taxes and the effective tax rate for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended						Nine months ended
(dollar amounts in thousands)	July 1, 2023			July 2, 2022			July 1, 2023			July 2, 2022
Provision for income taxes	$	148		$	5,165		$	9,462		$	36,813
Effective tax rate	3.4		%	4.2		%	21.9		%	9.1		%

22

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

For the three months ended July 1, 2023, the decrease in provision for income taxes as compared to the prior year period was primarily due to a decrease in profitability and the decrease in effective tax rate was primarily related to tax benefits from the reversal of uncertain tax positions partially offset by the increase in global intangible low-taxed income (“GILTI”) resulting from the capitalization of research and development expenditures as mandated by the U.S. Tax Cuts and Jobs Act of 2017. For the three months ended July 1, 2023, the effective tax rate is lower than the U.S. federal statutory tax rate primarily due to foreign income earned in lower tax jurisdictions, tax incentives, tax credits, and tax benefits from the reversal of uncertain tax positions, partially offset by GILTI.

For the nine months ended July 1, 2023, the decrease in provision for income taxes as compared to the prior year period was primarily due to a decrease in profitability and the increase in effective tax rate was primarily related to the increase in GILTI resulting from the capitalization of research and development expenditures as mandated by the U.S. Tax Cuts and Jobs Act of 2017, partially offset by tax benefits from the reversal of uncertain tax positions. For the nine months ended July 1, 2023, the effective tax rate is higher than the U.S. federal statutory tax rate primarily due to GILTI, partially offset by foreign income earned in lower tax jurisdictions, tax incentives, tax credits, and tax benefits from the reversal of uncertain tax positions.

NOTE 15. SEGMENT INFORMATION

Reportable segments are defined as components of an enterprise that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker (the “CODM”) in deciding how to allocate resources and assess performance. The Company’s Chief Executive Officer is the CODM. The CODM does not review discrete asset information.

As discussed in Note 1, during the third quarter of fiscal year 2023, the Company reconsidered the guidance under ASC 280, Segment Reporting, and determined that certain prior period conclusions about the Company’s operating and reportable segments were erroneous. As a result, the Company had incorrectly presented certain segment-related disclosures in the notes to our previously issued consolidated financial statements.

The Company has revised the prior period presentation to reflect its four reportable segments as follows: (1) Ball Bonding Equipment, (2) Wedge Bonding Equipment, (3) Advanced Solutions, and (4) Aftermarket Products and Services (“APS”). The four reportable segments are disclosed below:

Ball Bonding Equipment: Reflects the results of the Company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment.

Wedge Bonding Equipment: Reflects the results of the Company from the design, development, manufacture and sale of wedge bonding equipment.

Advanced Solutions: Reflects the results of the Company from the design, development, manufacture and sale of certain advanced display, die-attach and thermocompression systems and solutions.

APS: Reflects the results of the Company from the design, development, manufacture and sale of a variety of tools, spares and services for our equipment.

Any other operating segments that have not been aggregated within the reportable segments described above which do not meet the quantitative threshold to be disclosed as a separate reportable segment have been grouped within an “All Others” category. This group is reflective of the results of the Company from the design, development, manufacture and sale of certain advanced display, advanced dispense, electronics assembly, die-attach and lithography systems and solutions. Results for the “All Others” category and other corporate expenses are included as a reconciling item between the Company’s reportable segments and its consolidated results of operations.

23

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

The following table reflects operating information by segment for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Net revenue:
Ball Bonding Equipment	$	76,865	$	217,912	$	184,049	$	751,496
Wedge Bonding Equipment	42,563		50,800		145,805		142,284
Advanced Solutions	23,858		34,614		58,997		71,651
APS	39,672		50,191		119,822		152,924
All Others	7,959		18,620		31,498		98,952
Net revenue	190,917		372,137		540,171		1,217,307
Income/(loss) from operations:
Ball Bonding Equipment	18,534		93,863		49,337		323,884
Wedge Bonding Equipment	15,974		19,443		$	53,958	$	49,599
Advanced Solutions	(2,570)		3,134		$	(21,160)	$	(7,574)
APS	11,510		22,282		34,778		64,651
All Others	(23,857)		2,671		(35,025)		28,372
Corporate Expenses	(24,079)		(19,316)		(61,925)		(56,404)
(Loss)/Income from operations	$	(4,488)	$	122,077	$	19,963	$	402,528

We have considered: (1) information that is regularly reviewed by our CODM in evaluating financial performance and how to allocate resources; and (2) other financial data, including information that we include in our earnings releases but which is not included in our financial statements, to disaggregate revenues by end markets served. The principal category we use to disaggregate revenues is by the end markets served.

The following table reflects net revenue by end markets served for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
General Semiconductor	$	77,745	$	223,034	$	217,186	$	670,251
Automotive & Industrial	44,973		51,018		149,608		160,366
LED	17,678		20,203		32,765		128,394
Memory	10,849		27,691		20,790		105,372
APS	39,672		50,191		119,822		152,924
Total revenue	$	190,917	$	372,137	$	540,171	$	1,217,307

24

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

The following table reflects capital expenditures, depreciation expense and amortization expense for the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Capital expenditures:
Ball Bonding Equipment	$	316	$	179	$	805	$	855
Wedge Bonding Equipment	83		358		403		780
Advanced Solutions	6,439		1,049		29,425		2,423
APS	1,251		1,151		4,443		2,851
All Others	30		437		279		700
Corporate Expenses	2,332		1,779		8,130		3,604
	$	10,451	$	4,953	$	43,485	$	11,213
Depreciation expense:
Ball Bonding Equipment	$	388	$	346	$	1,173	$	1,012
Wedge Bonding Equipment	304		252		878		732
Advanced Solutions	2,989		519		4,821		1,494
APS	1,517		1,681		4,742		4,971
All Others	416		250		1,017		792
Corporate Expenses	1,191		1,053		3,372		3,229
	$	6,805	$	4,101	$	16,003	$	12,230
Amortization expense:
Ball Bonding Equipment	$	—	$	—	$	—	$	—
Wedge Bonding Equipment	—		—		—		—
Advanced Solutions	—		—		—		—
APS	380		208		1,116		684
All Others	1,314		809		3,352		2,584
Corporate Expenses	92		92		275		275
	$	1,786	$	1,109	$	4,743	$	3,543

NOTE 16. COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS

Warranty Expense

The Company’s equipment is generally shipped with a one-year warranty against manufacturing defects. The Company establishes reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management’s estimate of future warranty costs, including product part replacement, freight charges and related labor costs expected to be incurred in correcting manufacturing defects during the warranty period.

25

KULICKE AND SOFFA INDUSTRIES, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

Unaudited (continued)

The following table reflects the reserve for warranty activity for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Reserve for warranty, beginning of period	$	10,468	$	15,518	$	13,443	$	16,961
Provision for warranty	4,007		2,842		8,989		9,001
Utilization of reserve	(3,908)		(4,118)		(11,865)		(11,720)
Reserve for warranty, end of period	$	10,567	$	14,242	$	10,567	$	14,242

Other Commitments and Contingencies

The following table reflects obligations not reflected on the Consolidated Condensed Balance Sheets as of July 1, 2023:

			Payments due by fiscal year
(in thousands)	Total		2023		2024		2025		2026		2027		thereafter
Inventory purchase obligation (1)	$	198,566	$	21,676	$	176,890	$	—	$	—	$	—	$	—

(1)The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancelable and a portion may have varying penalties and charges in the event of cancellation.

From time to time, the Company is party to or the target of lawsuits, claims, investigations and proceedings, including for personal injury, intellectual property, commercial, contract, and employment matters, which are handled and defended in the ordinary course of business. The Company accrues a contingent loss liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When a single amount cannot be reasonably estimated but the cost can be estimated within a range, the Company accrues the minimum amount. The Company expenses legal costs, including those expected to be incurred in connection with a loss contingency, as incurred.

Unfunded Capital Commitments

As of July 1, 2023, the Company also has an obligation to fund uncalled capital commitments of approximately $9.6 million, as and when required, in relation to its investment in a private equity fund.

Concentrations

The following table reflects significant customer concentrations as a percentage of net revenue for the nine months ended July 1, 2023 and July 2, 2022:

	Nine months ended
	July 1, 2023		July 2, 2022
First Technology China Ltd.(1)	10.0	%	*

* Represents less than 10% of total net revenue

(1) Distributor of the Company's products

The following table reflects significant customer concentrations as a percentage of total accounts receivable as of July 1, 2023 and July 2, 2022:

	As of
	July 1, 2023		July 2, 2022
Intel Corporation	12.2	%	*
Apple Inc.	10.3	%	*
Tianshui Huatian Technology Co., Ltd.	*		20.6	%

* Represents less than 10% of total accounts receivable

26

Table of Contents

Item 2. - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

In addition to historical information, this filing contains statements relating to future events or our future results. These statements are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the safe harbor provisions created by statute. Such forward-looking statements include, but are not limited to, statements with respect to our future revenue increasing, continuing or strengthening, or decreasing or weakening; our capital allocation strategies, including any share repurchases; demand for our products, including replacement demand; our research and development effort; our ability to identify and realize new growth opportunities; our ability to control costs; and our operational flexibility as a result of (among other factors):

•our expectations regarding the potential impacts on our business of actual or potential inflationary pressures, interest rate and risk premium adjustments, falling consumer sentiment, or economic recession caused, directly or indirectly, by the prolonged Ukraine/Russia conflict, geopolitical tensions and other macroeconomic factors;

•our expectations regarding the potential impacts on our business of the broader supply chain disruptions caused, directly or indirectly, by geopolitical tensions, catastrophic events resulting from climate change and other macroeconomic factors;

•our expectations regarding our effective tax rate and our unrecognized tax benefit;

•our ability to operate our business in accordance with our business plan;

•our ability to adequately protect our trade secrets and intellectual property rights from misappropriation;

•our expectations regarding our success in integrating companies we may acquire with our business, and our ability to continue to acquire or divest companies;

•risks inherent in doing business on an international level, including currency risks, regulatory requirements, systems and cybersecurity risks, political risks, export restrictions and other trade barriers;

•projected growth rates in the overall semiconductor industry, the semiconductor assembly equipment market, and the market for semiconductor packaging materials; and

•projected demand for our products and services.

Generally, words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” “goal” and “believe,” or the negative of or other variations on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this filing. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Forward-looking statements are based on current expectations and involve risks and uncertainties. Our future results could differ significantly from those expressed or implied by our forward-looking statements. These risks and uncertainties include, without limitation, those described below and in our Annual Report on Form 10-K/A for the fiscal year ended October 1, 2022 (our “2022 Annual Report”) and our other reports filed from time to time with the Securities and Exchange Commission. This discussion should be read in conjunction with the Consolidated Condensed Financial Statements and Notes included in this report, as well as our audited financial statements included in our Annual Report.

We operate in a rapidly changing and competitive environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. Given those risks and uncertainties, investors should not place undue reliance on forward-looking statements as predictions of actual results.

27

Table of Contents

OVERVIEW

Founded in 1951, Kulicke and Soffa Industries, Inc. (“we,” “us,” “our,” or the “Company”) specializes in developing cutting-edge semiconductor and electronics assembly solutions enabling a smarter and more sustainable future. Our ever-growing range of products and services supports growth and facilitates technology transitions across large-scale markets, such as advanced display, automotive, communications, compute, consumer, data storage, energy storage and industrial.

We design, develop, manufacture and sell capital equipment, consumables and services used to assemble semiconductor and electronic devices, such as integrated circuits, power discretes, light-emitting diode (“LEDs”), advanced displays and sensors. We also service, maintain, repair and upgrade our equipment and sell consumable aftermarket solutions and services for our and our peer companies’ equipment. Our customers primarily consist of integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), foundry service providers, and other electronics manufacturers and automotive electronics suppliers.

Our goal is to be the technology leader and the most competitive supplier in terms of cost and performance in each of our major product lines. Accordingly, we invest in research and engineering projects intended to expand our market access and enhance our leadership position in semiconductor, electronics and display assembly. We also remain focused on enhancing our value to customers through higher productivity systems, more autonomous capabilities and also through continuous improvement and optimization of our operational costs. Delivering new levels of value to our customers is a critically important goal for the Company.

As discussed in Note 1, during the third quarter of fiscal year 2023, the Company reconsidered its reportable segments and has revised the segment-related prior period presentation in its 2022 Annual Report. As a result, its four reportable segments are (1) Ball Bonding Equipment, (2) Wedge Bonding Equipment, (3) Advanced Solutions, and (4) Aftermarket Products and Services (“APS”). We have aggregated seven operating segments as of July 1, 2023, with one operating segment within the Ball Bonding Equipment reportable segment, Wedge Bonding Equipment reportable segment, Advanced Solutions reportable segment and APS reportable segment respectively, and the remaining three operating segments grouped within the “All Others” category.

Our Ball Bonding Equipment, Wedge Bonding Equipment and Advanced Solutions reportable segments engages in the design, development, manufacture and sale of ball bonding equipment, wafer level bonding equipment, wedge bonding equipment, certain advanced display, die-attach and thermocompression systems and solutions to IDMs, OSATs, foundry service providers, and other electronics manufacturers and automotive electronics suppliers.

Our APS segment engages in the design, development, manufacture and sale of a variety of tools, spares and services for our equipment. For example, we manufacture capillaries, blades, wedge bonder consumables and other spare parts which complements our equipment and to support a broader range of semiconductor packaging applications. We also provide equipment repair, post-sale support, maintenance and servicing, training services, refurbishment and upgrades for our equipment.

All other operating segments that do not meet the quantitative threshold to be disclosed as a separate reportable segment have been grouped within an “All Others” category. This group is reflective of the results of the Company from the design, development, manufacture and sale of certain advanced display, advanced dispense, electronics assembly, die-attach and lithography systems and solutions. Please refer to Note 15: Segment Information for further information on the revision of the reportable and operating segments.

Business Environment

The semiconductor business environment is highly volatile and is driven by internal dynamics, both cyclical and seasonal, in addition to macroeconomic forces. Over the long term, semiconductor consumption has historically grown, and is forecasted to continue to grow. This growth is driven, in part, by regular advances in device performance and by price declines that result from improvements in manufacturing technology. In order to exploit these trends, semiconductor manufacturers, both IDMs and OSATs, periodically invest aggressively in latest generation capital equipment. This buying pattern often leads to periods of excess supply and reduced capital spending—the so-called semiconductor cycle. Within this broad semiconductor cycle there are also, generally weaker, seasonal effects that are specifically tied to annual, end-consumer purchasing patterns. Typically, semiconductor manufacturers prepare for heightened demand by adding or replacing equipment capacity by the end of the September quarter. Occasionally, this results in subsequent reductions in demand during the December quarter. This annual seasonality can be overshadowed by effects of the broader semiconductor cycle. Macroeconomic factors also affect the industry, primarily through their effect on business and consumer demand for electronic devices, as well as other products that

28

Table of Contents

have significant electronic content such as automobiles, white goods, and telecommunication equipment. There can be no assurances regarding levels of demand for our products and we believe historic industry-wide volatility will persist.

Our Ball Bonding Equipment, Wedge Bonding Equipment and Advanced Solutions reportable segments, and the remaining operating segments in the “All Others” category are primarily affected by the industry’s internal cyclical and seasonal dynamics in addition to broader macroeconomic factors that can positively or negatively affect our financial performance. The sales mix of IDM and OSAT customers, as well as our end market mix, in any period also impacts our financial results. Different customer types and end markets can affect our products’ average selling prices and gross margins due to differences in features, capabilities, order size, and machine configurations.

Our APS reportable segment has historically been less volatile than other reportable segments. APS sales are more directly tied to semiconductor unit consumption rather than incremental capacity requirements and/or production capability improvements. 

From time to time, our customers may request that we deliver our products to countries where they own or operate production facilities or to countries where they utilize third-party subcontractors or warehouses as part of their supply chain. For example, customers headquartered in the U.S. may require us to deliver our products to their back-end production facilities in China. Our customer base in the Asia/Pacific region has become more geographically concentrated over time as a result of general economic and industry conditions and trends. Approximately 89.7% and 90.9% of our net revenue for the three months ended July 1, 2023 and July 2, 2022, respectively, were for shipments to customer locations outside of the U.S., primarily in the Asia/Pacific region. Approximately 46.8% and 36.1% of our net revenue for the three months ended July 1, 2023 and July 2, 2022, respectively, were for shipments to customers headquartered in China.

Similarly, approximately 90.4% and 94.4% of our net revenue for the nine months ended July 1, 2023 and July 2, 2022, respectively, were for shipments to customer locations outside of the U.S., primarily in the Asia/Pacific region. Approximately 37.6% and 46.7% of our net revenue for the nine months ended July 1, 2023 and July 2, 2022, respectively, were for shipments to customers headquartered in China.

While our customers are impacted by the current global macroeconomic conditions, those with operations in China, an important manufacturing and supply chain hub, have witnessed a faster decline in demand and, accordingly, a faster decline in product shipments, compared to the rest of the world. The shipments to customers headquartered in China are subject to heightened risks and uncertainties related to the respective policies of the governments of China and the U.S. Furthermore, there is a potential risk of conflict and instability in the relationship between Taiwan and China that could disrupt the operations of our customers and/or suppliers in both Taiwan and China and our manufacturing operations in Taiwan and China.

The U.S. and several other countries have levied tariffs on certain goods and have introduced other trade restrictions resulting in substantial uncertainties in the semiconductor, LED, memory and automotive markets.

We continue to position our business to leverage our research and development leadership and innovation and to focus our efforts on mitigating volatility, improving profitability and ensuring longer-term growth. We remain focused on operational excellence, expanding our product offerings through continuous research and development or acquisitions and managing our business efficiently throughout the business cycles. However, our visibility into future demand is generally limited, and we generally experience typical industry seasonality.

To limit potential adverse cyclical, seasonal and macroeconomic effects on our financial position, we have continued our efforts to maintain a strong balance sheet. As of July 1, 2023, our total cash, cash equivalents and short-term investments were $711.8 million, a $63.7 million decrease from the prior fiscal year end. We believe our strong cash position allows us to continue investing in product development, pursuing non-organic opportunities and returning capital to investors through our share repurchase and dividend programs.

29

Table of Contents

Key Events in Fiscal 2023 to Date

Business Combinations

As part of our corporate strategy, we continually evaluate our portfolio of businesses and may decide to buy or sell businesses or enter into joint ventures or other strategic alliances. On February 22, 2023, we completed the acquisition of Advanced Jet Automation Co., Ltd. (“AJA”), including the material business and assets formerly owned by its affiliate, Samurai Spirit Inc., a leading developer and manufacturer of high-precision micro-dispensing equipment and solutions in Taiwan. The purchase price consisted of $38.1 million in cash paid at closing, of which $4.0 million from the purchase price will be held by us in escrow. This acquisition broadens our existing semiconductor, electronic assembly and advanced display portfolio, increasing opportunities across several exciting growth areas including mini and micro LED, which support both backlighting and direct-emissive approaches. As of February 22, 2023, AJA became our wholly-owned subsidiary. Further as of March 30, 2023, AJA was renamed Kulicke and Soffa Hi-Tech Co., Ltd. (“K&S Hi-Tech”). As part of management’s reassessment of its operating and reportable segments, the newly acquired business of K&S Hi-Tech is deemed a separate operating segment (advanced dispensing) under the “All Others” category.

Macroeconomic Headwinds

Supply chain disruptions and global shortages in electronic components are generally abating in many jurisdictions. However, the cost of logistics remains high as a result of macroeconomic conditions, and labor shortages persist across layers of the supply chain. Additionally, management is continuing to monitor the prolonged Ukraine/Russia conflict, especially regarding the availability and cost of raw materials that are produced in Europe in general. Management is also monitoring for signs of any expansion of economic or supply chain disruptions or broader supply chain inflationary costs resulting either directly or indirectly from the crisis in Eastern Europe.

During fiscal years 2021 and 2022, semiconductor suppliers rapidly increased production output in response to increases in end-consumer demand. Concerns surrounding supply availability spurred defensive inventory purchases, which led to a heightened demand for our products.

The current macroeconomic conditions and declining consumer sentiment have resulted in significant inventory buildup in the semiconductor industry. Many of our consumers who accumulated our products in the past two years are reducing their order rates as a result of inventory adjustment and shorter lead times. The general reduction in demand within the semiconductor industry may also result in the instability of our key suppliers, as they struggle with oversupply and the rising cost of business.

Due to general inflationary pressures, declining consumer sentiment, and an economic downturn caused, directly or indirectly, by various macroeconomic factors, including the prolonged Ukraine/Russia conflict, the sector is seeing short-term volatility and disruption. However, we believe that the semiconductor industry macroeconomics have not changed and we anticipate that the industry’s long-term growth projections will normalize.

The prolonged Ukraine/Russia conflict has no material impact on our financial condition and operating results in fiscal 2023 to date. We believe that our existing cash, cash equivalents, short-term investments, existing Facility Agreements, and anticipated cash flows from operations will be sufficient to meet our liquidity and capital requirements, notwithstanding the prolonged Ukraine/Russia conflict and other macroeconomic factors, for at least the next twelve months from the date of filing. However, this is a highly dynamic situation. As the macroeconomic situation remains highly volatile and the geopolitical situation remains uncertain, there is uncertainty surrounding the operations of our manufacturing locations, our business, our expectations regarding future demand or supply conditions, our near- and long-term liquidity and our financial condition. Consequentially, our operating results could deteriorate.

For a description of the risks to our business arising from or relating to the general macroeconomic conditions, please see Part I, Item 1A, “Risk Factors” of our 2022 Annual Report.

30

Table of Contents

RESULTS OF OPERATIONS

As discussed in Note 1: Basis of Presentation of the Notes to the Consolidated Condensed Financial Statements, the segment-related information within Management's Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended July 2, 2022 has been revised to correct certain erroneous conclusions about the Company’s operating and reportable segments during prior periods. Accordingly, the following discussion and related tables on Net Revenue, Gross Profit Margin and Income/(Loss) from Operations will reflect the four reportable segments of (1) Ball Bonding Equipment, (2) Wedge Bonding Equipment, (3) Advanced Solutions, and (4) Aftermarket Product and Services (“APS”) and a separate “All Others” category.

The following tables reflect our (loss)/income from operations for the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended
(dollar amounts in thousands)	July 1, 2023		July 2, 2022		$ Change		% Change
Net revenue	$	190,917	$	372,137	$	(181,220)	(48.7)	%
Cost of sales	100,899		181,452		(80,553)		(44.4)	%
Gross profit	90,018		190,685		(100,667)		(52.8)	%
Selling, general and administrative	36,393		33,216		3,177		9.6	%
Research and development	36,578		34,046		2,532		7.4	%
Impairment charges	21,535		1,346		20,189		1,499.9	%
Operating expenses	94,506		68,608		25,898		37.7	%
(Loss)/income from operations	$	(4,488)	$	122,077	$	(126,565)	(103.7)	%

	Nine months ended
(dollar amounts in thousands)	July 1, 2023		July 2, 2022		$ Change		% Change
Net revenue	$	540,171	$	1,217,307	$	(677,136)	(55.6)	%
Cost of sales	277,355		601,674		(324,319)		(53.9)	%
Gross profit	262,816		615,633		(352,817)		(57.3)	%
Selling, general and administrative	114,233		107,263		6,970		6.5	%
Research and development	107,085		104,496		2,589		2.5	%
Impairment charges	21,535		1,346		20,189		1,499.9	%
Operating expenses	242,853		213,105		29,748		14.0	%
Income from operations	$	19,963	$	402,528	$	(382,565)	(95.0)	%

Net Revenue

Our net revenue for the three and nine months ended July 1, 2023 decreased as compared to our net revenue for the three and nine months ended July 2, 2022. The decrease in net revenue is primarily due to lower volume in Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, APS and All Others, as further outlined in the following tables presented immediately below.

31

Table of Contents

The following tables reflect net revenue for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended
(dollar amounts in thousands)	July 1, 2023				July 2, 2022				$ Change		% Change
	Net Revenue		% of total net revenue		Net Revenue		% of total net revenue
Ball Bonding Equipment	$	76,865	40.3	%	$	217,912	58.6	%	$	(141,047)	(64.7)	%
Wedge Bonding Equipment	42,563		22.3	%	50,800		13.7	%	$	(8,237)	(16.2)	%
Advanced Solutions	23,858		12.5	%	34,614		9.3	%	$	(10,756)	(31.1)	%
APS	39,672		20.8	%	50,191		13.5	%	(10,519)		(21.0)	%
All Others	7,959		4.1	%	18,620		4.9	%	(10,661)		(57.3)	%
Total net revenue	$	190,917	100.0	%	$	372,137	100.0	%	$	(181,220)	(48.7)	%

	Nine months ended
(dollar amounts in thousands)	July 1, 2023				July 2, 2022				$ Change		% Change
	Net Revenue		% of total net revenue		Net Revenue		% of total net revenue
Ball Bonding Equipment	$	184,049	34.1	%	$	751,496	61.7	%	$	(567,447)	(75.5)	%
Wedge Bonding Equipment	145,805		27.0	%	142,284		11.7	%	$	3,521	2.5	%
Advanced Solutions	58,997		10.9	%	71,651		5.9	%	$	(12,654)	(17.7)	%
APS	119,822		22.2	%	152,924		12.6	%	$	(33,102)	(21.6)	%
All Others	31,498		5.8	%	98,952		8.1	%	$	(67,454)	(68.2)	%
Total net revenue	$	540,171	100.0	%	$	1,217,307	100.0	%	$	(677,136)	(55.6)	%

Ball Bonding Equipment

For the three and nine months ended July 1, 2023, the decrease in Ball Bonding Equipment net revenue as compared to the prior year period was primarily due to lower volume of customer purchases primarily in the general semiconductor and memory markets. The lower volume in these end markets was a result of uncertainties in the overall macroeconomic environment, leading to a decline in consumer and industrial purchases. This was exacerbated by high semiconductor supply chain inventory levels, which contributed to a low utilization of our equipment by our customers, resulting in less demand for our products.

Wedge Bonding Equipment

For the three months ended July 1, 2023, the decrease in Wedge Bonding Equipment net revenue as compared to the prior year period was primarily due to lower volume of customer purchases primarily in the general semiconductor markets due to lower demand for Power Discrete devices.

For the nine months ended July 1, 2023, the increase in Wedge Bonding Equipment net revenue as compared to the prior year period was primarily due to higher volume of customer purchases primarily in the automotive and renewable energy market, which was partially offset by the lower demand in the general semiconductor market.

Advanced Solutions

For the three months and nine months ended July 1, 2023, the decrease in Advanced Solutions net revenue as compared to the prior year period was primarily due to the timing of revenue recognition for certain customer contracts.

APS

For the three and nine months ended July 1, 2023, the decrease in APS net revenue as compared to the prior year period was due to lower volume of customer purchases primarily in spares, services, and bonding tools. The lower volume was also due to a low utilization of our equipment resulting from the decline in consumer and industrial purchases and high semiconductor supply chain inventory levels, primarily in the general semiconductor end market, by an estimated 10% compared to the prior period.

32

Table of Contents

All Others

For the three and nine months ended July 1, 2023, the decrease in net revenue in the “All Others” category as compared to the prior year period was primarily due to the lower volume of customer purchases in the general semiconductor market and mini LED transfer solutions. The lower volume was a result of uncertainties in the overall macroeconomic environment, leading to a decline in consumer purchases.

Gross Profit Margin

The following tables reflect gross profit margin as a percentage of net revenue by reportable segments for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Basis Point
	July 1, 2023		July 2, 2022		Change
Ball Bonding Equipment	40.5	%	50.1	%	(960)
Wedge Bonding Equipment	54.8	%	51.0	%	380
Advanced Solutions	47.1	%	44.0	%	310
APS	54.3	%	60.8	%	(650)
All Others	34.4	%	53.2	%	(1,880)
Total gross profit margin	47.2	%	51.2	%	(400)

	Nine months ended				Basis Point
	July 1, 2023		July 2, 2022		Change
Ball Bonding Equipment	46.6	%	49.4	%	(280)
Wedge Bonding Equipment	51.6	%	48.6	%	300
Advanced Solutions	37.5	%	38.4	%	(90)
APS	55.7	%	60.8	%	(510)
All Others	40.8	%	55.5	%	(1,470)
Total gross profit margin	48.7	%	50.6	%	(190)

Ball Bonding Equipment

For the three and nine months ended July 1, 2023, the decrease in Ball Bonding Equipment gross profit margin as compared to the prior year period was primarily driven by lower volume of customer purchases resulting from uncertainties in the overall macroeconomic environment, high semiconductor supply chain inventory levels and less favorable product mix (lower sales of higher margin products).

Wedge Bonding Equipment

For the three and nine months ended July 1, 2023, the increase in Wedge Bonding Equipment gross profit margin as compared to the prior year period was primarily driven by favorable product mix (higher sales of higher margin products).

Advanced Solutions

For the three months ended July 1, 2023, the increase in Advanced Solutions gross profit margin as compared to the prior year period was primarily driven by favorable product mix (higher sales of higher margin products).

APS

For the three and nine months ended July 1, 2023, the decrease in APS gross profit margin as compared to the prior year period was primarily driven by less favorable product mix among the spares, services and bonding tools, and lower average selling prices of bonding tools.

All others

For the three and nine months ended July 1, 2023, the decrease in gross profit margin for the “All Others” category as compared to the prior year period was primarily due to less favorable product mix in the mini LED transfer solutions and general semiconductor.

Operating Expenses

33

Table of Contents

The following tables reflect operating expenses for the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended
(dollar amounts in thousands)	July 1, 2023		July 2, 2022		$ Change		% Change
Selling, general & administrative	$	36,393	$	33,216	$	3,177	9.6	%
Research & development	36,578		34,046		2,532		7.4	%
Impairment charges	21,535		1,346		20,189		1,499.9	%
Total	$	94,506	$	68,608	$	25,898	37.7	%

	Nine months ended
(dollar amounts in thousands)	July 1, 2023		July 2, 2022		$ Change		% Change
Selling, general & administrative	$	114,233	$	107,263	$	6,970	6.5	%
Research & development	107,085		104,496		2,589		2.5	%
Impairment charges	21,535		1,346		20,189		1,499.9	%
Total	$	242,853	$	213,105	$	29,748	14.0	%

Selling, General and Administrative (“SG&A”)

For the three months ended July 1, 2023, the increase in SG&A expenses as compared to the prior year period was primarily due to $4.5 million net unfavorable variance in foreign exchange and $0.5 million higher staff costs due to an increase in headcount. This was partially offset by $2.1 million lower sales representative commissions.

For the nine months ended July 1, 2023, the increase in SG&A expenses as compared to the prior year period was primarily due to $12.1 million net unfavorable variance in foreign exchange, $1.2 million higher amortization and $1.2 million higher professional services. These were partially offset by $8.9 million lower sales representative commissions.

Research and Development (“R&D”)

For the three months ended July 1, 2023, the higher R&D expenses as compared to the prior year period was primarily due to $1.3 million higher prototype materials and $1.0 million higher staff costs related to an increase in headcount.

For the nine months ended July 1, 2023, the higher R&D expenses as compared to the prior year period was primarily due to $2.0 million higher prototype materials and $0.3 million higher staff costs related to an increase in headcount.

Impairment Charges

For the three and nine months ended July 1, 2023, the Company recognized a non-cash impairment charge of $21.5 million related to goodwill and intangible assets in the Lithography reporting unit, as well as on an investment in a non-marketable equity security. The impairment charge in the prior year period relates to the impairment on an investment in a non-marketable equity security. See Note 4: Goodwill and Intangible Assets and Note 6: Equity Investments of the Notes to the Consolidated Condensed Financial Statements for further information.

34

Table of Contents

Income/(Loss) from Operations

The following tables reflect income/(loss) from operations by reportable segments for the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended
(dollar amounts in thousands)	July 1, 2023		July 2, 2022		$ Change		% Change
Ball Bonding Equipment	$	18,534	$	93,863	$	(75,329)	(80.3)	%
Wedge Bonding Equipment	15,974		19,443		(3,469)		(17.8)	%
Advanced Solutions	(2,570)		3,134		(5,704)		(182.0)	%
APS	11,510		22,282		(10,772)		(48.3)	%
All Others	(23,857)		2,671		(26,528)		(993.2)	%
Corporate Expenses	(24,079)		(19,316)		(4,763)		(24.7)	%
Total (loss)/income from operations	$	(4,488)	$	122,077	$	(126,565)	(103.7)	%

	Nine months ended
(dollar amounts in thousands)	July 1, 2023		July 2, 2022		$ Change		% Change
Ball Bonding Equipment	$	49,337	$	323,884	$	(274,547)	(84.8)	%
Wedge Bonding Equipment	53,958		49,599		4,359		8.8	%
Advanced Solutions	(21,160)		(7,574)		(13,586)		(179.4)	%
APS	34,778		64,651		(29,873)		(46.2)	%
All Others	(35,025)		28,372		(63,397)		(223.4)	%
Corporate Expenses	(61,925)		(56,404)		(5,521)		(9.8)	%
Total income from operations	$	19,963	$	402,528	$	(382,565)	(95.0)	%

Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, APS and All Others

For the three months ended July 1, 2023, the decrease in Ball Bonding Equipment, Wedge Bonding Equipment and APS income from operations as compared to the prior year period was primarily due to the changes in revenue and operating expenses as explained under “Net Revenue” and “Operating Expenses” above.

For the nine months ended July 1, 2023, the lower Ball Bonding Equipment and APS income from operations, and higher Advanced Solutions loss from operations as compared to the prior year period was primarily due to the changes in revenue and operating expenses as explained under “Net Revenue” and “Operating Expenses” above. For Wedge Bonding Equipment, the higher income from operations was primarily due to the changes in revenue as explained under “Net Revenue” above.

For the three and nine months ended July 1, 2023, the loss from operations in the “All Others” category as compared to the income from operations in prior year period was primarily due to decrease in revenue as explained under “Net Revenue”, the goodwill impairment charge, integration of newly acquired business and net unfavorable variance in foreign exchange.

Interest Income and Expense

The following tables reflect interest income and interest expense for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended
(dollar amounts in thousands)	July 1, 2023		July 2, 2022		$ Change		% Change
Interest income	$	8,847	$	2,158	$	6,689	310.0	%
Interest expense	$	(50)	$	(36)	$	(14)	(38.9)	%

35

Table of Contents

	Nine months ended
(dollar amounts in thousands)	July 1, 2023		July 2, 2022		$ Change		% Change
Interest income	$	23,406	$	3,099	$	20,307	655.3	%
Interest expense	$	(116)	$	(173)	$	57	32.9	%

Interest income

For the three and nine months ended July 1, 2023, interest income increased as compared to the prior year period primarily due to a higher average balance in short-term investments and higher weighted average interest rate on cash, cash equivalents and short-term investments.

Provision for Income Taxes

The following table reflects the provision for income taxes and the effective tax rate for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended									Nine months ended
(dollar amounts in thousands)	July 1, 2023			July 2, 2022			Change			July 1, 2023			July 2, 2022			Change
Provision for income taxes	$	148		$	5,165		$	(5,017)		$	9,462		$	36,813		$	(27,351)
Effective tax rate	3.4		%	4.2		%	(0.8)		%	21.9		%	9.1		%	12.8		%

For the three months ended July 1, 2023, the decrease in provision for income taxes as compared to the prior year period was primarily due to a decrease in profitability and the decrease in effective tax rate was primarily related to tax benefits from the reversal of uncertain tax positions partially offset by the increase in GILTI, resulting from the capitalization of research and development expenditures as mandated by the U.S. Tax Cuts and Jobs Act of 2017.

For the nine months ended July 1, 2023, the decrease in provision for income taxes as compared to the prior year period was primarily due to a decrease in profitability and the increase in effective tax rate was primarily related to the increase in GILTI, resulting from the capitalization of research and development expenditures as mandated by the U.S. Tax Cuts and Jobs Act of 2017, partially offset by tax benefits from the reversal of uncertain tax positions.

LIQUIDITY AND CAPITAL RESOURCES

The following table reflects total cash, cash equivalents, and short-term investments as of July 1, 2023 and October 1, 2022:

	As of
(dollar amounts in thousands)	July 1, 2023		October 1, 2022		$ Change
Cash and cash equivalents	$	401,806	$	555,537	$	(153,731)
Short-term investments	310,000		220,000		90,000
Total cash, cash equivalents, and short-term investments	$	711,806	$	775,537	$	(63,731)
Percentage of total assets	47.2%		48.8%

36

Table of Contents

The following table reflects a summary of the Consolidated Condensed Statements of Cash Flow information for the nine months ended July 1, 2023 and July 2, 2022:

	Nine months ended
(in thousands)	July 1, 2023		July 2, 2022
Net cash provided by operating activities	$	95,912	$	273,625
Net cash (used in)/provided by investing activities	(161,724)		66,342
Net cash used in financing activities	(92,358)		(250,905)
Effect of exchange rate changes on cash and cash equivalents	4,439		(6,069)
Changes in cash and cash equivalents	$	(153,731)	$	82,993
Cash and cash equivalents, beginning of period	555,537		362,788
Cash and cash equivalents, end of period	$	401,806	$	445,781

Nine months ended July 1, 2023

Net cash provided by operating activities was primarily due to net income of $33.8 million, non-cash adjustments to net income of $49.9 million and a net favorable change in operating assets and liabilities of $12.3 million. The net change in operating assets and liabilities was primarily driven by a decrease in accounts and other receivable of $112.9 million, prepaid expenses and other current assets of $17.2 million. This was partially offset by an increase in inventories of $44.1 million, a decrease in accounts payable and accrued expenses and other current liabilities of $35.5 million and income tax payable of $37.0 million.

The decrease in accounts and other receivable in the nine months ended July 1, 2023 was mainly due to lower sales in the period. The decrease in income tax payable was primarily due to lower profitability. The decrease in accounts payable and accrued expenses and other current liabilities was primarily due to higher payments to suppliers, lower material purchases and lower accrued employee compensation that was paid out in the period. The increase in inventories was due to slower utilization in the period and buildup of long lead time materials to fulfill certain customer purchase orders.

Net cash used in investing activities was due to net purchase of short-term investments of $90.0 million, cash outflow for the AJA acquisition of $36.9 million and capital expenditures of $35.1 million.

Net cash used in financing activities was primarily due to common stock repurchases of $60.6 million and dividend payments of $31.3 million.

Nine months ended July 2, 2022

Net cash provided by operating activities was primarily due to net income of $368.6 million, non-cash adjustments to net income of $24.8 million and a net unfavorable change in operating assets and liabilities of $119.9 million. The net change in operating assets and liabilities was primarily driven by an increase in inventories of $49.2 million, prepaid expenses and other current assets of $50.7 million and a decrease in accounts payable and accrued expenses and other current liabilities of $84.0 million and income tax payable of $6.7 million. This was partially offset by a decrease in accounts and other receivable of $71.8 million.

The increase in inventories was due to higher manufacturing activities to meet higher demand in the first two quarters of fiscal 2022. The increase in prepaid expenses and other current assets was mainly due to the addition of contract assets in the period. The decrease in accounts payable and accrued expenses and other current liabilities was primarily due to higher payments to suppliers and lower accrued employee compensation that was paid out in the period. The decrease in accounts and other receivable in the nine months ended July 2, 2022 was mainly due to lower sales in the period and a change in customer mix of different credit terms.

Net cash provided by investing activities was due to net redemption of short-term investments of $77.0 million. This was partially offset by capital expenditures of $10.4 million.

Net cash used in financing activities was primarily due to common stock repurchases of $221.1 million and dividend payments of $29.4 million.

37

Table of Contents

Fiscal 2023 Liquidity and Capital Resource Outlook

We expect our aggregate fiscal 2023 capital expenditures to be between approximately $50.0 million and $54.0 million, of which approximately $43.5 million has been incurred through the third quarter. Expenditures are anticipated to be primarily for research and development projects, enhancements to our manufacturing operations, improvements to our information technology security, implementation of an enterprise resource planning system and leasehold improvements for our facilities. Our ability to make these expenditures will depend, in part, on our future cash flows, which are determined by our future operating performance and, therefore, subject to prevailing macroeconomic conditions, including actual or potential inflationary pressures, supply chain challenges, geopolitical tensions including the prolonged Ukraine/Russia conflict and other factors, some of which are beyond our control.

As of July 1, 2023 and October 1, 2022, approximately $534.5 million and $499.8 million of cash, cash equivalents, and short-term investments, respectively, were held by the Company’s foreign subsidiaries, with a large portion of the cash amounts expected to be available for use in the U.S. without incurring additional U.S. income tax.

The Company’s operations and capital requirements are anticipated to be funded primarily by cash on hand, cash generated from operating activities, and cash from our existing Facility Agreements. We believe these sources of cash and liquidity are sufficient to meet our additional liquidity needs for the foreseeable future, including repayment of outstanding balances under the Facility Agreements, as well as payment of dividends, share repurchases and income taxes.

We believe that our existing cash, cash equivalents, short-term investments, existing Facility Agreements, and anticipated cash flows from operations will be sufficient to meet our liquidity and capital requirements, notwithstanding the macroeconomic headwinds, for at least the next twelve months and beyond. Our liquidity is affected by many factors, some based on normal operations of our business and others related to macroeconomic conditions including actual or potential inflationary pressures, industry-related uncertainties, and effects arising from the prolonged Ukraine/Russia conflict, which we cannot predict. We also cannot predict economic conditions or industry downturns or the timing, strength or duration of recoveries. We intend to continue to use our cash for working capital needs and for general corporate purposes.

In this unprecedented macroeconomic environment, we may seek, as we believe appropriate, additional debt or equity financing that would provide capital for general corporate purposes, working capital funding, additional liquidity needs or to fund future growth opportunities, including possible acquisitions. The timing and amount of potential capital requirements cannot be determined at this time and will depend on a number of factors, including the actual and projected demand for our products, semiconductor and semiconductor capital equipment industry conditions, competitive factors, the condition of financial markets and the global economic situation.

Share Repurchase Program

On August 15, 2017, the Company’s Board of Directors authorized a program (the “Program”) to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018, 2019 and 2020, the Board of Directors increased the share repurchase authorization under the Program to $200 million, $300 million, and $400 million, respectively. On March 3, 2022, the Board of Directors further increased the share repurchase authorization under the Program by an additional $400 million to $800 million, and extended its duration through August 1, 2025. On May 7, 2022, the Company entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. This trading plan was most recently modified on May 29, 2023. The Program may be suspended or discontinued at any time and is funded using the Company’s available cash, cash equivalents and short-term investments. Under the Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations.

During the three and nine months ended July 1, 2023, the Company repurchased a total of approximately 174.9 thousand and 1,331.1 thousand shares of common stock under the Program at a cost of approximately $8.5 million and $58.9 million, respectively. The stock repurchases were recorded in the periods in which the shares were delivered and accounted for as treasury stock in the Company’s Consolidated Condensed Balance Sheets. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon re-issuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital.

If the Company reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings.

As of July 1, 2023, our remaining stock repurchase authorization under the Program was approximately $190.2 million.

38

Table of Contents

Dividends

On November 16, 2022, the Board of Directors declared a quarterly dividend of $0.19 per share of common stock. Dividends paid during the three and nine months ended July 1, 2023 totaled $10.8 million and $31.3 million, respectively. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company’s financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company’s shareholders.

Other Obligations and Contingent Payments

In accordance with U.S. GAAP, certain obligations and commitments are not required to be included in the Consolidated Condensed Balance Sheets and Statements of Operations. These obligations and commitments, while entered into in the normal course of business, may have a material impact on our liquidity and are disclosed in the table below.

As of July 1, 2023, the Company had deferred tax liabilities of $36.7 million and unrecognized tax benefits within the income taxes payable for uncertain tax positions of $15.6 million, inclusive of accrued interest on uncertain tax positions of $2.5 million, substantially all of which would affect our effective tax rate in the future, if recognized.

It is reasonably possible that the amount of the unrecognized tax benefit with respect to certain unrecognized tax positions will increase or decrease during the next twelve months due to the expected lapse of statutes of limitation and / or settlements of tax examinations. Given the number of years and numerous matters that remain subject to examination in various tax jurisdictions, we cannot practicably estimate the timing or financial outcomes of these examinations and, therefore, these amounts are excluded from the amounts below. When estimating its tax positions, the Company considers and evaluates numerous complex areas of taxation, which may require periodic adjustments and which may not reflect the final tax liabilities.

The following table presents certain payments due by the Company under contractual and statutory obligations with minimum firm commitments as of July 1, 2023:

			Payments due in
(in thousands)	Total		Less than 1 year		1 - 3 years		3 - 5 years		More than 5 years
Inventory purchase obligations (1)	$	198,566	$	21,676	$	176,890	$	—	$	—
U.S. one-time transition tax payable (2) (reflected on our Consolidated Condensed Balance Sheets)	$	47,686	12,606		35,080		—		—
Total	$	246,252	$	34,282	$	211,970	$	—	$	—

(1)The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancellable and some orders impose varying penalties and charges in the event of cancellation.

(2)Associated with the U.S. one-time transition tax on certain earnings and profits of our foreign subsidiaries in relation to the U.S. Tax Cuts and Job Act of 2017.

Credit facilities

On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company and one of its subsidiaries with an overdraft facility of up to $150.0 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the Secured Overnight Financing Rate (“SOFR”) plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of two of its subsidiaries (the “Subsidiaries”) or encumber its assets with material security interests (including any pledge of monies in the Subsidiaries’ cash deposit account with the Bank). The Facility Agreements also contain typical events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other material indebtedness of the Company, and breach of a representation or warranty under the Facility Agreements. As of July 1, 2023, there were no outstanding amounts under the Overdraft Facility.

As of July 1, 2023, other than the bank guarantee disclosed in Note 10 of Item 1, we did not have any other off-balance sheet arrangements, such as contingent interests or obligations associated with variable interest entities.

39

Table of Contents

Item 3. - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk

Our available-for-sale securities, if applicable, may consist of short-term investments in highly rated debt instruments of the U.S. Government and its agencies, financial institutions, and corporations. We continually monitor our exposure to changes in interest rates and credit ratings of issuers with respect to any available-for-sale securities and target an average life to maturity of less than 18 months. Accordingly, we believe that the effects on us of changes in interest rates and credit ratings of issuers are limited and would not have a material impact on our financial condition or results of operations.

Foreign Currency Risk

Our international operations are exposed to changes in foreign currency exchange rates due to transactions denominated in currencies other than the location’s functional currency. Our international operations are also exposed to foreign currency fluctuations that impact the remeasurement of net monetary assets of those operations whose functional currency, the U.S. dollar, differs from their respective local currencies, most notably in Israel, Singapore and Switzerland. Our U.S. operations also have foreign currency exposure due to net monetary assets denominated in currencies other than the U.S. dollar. In addition to net monetary remeasurement, we have exposures related to the translation of subsidiary financial statements from their functional currency, the local currency, into its reporting currency, the U.S. dollar, most notably in the Netherlands, China, Taiwan, Japan and Germany.

Based on our foreign currency exposure as of July 1, 2023, a 10.0% fluctuation could impact our financial position, results of operations or cash flows by $4.0 million to $5.0 million. Our attempts to hedge against these risks may not be successful and may result in a material adverse impact on our financial results and cash flow.

We enter into foreign exchange forward contracts to hedge a portion of our forecasted foreign currency-denominated expenses in the normal course of business and, accordingly, they are not speculative in nature. These instruments generally mature within twelve months. We have foreign exchange forward contracts with a notional amount of $58.3 million outstanding as of July 1, 2023.

40

Table of Contents

Item 4. - CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of July 1, 2023. At the time that the Original Form 10-K was filed on November 17, 2022, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of October 1, 2022. Based on the identification of the material weakness described below, the Company, under the supervision of the Company’s management, including the Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were not effective as of October 1, 2022, December 31, 2022, April 1, 2023 and July 1, 2023.

Material Weakness in Internal Control Over Financial Reporting

As described in the Explanatory Note in the 2022 Annual Report, we identified a material weakness in our internal control over financial reporting that existed as of October 1, 2022. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness is a result of a design gap in the existing review of the segment reporting process, which failed to (a) identify all of the key metrics used by the CODM to evaluate performance and allocate resources, (b) assess in totality the level of information provided to and utilized by the CODM to evaluate performance and allocate resources, and (c) appropriately analyze every factor pertinent to whether operating segments share economic similarities that are required for aggregation under ASC 280. There were no material misstatements as a result of this material weakness; however, it could result in omitted disclosures within the segment reporting footnote disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected on a timely basis.

Management’s Plans for Remediation of the Material Weakness

The Company is in the process of assessing and finalizing its plan for remediation of the material weakness, with the oversight of the Audit Committee of the Board of Directors, the Chief Executive Officer and the Chief Financial Officer. Specifically, we have improved our review process including the documentation of the evaluation of segment reporting under ASC 280. In addition, the Company has engaged an outside consultant to assist management in the development of a segment analysis framework to be used on a go forward basis to support the segment-related disclosures, particularly when the Company has significant organizational structure or reporting structure changes that may impact the Company’s analysis under ASC 280.

The material weakness will not be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. However, our management, including our Chief Executive Officer and Chief Financial Officer, has concluded that, notwithstanding the identified material weakness in our internal control over financial reporting, the financial statements fairly present, in all material respects, our financial condition, results of operations and cash flows for the periods presented in conformity with U.S. GAAP.

Changes in Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP.

We completed the acquisition of AJA on February 22, 2023, as discussed in Note 3: Business Combination of the Notes to the Consolidated Condensed Financial Statements. Although existing event driven controls were followed related to the business combination accounting for the acquisition of AJA, management intends to exclude AJA from its assessment of the Company’s internal control over financial reporting for the fiscal year ending September 30, 2023. This exclusion would be in accordance with the SEC’s general guidance that an assessment of a recently acquired business may be omitted from our scope in the first fiscal year in which the acquisition occurred.

There has been no change in the Company’s internal control over financial reporting during the three months ended July 1, 2023 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

41

Table of Contents

PART II. - OTHER INFORMATION 

Item 1. - LEGAL PROCEEDINGS

From time to time, we may be a plaintiff or defendant in cases arising out of our business. We are party to ordinary, routine litigation incidental to our business. We cannot be assured of the results of any pending or future litigation, but we do not believe resolution of any currently pending matters will have a material adverse effect on our business, financial condition or operating results.

Item 1A. - RISK FACTORS

Certain Risks Related to Our Business

Except for the below additional risks factors listed below, there have been no other material changes from the risk factors discussed in Part I, Item 1A, “Risk Factors”, of our 2022 Annual Report.

We identified a material weakness in our internal control over financial reporting, and although it has not resulted in any material misstatements or omissions of our consolidated financial statements to date, if it is not fully remediated, it could result in material misstatements of our consolidated financial statements in the future.

Pursuant to the Sarbanes-Oxley Act, management is responsible for establishing and maintaining effective internal control over financial reporting. Our internal controls over financial reporting are processes designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. In addition, management is required to evaluate the effectiveness of our internal control over financial reporting.

As described in Item 4 “Controls and Procedures” of this Quarterly Report on Form 10-Q, and in Part II, Item 9A “Controls and Procedures” of our 2022 Annual Report, we identified a material weakness in our internal control over financial reporting that existed as of October 1, 2022 and which related to a design gap in the existing review of our segment reporting process, which failed to (a) identify all of the key metrics used by the CODM to evaluate performance and allocate resources, (b) assess in totality the level of information provided to and utilized by the CODM to evaluate performance and allocate resources, and (c) appropriately analyze every factor pertinent to whether operating segments share economic similarities that is required for aggregation under ASC 280. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

We are in the process of assessing and finalizing our plan for remediation of the material weakness, with the oversight of the Audit Committee of the Board of Directors, our Chief Executive Officer and our Chief Financial Officer. The material weakness will not be considered remediated until the applicable remedial controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. These remediation measures may be time consuming and costly. In addition, the measures we have taken to date, and actions we may take in the future, may not be sufficient to remediate the control deficiency that led to such material weakness, and they may not prevent or avoid a potential future material weakness. Any control system, no matter how well designed and implemented, can only provide reasonable and not absolute assurance that the objectives of the control system will be achieved.

If our remediation efforts are insufficient or if additional material weaknesses in internal control over financial reporting are discovered or occur in the future, it could result in errors in our consolidated financial statements that could result in a restatement of our financial statements, and could cause us to fail to meet our reporting obligations. This could materially and adversely affect our business, results of operations and financial condition, restrict our ability to access the capital markets, require us to expend significant resources to correct the material weakness, subject us to fines, penalties or judgments, harm our reputation, adversely affect the trading price of our common stock, or otherwise cause a decline in investor confidence.

42

Table of Contents

Intellectual Property Risks

Our success depends in part on our intellectual property, which we may be unable to protect.

Our success depends in part on our proprietary technology. To protect this technology, we rely principally on contractual restrictions (such as nondisclosure and confidentiality provisions) in our agreements with employees, subcontractors, vendors, consultants and customers and on the common law of trade secrets and proprietary “know-how”. We also rely, in some cases, on patent and copyright protection, although this protection may in some cases be insufficient due to the rapid development of technology in our industry. We may not be successful in protecting our technology for a number of reasons, including the following:

•employees, subcontractors, vendors, consultants and customers may violate their contractual agreements or post-employment non-competition obligations, and the cost of enforcing those agreements may be prohibitive, or those agreements may be unenforceable or more limited than we anticipate;

•foreign intellectual property laws may not adequately protect our intellectual property rights;

•our patent and copyright claims may not be sufficiently broad to effectively protect our technology; our patents or copyrights may be challenged, invalidated or circumvented; or we may otherwise be unable to obtain adequate protection for our technology; and

•when our patents expire, or if they are invalidated, narrowed or circumvented, our competitors may be able to utilize the inventions protected by our patents.

Also, competitors may copy or misappropriate our trade secrets, products or designs either through lawful means of reverse engineering or through independent development. We remain vigilant and take note of similar products and solutions offered by our competitors and, based on reasonable efforts, investigate whether any of our competitors’ products or solutions is the outcome of unlawful reverse engineering. For example, we are currently investigating a potential unlawful reverse engineering incident and, where necessary, plan to pursue appropriate legal action against parties that may be involved in such unlawful reverse engineering.

Competitors or third parties (including ex-employees violating their surviving contractual obligations with us) may also copy or reverse engineer aspects of our products or solutions through unlawful means, or illegally use information that we regard as proprietary. We conduct active surveillance and monitor potential threats surrounding any unauthorized use from competitors or third parties. As a result of our active surveillance, we recently learned that certain ex-employees in China, who had access to materials containing proprietary information and trade secrets about our products and designs, may have provided them to their current employer that is our direct competitor. We intend to fully investigate this matter and, if appropriate, pursue litigation against all parties that may be involved to protect our confidential information and trade secrets.

Despite our best efforts in active surveillance and monitoring, such policing may be difficult, time-consuming, non-definitive and non-exhaustive, and we cannot be certain that the steps we have taken will prevent misappropriation of our intellectual property.

Additionally, laws of foreign countries may not provide us with adequate remedy against unauthorized use of our intellectual property, or we may be unable to prove unauthorized use as prescribed by such foreign laws. In either case, if the protection of our intellectual property proves to be inadequate or unenforceable, others may be able to use our proprietary developments without compensation or appropriate remediation to us, resulting in potential cost advantages to our competitors and consequentially eroding our market share.

Furthermore, our partners and alliances may have rights to technology developed by us. We may incur significant expense to protect or enforce our intellectual property rights. If we are unable to protect our intellectual property rights, our competitive position may be weakened.

43

Table of Contents

Third parties may claim we are infringing on their intellectual property, which could cause us to incur significant litigation costs or other expenses, or prevent us from selling some of our products.

The semiconductor industry is characterized by rapid technological change, with frequent introductions of new products and technologies. Industry participants often develop products and features similar to those introduced by others, creating a risk that their products and processes may give rise to claims they infringe on the intellectual property of others. We may unknowingly infringe on the intellectual property rights of others and incur significant liability for that infringement. If we are found to have infringed on the intellectual property rights of others, we could be enjoined from continuing to manufacture, market or use the affected product, or be required to obtain a license to continue manufacturing or using the affected product. A license could be very expensive to obtain or may not be available at all. Similarly, changing or re-engineering our products or processes to avoid infringing the rights of others may be costly, impractical or time consuming.

Occasionally, third parties assert that we are, or may be, infringing on or misappropriating their intellectual property rights. Some of these assertions may not be legitimate. In these cases, we defend or in some instances dispel, and will continue to defend or dispel, against claims or negotiate licenses where we consider these actions appropriate. Intellectual property cases are uncertain, time-consuming and involve complex legal and factual questions. If we become involved in this type of litigation, it could consume significant resources and divert our attention from our business.

Information Technology and Enterprise System Risks

We may be subject to disruptions or failures in our information technology systems and network infrastructures that could have a material adverse effect on us.

We maintain and rely extensively on information technology systems and network infrastructures for the effective operation of our business. We also hold large amounts of data in data center facilities around the world, primarily in Singapore and the U.S., on which our business depends. A disruption, infiltration or failure of our information technology systems or any of our data centers as a result of software or hardware malfunctions, computer viruses, cyber-attacks, employee theft or misuse, power disruptions, natural disasters or accidents could cause breaches of data security and loss of critical data, which in turn could materially adversely affect our business. Our security procedures, such as virus protection software, data loss protection and our business continuity planning, such as our disaster recovery policies and back-up systems, may not be adequate or implemented properly to fully address the adverse effect of such events, which could adversely impact our operations. In addition, our business could be adversely affected to the extent we do not make the appropriate level of investment in our technology systems as our technology systems become out-of-date or obsolete and are not able to deliver the type of data integrity and reporting we need to run our business. Furthermore, when we implement new systems and/or upgrade existing systems, we could be faced with temporary or prolonged disruptions that could adversely affect our business.

We have experienced, and expect to continue to be subject to, cybersecurity threats and incidents, ranging from employee error or misuse, to individual attempts to gain unauthorized access to information systems, to sophisticated and targeted measures known as advanced persistent threats, none of which have been material to the Company to date. We devote significant resources to network security and other measures to protect our systems and data from unauthorized access or misuse. However, depending on its nature and scope, cybersecurity incidents could result in business disruption; misappropriation, corruption or loss of confidential information and critical data (of the Company or that belonging to its third parties); reputational damage; litigation with third parties; diminution in the value of our investment in research, development and engineering; data privacy issues; and increased cybersecurity protection and remediation costs.

We also try to protect the confidential nature of our proprietary information by using commonly accepted information technology systems and network security measures. Such measures may not provide adequate protection for our proprietary information. For example, our internal procedures may not prevent an existing or former employee or consultant from misappropriating our trade secrets and providing them to a competitor, and recourse we take against such misconduct may not provide an adequate remedy to fully protect our interests.

44

Table of Contents

Item 2. - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

The following table summarizes the repurchases of common stock during the three months ended July 1, 2023 (in millions, except number of shares, which are reflected in thousands, and per share amounts):

Period	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs(1)
April 2, 2023 to April 29, 2023	73	$	47.86	73	$	195.3
April 30, 2023 to June 3, 2023	84	$	48.06	84	$	191.3
June 4, 2023 to July 1, 2023	18	$	56.57	18	$	190.2
For the three months ended July 1, 2023	175			175

(1)On August 15, 2017, the Company’s Board of Directors authorized the Program to repurchase up to $100 million in total of the Company’s common stock on or before August 1, 2020. In 2018, 2019 and 2020, the Board of Directors increased the share repurchase authorization under the Program to $200 million, $300 million and $400 million, respectively. On March 3, 2022, the Board of Directors further increased the share repurchase authorization under the Company’s existing share repurchase program by an additional $400 million to $800 million, and extended its duration through August 1, 2025. The Company may repurchase shares of its common stock through open market and privately negotiated transactions at prices deemed appropriate by management. The Company has entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. The Program may be suspended or discontinued at any time and will be funded using the Company’s available cash, cash equivalents and short-term investments. Under the Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations.

Item 3. – Defaults Upon Senior Securities.

None.

Item 4. – Mine Safety Disclosures

None.

Item 5. – Other Information

Director and Officer Trading Plans and Arrangements

None of the Company’s directors or officers have adopted, modified or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the Company’s fiscal quarter ended July 1, 2023, as such terms are defined under Item 408(a) of Regulation S-K.

45

Table of Contents

Item 6. -     Exhibits

Exhibit No.	Description
3.1	The Company's Amended and Restated Articles of Incorporation, dated December 5, 2007, are incorporated herein by reference to Exhibit 3(i) to the Company's Annual Report on Form 10-K for the fiscal year ended September 29, 2007, SEC file number 000-00121.
3.2	The Company's Amended and Restated By-Laws, dated October 22, 2015, are incorporated herein by reference to Exhibit 3(ii) to the Company's Current Report on Form 8-K dated October 22, 2015, SEC file number 000-00121.
31.1	Certification of Fusen Chen, Chief Executive Officer of Kulicke and Soffa Industries, Inc., pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Lester Wong, Chief Financial Officer of Kulicke and Soffa Industries, Inc., pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act as adopted pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Fusen Chen, Chief Executive Officer of Kulicke and Soffa Industries, Inc., pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*	Certification of Lester Wong, Chief Financial Officer of Kulicke and Soffa Industries, Inc., pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	Inline XBRL Instance Document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS).
*	This exhibit shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act or the Exchange Act.

46

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	KULICKE AND SOFFA INDUSTRIES, INC.
Date: August 9, 2023	By:	/s/ LESTER WONG
		Lester Wong
		Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer)

47

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Fusen Chen, certify that:

1.    I have reviewed this quarterly report on Form 10-Q of Kulicke and Soffa Industries, Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 9, 2023	By:	/s/ FUSEN CHEN
		Fusen Chen
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Lester Wong, certify that:

1.    I have reviewed this quarterly report on Form 10-Q of Kulicke and Soffa Industries, Inc.;

2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 9, 2023	By:	/s/ LESTER WONG
		Lester Wong
		Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Fusen Chen, President and Chief Executive Officer of Kulicke and Soffa Industries, Inc., do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1.the Quarterly Report on Form 10-Q of Kulicke and Soffa Industries, Inc. for the period ended July 1, 2023 (the “ July 1, 2023 Form 10-Q”), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.the information contained in the July 1, 2023 Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Kulicke and Soffa Industries, Inc.

Date: August 9, 2023	By:	/s/ FUSEN CHEN
		Fusen Chen
		President and Chief Executive Officer

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Lester Wong, Executive Vice President and Chief Financial Officer of Kulicke and Soffa Industries, Inc., do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

1. the Quarterly Report on Form 10-Q of Kulicke and Soffa Industries, Inc. for the period ended July 1, 2023 (the “July 1, 2023 Form 10-Q”), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2. the information contained in the July 1, 2023 Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Kulicke and Soffa Industries, Inc.

Date: August 9, 2023	By:	/s/ LESTER WONG
		Lester Wong
		Executive Vice President and Chief Financial Officer

XML

DOCUMENT AND ENTITY INFORMATION - shares	9 Months Ended
	Jul. 01, 2023	Aug. 04, 2023
Entity Addresses [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	0-121
Entity Central Index Key	0000056978
Entity Incorporation, State or Country Code	PA
Entity Tax Identification Number	23-1498399
Entity Address, Address Line One	23A Serangoon North Avenue 5
Entity Address, Address Line Two	#01-01,
Entity Address, Country	SG
Entity Address, Postal Zip Code	554369
City Area Code	215
Local Phone Number	784-6000
Title of 12(b) Security	Common Stock, Without Par Value
Trading Symbol	KLIC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		56,473,297
Amendment Flag	false
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--09-30
Entity Registrant Name	KULICKE AND SOFFA INDUSTRIES, INC.
Entity Address, City or Town	Singapore
Document Period End Date	Jul. 01, 2023
Principal Executive Offices
Entity Addresses [Line Items]
Entity Address, Address Line One	1005 Virginia Dr.
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19034
Entity Address, City or Town	Fort Washington

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Current assets:
Cash and cash equivalents	$ 401,806	$ 555,537
Short-term investments	310,000	220,000
Accounts and other receivable, net of allowance for doubtful accounts of $49 and $0, respectively	198,107	309,323
Inventories, net	227,991	184,986
Prepaid expenses and other current assets	45,144	62,200
Total current assets	1,183,048	1,332,046
Property, plant and equipment, net	113,567	80,908
Operating right-of-use assets	46,351	41,767
Goodwill	89,291	68,096
Intangible assets, net	31,418	31,939
Deferred tax assets	40,926	25,572
Equity investments	433	5,397
Other assets	3,088	2,874
TOTAL ASSETS	1,508,122	1,588,599
Current liabilities:
Accounts payable	52,857	67,311
Operating lease liabilities	6,569	6,766
Income taxes payable	16,844	40,063
Accrued expenses and other current liabilities	120,506	134,541
Total current liabilities	196,776	248,681
Deferred tax liabilities	36,735	34,037
Income taxes payable	50,673	64,634
Operating lease liabilities	41,390	34,927
Other liabilities	12,836	11,670
TOTAL LIABILITIES	338,410	393,949
Commitments and contingent liabilities (Note 16)
Shareholders’ equity:
Preferred stock, without par value: Authorized 5,000 shares; issued - none	0	0
Common stock, without par value: Authorized 200,000 shares; issued 85,364 and 85,364, respectively; outstanding 56,488 and 57,128 shares, respectively	572,338	561,684
Treasury stock, at cost, 28,875 and 28,237 shares, respectively	(728,064)	(675,800)
Retained earnings	1,343,163	1,341,666
Accumulated other comprehensive loss	(17,725)	(32,900)
TOTAL SHAREHOLDERS’ EQUITY	1,169,712	1,194,650
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 1,508,122	$ 1,588,599

XML

CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Consolidated Balance Sheets Parenthetical [Abstract]
Allowance for doubtful accounts and notes receivable	$ 49	$ 0
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Common Stock, Shares Authorized	200,000,000	200,000,000
Common Stock, Shares, Issued	85,364,000	85,364,000
Common Stock, Shares, Outstanding	56,488,000	57,128,000
Treasury Stock, Common, Shares	28,875,000	28,237,000
Preferred Stock, Shares Issued	0	0

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Income Statement [Abstract]
Revenues	$ 190,917	$ 372,137	$ 540,171	$ 1,217,307
Cost of sales	100,899	181,452	277,355	601,674
Gross profit	90,018	190,685	262,816	615,633
Selling, general and administrative	36,393	33,216	114,233	107,263
Research and development	36,578	34,046	107,085	104,496
Impairment charges	21,535	1,346	21,535	1,346
Operating expenses	94,506	68,608	242,853	213,105
(Loss)/income from operations	(4,488)	122,077	19,963	402,528
Interest income	8,847	2,158	23,406	3,099
Interest expense	(50)	(36)	(116)	(173)
Income before income taxes	4,309	124,199	43,253	405,454
Provision for income taxes	148	5,165	9,462	36,813
Net income	$ 4,161	$ 119,034	$ 33,791	$ 368,641
Net income per share:
Basic (in dollars per share)	$ 0.07	$ 2.02	$ 0.60	$ 6.05
Diluted (in dollars per share)	$ 0.07	$ 1.99	$ 0.59	$ 5.95
Weighted average shares outstanding:
Basic (in shares)	56,553	58,985	56,763	60,951
Diluted (in shares)	57,519	59,955	57,684	61,940

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 4,161	$ 119,034	$ 33,791	$ 368,641
Other comprehensive income:
Foreign currency translation adjustment	(2,459)	(12,009)	13,514	(18,025)
Unrecognized actuarial (gain)/loss on pension plan, net of tax	(17)	122	(73)	103
Foreign currency translation and pension plan, net of tax	(2,476)	(11,887)	13,441	(17,922)
Derivatives designated as hedging instruments:
Unrealized (loss)/gain on derivative instruments, net of tax	(1,280)	(1,233)	2,550	(1,168)
Reclassification adjustment for (gain)/loss on derivative instruments recognized, net of tax	518	(170)	816	(793)
Net (decrease)/increase from derivatives designated as hedging instruments, net of tax	(1,798)	(1,063)	1,734	(375)
Other comprehensive income	(4,274)	(12,950)	15,175	(18,297)
Comprehensive (loss)/income	$ (113)	$ 106,084	$ 48,966	$ 350,344

XML

CONSOLIDATED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive (Loss)/Income
Beginning balance (shares) at Oct. 02, 2021		61,931
Beginning balance at Oct. 02, 2021	$ 1,095,237	$ 550,117	$ (400,412)	$ 948,554	$ (3,022)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		4
Issuance of stock for services rendered	238	$ 197	41
Repurchase of common stock (shares)		(276)
Repurchase of common stock	(15,380)		(15,380)
Issuance of shares for equity based compensation (shares)		725
Issuance of shares for equity-based compensation	0	$ (6,963)	6,963
Equity-based compensation	5,074	$ 5,074
Cash dividend declared	(10,610)			(10,610)
Net income	133,606			133,606
Other comprehensive income	(989)				(989)
Total comprehensive income	132,617			133,606	(989)
Ending balance (shares) at Jan. 01, 2022		62,384
Ending balance at Jan. 01, 2022	1,207,176	$ 548,425	(408,788)	1,071,550	(4,011)
Beginning balance (shares) at Oct. 02, 2021		61,931
Beginning balance at Oct. 02, 2021	1,095,237	$ 550,117	(400,412)	948,554	(3,022)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	368,641
Other comprehensive income	(18,297)
Total comprehensive income	350,344
Ending balance (shares) at Jul. 02, 2022		58,480
Ending balance at Jul. 02, 2022	1,206,733	$ 557,236	(615,689)	1,286,505	(21,319)
Beginning balance (shares) at Jan. 01, 2022		62,384
Beginning balance at Jan. 01, 2022	1,207,176	$ 548,425	(408,788)	1,071,550	(4,011)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		4
Issuance of stock for services rendered	237	$ 202	35
Repurchase of common stock (shares)		(2,944)
Repurchase of common stock	(176,153)	$ (30,000)	(146,153)
Issuance of shares for equity based compensation (shares)		24
Issuance of shares for equity-based compensation	0	$ (222)	222
Equity-based compensation	4,459	$ 4,459
Cash dividend declared	(10,110)			(10,110)
Net income	116,001			116,001
Other comprehensive income	(4,358)				(4,358)
Total comprehensive income	111,643			116,001	(4,358)
Ending balance (shares) at Apr. 02, 2022		59,468
Ending balance at Apr. 02, 2022	1,137,252	$ 522,864	(554,684)	1,177,441	(8,369)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		4
Issuance of stock for services rendered	237	$ 196	41
Repurchase of common stock (shares)		(997)
Repurchase of common stock	(31,098)		(61,098)
Issuance of shares for equity based compensation (shares)		5
Issuance of shares for equity-based compensation	0	$ (52)	52
Equity-based compensation	4,228	$ 4,228
Cash dividend declared	(9,970)			(9,970)
Net income	119,034			119,034
Other comprehensive income	(12,950)				(12,950)
Total comprehensive income	106,084			119,034	(12,950)
Ending balance (shares) at Jul. 02, 2022		58,480
Ending balance at Jul. 02, 2022	1,206,733	$ 557,236	(615,689)	1,286,505	(21,319)
Beginning balance (shares) at Oct. 01, 2022		57,128
Beginning balance at Oct. 01, 2022	1,194,650	$ 561,684	(675,800)	1,341,666	(32,900)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		6
Issuance of stock for services rendered	237	$ 180	57
Repurchase of common stock (shares)		(1,054)
Repurchase of common stock	(45,382)		(45,382)
Issuance of shares for equity based compensation (shares)		667
Issuance of shares for equity-based compensation	0	$ (6,412)	6,412
Equity-based compensation	6,284	$ 6,284
Cash dividend declared	(10,794)			(10,794)
Net income	14,589			14,589
Other comprehensive income	17,645				17,645
Total comprehensive income	32,234			14,589	17,645
Ending balance (shares) at Dec. 31, 2022		56,747
Ending balance at Dec. 31, 2022	1,177,229	$ 561,736	(714,713)	1,345,461	(15,255)
Beginning balance (shares) at Oct. 01, 2022		57,128
Beginning balance at Oct. 01, 2022	1,194,650	$ 561,684	(675,800)	1,341,666	(32,900)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	33,791
Other comprehensive income	15,175
Total comprehensive income	48,966
Ending balance (shares) at Jul. 01, 2023		56,488
Ending balance at Jul. 01, 2023	1,169,712	$ 572,338	(728,064)	1,343,163	(17,725)
Beginning balance (shares) at Dec. 31, 2022		56,747
Beginning balance at Dec. 31, 2022	1,177,229	$ 561,736	(714,713)	1,345,461	(15,255)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		5
Issuance of stock for services rendered	237	$ 184	53
Repurchase of common stock (shares)		(102)
Repurchase of common stock	(4,990)	$ 0	(4,990)
Issuance of shares for equity based compensation (shares)		3
Issuance of shares for equity-based compensation	0	$ (31)	31
Equity-based compensation	5,142	$ 5,142
Cash dividend declared	(10,766)			(10,766)
Net income	15,041			15,041
Other comprehensive income	1,804				1,804
Total comprehensive income	16,845			15,041	1,804
Ending balance (shares) at Apr. 01, 2023		56,653
Ending balance at Apr. 01, 2023	1,183,697	$ 567,031	(719,619)	1,349,736	(13,451)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock for services rendered (shares)		5
Issuance of stock for services rendered	237	$ 194	43
Repurchase of common stock (shares)		(175)
Repurchase of common stock	(8,541)	$ 0	(8,541)
Issuance of shares for equity based compensation (shares)		5
Issuance of shares for equity-based compensation	0	$ (53)	53
Equity-based compensation	5,166	$ 5,166
Cash dividend declared	(10,734)			(10,734)
Net income	4,161			4,161
Other comprehensive income	(4,274)				(4,274)
Total comprehensive income	(113)			4,161	(4,274)
Ending balance (shares) at Jul. 01, 2023		56,488
Ending balance at Jul. 01, 2023	$ 1,169,712	$ 572,338	$ (728,064)	$ 1,343,163	$ (17,725)

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 33,791	$ 368,641
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	20,746	15,773
Impairment charges	21,535	1,346
Equity-based compensation and employee benefits	17,303	14,473
Adjustment for doubtful accounts	49	(245)
Adjustment for inventory valuation	2,598	1,110
Deferred taxes	(14,441)	(3,675)
Gain on disposal of property, plant and equipment	(539)	(129)
Unrealized foreign currency translation	2,610	(3,806)
Changes in operating assets and liabilities, net of assets and liabilities assumed in businesses combinations:
Accounts and other receivable	112,881	71,825
Inventories	(44,106)	(49,230)
Prepaid expenses and other current assets	17,165	(50,725)
Accounts payable, accrued expenses and other current liabilities	(35,461)	(84,017)
Income taxes payable	(37,028)	(6,663)
Other, net	(1,191)	(1,053)
Net cash provided by operating activities	95,912	273,625
Acquisition of business, net of cash acquired	(36,881)	0
Proceeds from sales of property, plant and equipment	318	119
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of business, net of cash acquired	36,881	0
Purchases of property, plant and equipment	(35,125)	(10,380)
Proceeds from sales of property, plant and equipment	318	119
Investment in private equity fund	(36)	(397)
Purchase of short-term investments	(465,000)	(389,000)
Maturity of short-term investments	375,000	466,000
Net cash (used in)/provided by investing activities	(161,724)	66,342
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment on short-term debt	0	(54,500)
Payment for finance lease	(447)	(373)
Repurchase of common stock/treasury stock	(60,608)	(221,139)
Common stock cash dividends paid	(31,303)	(29,393)
Proceeds from short-term debt	0	54,500
Net cash used in financing activities	(92,358)	(250,905)
Effect of exchange rate changes on cash and cash equivalents	4,439	(6,069)
Changes in cash and cash equivalents	(153,731)	82,993
Cash and cash equivalents at beginning of period	555,537	362,788
Cash and cash equivalents at end of period	401,806	445,781
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES:
Other Significant Noncash Transaction, Value of Consideration Given	8,098	660
CASH PAID FOR:
Interest	116	173
Income taxes, net of refunds	$ 55,998	$ 50,059

XML

BASIS OF PRESENTATION

9 Months Ended

Jul. 01, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BASIS OF PRESENTATION

1. BASIS OF PRESENTATION

These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“we,” “us,” “our,” or the “Company”), with appropriate elimination of intercompany balances and transactions.

The interim consolidated condensed financial statements are unaudited and, in management’s opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K/A for the fiscal year ended October 1, 2022 (the “2022 Annual Report”) filed with the Securities and Exchange Commission on August 8, 2023, which includes the Consolidated Balance Sheets as of October 1, 2022 and October 2, 2021, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders’ Equity and Cash Flows for each of the years in the three-year period ended October 1, 2022. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.

Fiscal Year    

Each of the Company’s first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2023 quarters end on December 31, 2022, April 1, 2023, July 1, 2023 and September 30, 2023. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2022 quarters ended on January 1, 2022, April 2, 2022, July 2, 2022 and October 1, 2022.

Nature of Business

The Company designs, develops, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company’s operating results depend upon the capital and operating expenditures of integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), foundry service providers, and other electronics manufacturers and automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry’s demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, solutions and services, including those sold or provided by the Company. These downturns and slowdowns have in the past adversely affected the Company’s operating results. The Company believes such volatility will continue to characterize the industry and the Company’s operations in the future.

Use of Estimates

The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.

Due to the persistent macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of July 1, 2023. While there was no material impact to our consolidated condensed financial statements as of and for the quarter ended July 1, 2023, these estimates may change, as new events occur and additional information is obtained, including macroeconomic headwinds that could materially impact our consolidated condensed financial statements in future reporting periods.

Significant Accounting Policies

There have been no material changes to our significant accounting policies summarized in Note 1: Basis of Presentation to our Consolidated Financial Statements included in our 2022 Annual Report.

Revision of Segment-Related Disclosures within the Previously Issued Consolidated Financial Statements

During the third quarter of fiscal year 2023, in response to comment letters from and ongoing discussions with the staff of the SEC, the Company reconsidered the guidance under ASC 280, Segment Reporting, and determined that certain prior period conclusions about the Company’s operating and reportable segments were erroneous. As a result, the Company had incorrectly presented certain segment-related disclosures in the notes to our previously issued consolidated financial statements, included in our Annual Report on Form 10-K for the year ended October 1, 2022, originally filed with the SEC on November 17, 2022 (the “Original Form 10-K”).

The Company has evaluated the materiality of the incorrect presentation of its segment-related disclosures in the notes to its consolidated financial statements and has concluded that it did not result in a material misstatement of the Company’s previously issued consolidated financial statements.

In light of the changes to the Company’s operating and reportable segments, the Company has revised, in this Quarterly Report on Form 10-Q, the segment-related disclosures in Note 4: Goodwill and Intangible Assets and Note 15: Segment Information to update the prior period presentation. The effect of this revision has been reflected in all footnotes impacted by this revision.

Recent Accounting Pronouncements

Government Assistance

In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosure by Business Entities about Government Assistance which aims at increasing the transparency of government assistance received by most business entities. The standard requires business entities to make annual disclosures about the nature of the transactions and the related accounting policy used to account for the transactions, the line items and applicable amounts on the balance sheet and income statement that are affected by the transactions, and significant terms and conditions of the transactions, including commitments and contingencies. If an entity omits any required disclosures because it is legally prohibited, it must describe the general nature of the information and indicate that the omitted disclosures are legally prohibited from being disclosed. This ASU is effective for fiscal years beginning after December 15, 2021, which for the Company is in fiscal 2023. The Company will include disclosures for material items with the filing of its Annual Report on Form 10-K for the year ending on September 30, 2023.

Business Combinations

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination in accordance with Topic 606: Revenue from Contracts with Customers. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments with early adoption permitted. We elected for an early adoption of this ASU in fiscal year 2023. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.

XML

BALANCE SHEET COMPONENTS

9 Months Ended

Jul. 01, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BALANCE SHEET COMPONENTS

2. BALANCE SHEET COMPONENTS

The following tables reflect the components of significant balance sheet accounts as of July 1, 2023 and October 1, 2022:

	As of
(in thousands)	July 1, 2023		October 1, 2022
Short-term investments, available-for-sale (1)	$	310,000	$	220,000
Inventories, net:
Raw materials and supplies	$	127,216	$	118,833
Work in process	71,052		40,114
Finished goods	49,155		45,277
	247,423		204,224
Inventory reserves	(19,432)		(19,238)
	$	227,991	$	184,986
Property, plant and equipment, net:
Land	$	2,182	$	2,182
Buildings and building improvements	22,929		22,783
Leasehold improvements	83,785		32,400
Data processing equipment and software	37,483		38,223
Machinery, equipment, furniture and fixtures	93,192		90,151
Construction in progress	11,910		25,004
	251,481		210,743
Accumulated depreciation	(137,914)		(129,835)
	$	113,567	$	80,908
Accrued expenses and other current liabilities:
Accrued customer obligations (2)	$	52,268	$	58,916
Wages and benefits	31,735		50,279
Dividends payable	10,734		9,743
Commissions and professional fees	3,825		5,019
Accrued leasehold renovations	13,378		—
Severance	—		19
Other	8,566		10,565
	$	120,506	$	134,541

(1)All short-term investments were classified as available-for-sale and the fair value approximates cost basis. The Company did not recognize any realized gains or losses on the sale of investments during the three and nine months ended July 1, 2023 and July 2, 2022.

(2)Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.

XML

BUSINESS COMBINATION

9 Months Ended

Jul. 01, 2023

Business Combinations [Abstract]

BUSINESS COMBINATION

3. BUSINESS COMBINATION

Acquisition of Advanced Jet Automation Co., Ltd. (“AJA”)

On September 8, 2022, the Company through one of its subsidiaries, Kulicke and Soffa Luxembourg S.À R.L, entered into a definitive agreement (the “Definitive Agreement”) for the acquisition of Advanced Jet Automation Co., Ltd. (“AJA”), a technology company headquartered in Taiwan. Subsequent to the acquisition, AJA has been renamed to Kulicke and Soffa Hi-Tech Co., Ltd.

On February 22, 2023 (the “Closing Date”), pursuant to the Definitive Agreement, the Company completed its acquisition of AJA, including the material business and assets formerly owned by AJA’s affiliate, Samurai Spirit Inc., a leading developer and manufacturer of high-precision micro-dispensing equipment and solutions in Taiwan. AJA became a wholly-owned subsidiary of the Company and will operate as a business unit (the “dispensing business unit”), deemed a separate operating segment (advanced dispensing) which is reported under the "All Others" category. The acquisition broadens the Company’s existing semiconductor, electronic assembly and advanced display portfolio, increasing opportunities across several exciting growth areas including mini and micro LED, which support both backlighting and direct-emissive approaches.

The purchase price consisted of $38.1 million in cash paid at closing (the “Purchase Price”) and additional potential earn-out payments based on certain revenue and earnings before interest, tax, depreciation and amortization (“EBITDA”) benchmarks established for the dispensing business unit. As at July 1, 2023, the Company held $4.0 million in escrow and will continue to hold such sums for a period of twenty-four (24) months from the Closing Date, as security pending the completion of Ruo Chuan Inc.’s obligations as the seller under the Definitive Agreement.

The Company has estimated the preliminary fair value of acquired assets and liabilities as of the date of acquisition based on current information available. The valuation of these tangible and identifiable intangible assets and liabilities is subject to further management review and may change materially between the preliminary allocation and end of the purchase price allocation period of February 21, 2024. Any changes in these estimates may have a material impact on our Consolidated Condensed Statements of Operations or Consolidated Condensed Balance Sheets.

The acquisition of AJA was accounted for in accordance with ASC No. 805, Business Combinations, using the acquisition method.

The following table summarizes the allocation of the assets acquired and liabilities assumed based on the fair values as of the Closing Date:

(in thousands)	February 22, 2023
Cash and cash equivalents	$	1,238
Account and other receivables, net	1,156
Inventory	1,581
Property, plant and equipment, net	1,462
Right-of-use assets	989
Other assets	127
Goodwill	27,975
Intangible assets	7,768
Accounts and other payables	(965)
Accrued expenses and other liabilities	(251)
Contract liabilities	(187)
Lease liability	(989)
Deferred tax liabilities	(1,785)
Total purchase price	$	38,119

Excluding inventory and property, plant and equipment, all other tangible net assets (liabilities) were valued at their respective carrying amounts, which the Company believes approximate their current fair values at the Closing Date. In connection with the acquisition of AJA, the Company recorded deferred tax liabilities primarily relating to the acquired intangible assets.

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired and includes the value of expected future cash flows of AJA from expected synergies with our other affiliates and other unidentifiable intangible assets. None of the goodwill recorded as part of the acquisition will be deductible for income tax purposes.

The following table summarizes the fair value, useful life and valuation methodology of each identifiable intangible asset.

(in thousands)	Fair Value		Useful Lives
Developed technology(1)	$	4,261	8
Customer relationships(2)	2,131		8
In-process research and development (“IPR&D”)(3)	459		N.A.
Patents(3)	524		8
Order Backlog(4)	393		1
Total identifiable intangible assets	$	7,768

(1)The fair value of developed technology was determined using the Relief-from-Royalty Method under the income approach.

(2)Customer relationships represent the fair value of the existing relationships using the Multi-Period Excess Earnings Method under the income approach.

(3)The fair value of IPR&D and Patents were determined using the Replacement Cost Method, a form of the cost approach.

(4)Order backlog represents primarily the fair value of purchase arrangements with customers using the Multi-Period Excess Earnings Method under the income approach.

IPR&D is recorded as an indefinite-lived intangible asset and not amortized, but rather is reviewed for impairment on an annual basis or more frequently if indicators of impairment are present, until the project is completed, abandoned, or transferred to a third party. Developed technology, customer relationships, patents and order backlog are amortized using a straight-line method, representing the Company’s best estimate of the distribution of the economic value of the identifiable intangible assets.

For the three and nine months ended July 1, 2023, the acquired dispensing business unit contributed to a net loss of $0.9 million and $1.3 million respectively.

For the three and nine months ended July 1, 2023, the Company incurred $0.1 million and $0.5 million of expenses related to the acquisition, respectively, which is included within selling, general and administrative expense in the Consolidated Condensed Statements of Operations.

The acquisition did not result in material contributions to revenue and net income in the consolidated financial statements for the three and nine months ended July 1, 2023. Additionally, pro forma financial information is not provided for consolidated revenue and net income as such amounts attributable to AJA were insignificant to the Company’s consolidated financial statements taken as a whole.

XML

GOODWILL AND INTANGIBLE ASSETS

9 Months Ended

Jul. 01, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS

4. GOODWILL AND INTANGIBLE ASSETS

Goodwill

Intangible assets classified as goodwill are not amortized. The goodwill established in connection with our acquisitions represents the estimated future economic benefits arising from the assets we acquired that did not qualify to be identified and recognized individually. The goodwill also includes the value of expected future cash flows from the acquisitions, expected synergies with our other affiliates and other unidentifiable intangible assets.

The Company performs an annual impairment test of its goodwill during the fourth quarter of each fiscal year, which coincides with the completion of its annual forecasting and refreshing of business outlook process.

The Company performed its annual impairment test in the fourth quarter of fiscal 2022 and concluded that no impairment charge was required. Any future adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment in the future.

In each interim period, the Company reviewed qualitative factors to ascertain if a "triggering" event may have taken place that may have the effect of reducing the fair value of the reporting unit below its carrying value. During the three months ended July 1, 2023, the Company concluded that a triggering event had occurred in connection with the Lithography reporting unit. The triggering event occurred based on the long-term financial and business outlook for the Lithography reporting unit updated as part of the Company’s annual strategic planning process performed during the third quarter. This updated outlook projected that the near-term projected cash flows are expected to be lower than previously forecasted due to a shift in market penetration timeline and increase in cost of materials being purchased. Under ASC 350, the Company is required to test its goodwill and

other intangible assets for impairment annually or when a triggering event has occurred that would indicate it is more likely than not that the fair value of the reporting unit is less than the carrying value including goodwill and other intangible assets. Accordingly, the Company has performed the goodwill impairment test for the Lithography reporting unit with reference to the guidance under ASC 350.

The Company used a discounted cash flow model to determine the fair value of the Lithography reporting unit. The cash flow projections used within the discounted cash flow model were prepared using the forecasted financial results of the reporting unit, which was based upon underlying estimates of the total market size using independent third party industry reports, and market share data developed using the combination of independent third-party data and our internal data. Significant assumptions used to determine the fair value of the Lithography reporting unit include revenue forecasts, terminal growth rate of 2.5%, working capital, tax rate and a weighted average cost of capital (discount rate) of 11.7%.

In accordance with the guidance under ASC 350, the Company’s impairment test is performed by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount by which the carrying amount of the reporting unit exceeds its fair value. Based on the calculation, the Company determined that the carrying value exceeded the fair value of this reporting unit which resulted in a goodwill impairment charge of $9.8 million, representing the entire goodwill assigned to this reporting unit. This goodwill impairment charge, which is a non-cash charge, has been reflected in the Company’s Consolidated Condensed Statements of Operations for the three and nine months ended July 1, 2023.

While we have concluded that a triggering event for the other reporting units did not occur during the quarter ended July 1, 2023, the persistent macroeconomic headwinds could impact the results of operations due to changes to assumptions utilized in the determination of the estimated fair values of the reporting units that could be significant enough to trigger an impairment.

Net sales and earnings growth rates could be negatively impacted by reductions or changes in demand for our products. The discount rate utilized in our valuation model could also be impacted by changes in the underlying interest rates and risk premiums included in the determination of the cost of capital.

As discussed in Note 1, during the third quarter of fiscal year 2023, the Company reconsidered its reportable segments and has revised the related prior period presentation in its 2022 Annual Report. As a result, its four reportable segments are (1) Ball Bonding Equipment, (2) Wedge Bonding Equipment, (3) Advanced Solutions, and (4) Aftermarket Products and Services (“APS”). All other operating segments that do not meet the quantitative threshold to be disclosed as a separate reportable segment have been grouped within an “All Others” category. Please refer to Note 15 for further information on the revision of the reportable and operating segments.

Accordingly, the Company’s goodwill as previously reported under “Capital Equipment” in prior periods has been disaggregated and presented separately into the Wedge Bonding Equipment reportable segment and the “All Others” category. There are no changes to the goodwill reported under the APS reportable segment. While there were no changes in the methodology and level at which the Company provides its goodwill impairment tests, and no resulting amendments to the total carrying amount of the goodwill, the following table shows the allocation of goodwill based on these revised segments.

The following table summarizes the Company’s recorded goodwill, where applicable, by reportable segments and the “All Others” category (refer to Note 15 for further information) as of July 1, 2023 and October 1, 2022:

(in thousands)	Wedge Bonding Equipment		APS		All Others	Total
Balance at October 1, 2022(1)	$	18,280	$	25,907	23,909	$	68,096
Acquired in business combination	—		—		27,975	$	27,975
Goodwill impairment	—		—		(9,794)	$	(9,794)
Other	—		294		2,720	$	3,014
Balance at July 1, 2023	$	18,280	$	26,201	44,810	$	89,291

(1) Cumulative goodwill impairment pertaining to the “All Others” category as of October 1, 2022 was $35.2 million.

During the quarter ended April 1, 2023, the Company recorded goodwill relating to the acquisition of AJA. For further information on the acquisition of AJA, please refer to Note 3.

Intangible Assets

Intangible assets with determinable lives are amortized over their estimated useful lives. The Company’s intangible assets consist primarily of developed technology, customer relationships, in-process research and development, and trade and brand names.

In connection with the evaluation of the goodwill impairment in the Lithography reporting unit, the Company assessed tangible and intangible assets for impairment prior to performing the first step of the goodwill impairment test. The Company used a discounted cash flow model to determine the fair value of the asset group for the Lithography reporting unit, where significant assumptions include revenue forecasts, terminal growth rate of 2.5%, working capital, tax rate and a weighted average cost of capital (discount rate) of 11.7%.

As a result of the analysis, the Company determined an impairment charge of $6.9 million on the developed technology reported within the “All Others” category for the three and nine months ended July 1, 2023. The impairment of intangible assets is a non-cash charge which has been reflected in the Company’s Consolidated Condensed Statements of Operations for the three and nine months ended July 1, 2023.

The following table reflects net intangible assets as of July 1, 2023 and October 1, 2022: 

	As of				Average estimated
(dollar amounts in thousands)	July 1, 2023		October 1, 2022		useful lives (in years)
Developed technology	$	99,614	$	89,017	6.0 to 15.0
Accumulated amortization	(65,861)		(58,636)
Impairment charges	$	(6,900)	$	—
Net developed technology	$	26,853	$	30,381
Customer relationships	$	37,259	$	33,515	5.0 to 8.0
Accumulated amortization	(35,217)		(33,515)
Net customer relationships	$	2,042	$	—
In-process research and development	$	459	$	—	N.A
Net in-process research and development	$	459	$	—
Trade and brand name	$	7,212	$	6,945	7.0 to 8.0
Accumulated amortization	(7,212)		(6,945)
Net trade and brand name	—		—
Other intangible assets	$	5,634	$	4,700	1.0 to 8.0
Accumulated amortization	(3,570)		(3,142)
Net other intangible assets	$	2,064	$	1,558
	$	31,418	$	31,939

The following table reflects estimated annual amortization expense related to intangible assets as of July 1, 2023:

	As of
(in thousands)	July 1, 2023
Remaining fiscal 2023	$	1,378
Fiscal 2024	5,274
Fiscal 2025	5,110
Fiscal 2026	5,110
Fiscal 2027	4,835
Thereafter	9,711
Total amortization expense	$	31,418

XML

CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS

9 Months Ended

Jul. 01, 2023

Cash and Cash Equivalents [Abstract]

CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS

5. CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS

Cash equivalents consist of instruments with remaining maturities of three months or less at the date of purchase. In general, these investments are free of trading restrictions.

Cash, cash equivalents, and short-term investments consisted of the following as of July 1, 2023:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	31,696	$	—	$	—	$	31,696
Cash equivalents:
Money market funds (1)	215,114		—		(13)		215,101
Time deposits (2)	155,009		—		—		155,009
Total cash and cash equivalents	$	401,819	$	—	$	(13)	$	401,806
Short-term investments:
Time deposits (2)	310,000		—		—		310,000
Total short-term investments	$	310,000	$	—	$	—	$	310,000
Total cash, cash equivalents and short-term investments	$	711,819	$	—	$	(13)	$	711,806

(1)The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2)Fair value approximates cost basis.

Cash, cash equivalents and short-term investments consisted of the following as of October 1, 2022:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	173,402	$	—	$	—	$	173,402
Cash equivalents:
Money market funds (1)	157,145		—		(20)		157,125
Time deposits (2)	225,010		—		—		225,010
Total cash and cash equivalents	$	555,557	$	—	$	(20)	$	555,537
Short-term investments:
Time deposits (2)	220,000		—		—		220,000
Total short-term investments	$	220,000	$	—	$	—	$	220,000
Total cash, cash equivalents and short-term investments	$	775,557	$	—	$	(20)	$	775,537

(1)The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2)Fair value approximates cost basis.

XML

EQUITY INVESTMENTS

9 Months Ended

Jul. 01, 2023

Equity Method Investments [Abstract]

EQUITY INVESTMENTS

6. EQUITY INVESTMENTS

Equity investments consisted of the following as of July 1, 2023 and October 1, 2022:

	As of
(in thousands)	July 1, 2023		October 1, 2022
Non-marketable equity securities	$	433	$	5,397

During the three and nine months ended July 1, 2023, the Company recorded an impairment of $5.0 million on a non-marketable equity security without a readily determinable fair value. The entire amount of the investment in the non-marketable equity security was impaired due to a significant deterioration in the earnings performance of the equity investee. The impairment amount is recorded in the Company’s Consolidated Condensed Statements of Operations.

XML

FAIR VALUE MEASUREMENTS

9 Months Ended

Jul. 01, 2023

Fair Value Disclosures [Abstract]

FAIR VALUE MEASURMENTS

7. FAIR VALUE MEASUREMENTS

Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3).

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis 

We measure certain financial assets and liabilities at fair value on a recurring basis. There were no transfers between fair value measurement levels during the three and nine months ended July 1, 2023.

Fair Value Measurements on a Nonrecurring Basis

Our non-financial assets such as intangible assets and property, plant and equipment are carried at cost unless impairment is deemed to have occurred.

Fair Value of Financial Instruments

Amounts reported as accounts receivables, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value.

XML

DERIVATIVES FINANCIAL INSTRUMENTS (Notes)

9 Months Ended

Jul. 01, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVES FINANCIAL INSTRUMENTS

8. DERIVATIVE FINANCIAL INSTRUMENTS

The Company’s international operations are exposed to changes in foreign exchange rates due to transactions denominated in currencies other than U.S. dollars. Most of the Company’s revenue and cost of materials are transacted in U.S. dollars. However, a significant amount of the Company’s operating expenses is denominated in local currencies, primarily in Singapore.

The foreign currency exposure of our operating expenses is generally hedged with foreign exchange forward contracts. The Company’s foreign exchange risk management programs include using foreign exchange forward contracts with cash flow hedge accounting designation to hedge exposures to the variability in the U.S. dollar equivalent of forecasted non-U.S. dollar-denominated operating expenses. These instruments generally mature within twelve months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings and in the same line item on the Consolidated Condensed Statements of Operations as the impact of the hedged transaction.

The fair value of derivative instruments on our Consolidated Condensed Balance Sheets as of July 1, 2023 and October 1, 2022 were as follows:

	As of
	July 1, 2023				October 1, 2022
(in thousands)	Notional Amount		Fair Value Liability Derivatives(1)		Notional Amount		Fair Value Liability Derivatives(1)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts (2)	$	58,288	$	(500)	$	57,570	$	(2,234)
Total derivatives	$	58,288	$	(500)	$	57,570	$	(2,234)

(1)The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Condensed Balance Sheets.

(2)Hedged amounts expected to be recognized to income within the next twelve months.

The effects of derivative instruments designated as cash flow hedges in our Consolidated Condensed Statements of Comprehensive Income for the three and nine months ended July 1, 2023 and July 2, 2022 were as follows:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Foreign exchange forward contract in cash flow hedging relationships:
Net (loss)/gain recognized in OCI, net of tax (1)	$	(1,280)	$	(1,233)	$	2,550	$	(1,168)
Net gain/(loss) reclassified from accumulated OCI into income, net of tax (2)	$	518	$	(170)	$	816	$	(793)

(1)Net change in the fair value of the effective portion classified in OCI.

(2)Effective portion classified as selling, general and administrative expense.

XML

LEASES

9 Months Ended

Jul. 01, 2023

Leases [Abstract]

Leases

9. LEASESWe have entered into various non-cancellable operating and finance lease agreements for certain of our offices, manufacturing, technology, sales support and service centers, equipment, and vehicles. We determine if an arrangement is a lease, or contains a lease, at inception and record the leases in our financial statements upon lease commencement, which is the date when the underlying asset is made available for use by the lessor. Our lease terms may include one or more options to extend the lease terms, for periods from one year to 20 years, when it is reasonably certain that we will exercise that option. As of July 1, 2023, there were four options to extend the lease which was recognized as a right-of-use (“ROU”) asset, or a lease liability. We have lease agreements with lease and non-lease components, and non-lease components are accounted for separately and not included in our leased assets and corresponding liabilities. We have elected not to present short-term leases on the Consolidated Condensed Balance Sheets as these leases have a lease term of 12 months or less at lease inception.

Operating leases are included in operating ROU assets, current operating lease liabilities and non-current operating lease liabilities, and finance leases are included in property, plant and equipment, accrued expenses and other current liabilities, and other liabilities on the Consolidated Condensed Balance Sheets. As of July 1, 2023 and October 1, 2022, our finance leases are not material.

The following table shows the components of lease expense:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Operating lease expense (1)	$	2,846	$	2,173	$	8,119	$	6,217

(1)Operating lease expense includes short-term lease expense, which is immaterial for the three and nine months ended July 1, 2023 and July 2, 2022.

The following table shows the cash flows arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below:

	Nine months ended
(in thousands)	July 1, 2023		July 2, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	6,913	$	5,715

The following table shows the weighted-average lease terms and discount rates for operating leases:

	As of
	July 1, 2023		October 1, 2022
Operating leases:
Weighted-average remaining lease term (in years):	7.7		8.0
Weighted-average discount rate:	6.4	%	5.8	%

Future lease payments, excluding short-term leases are detailed as follows:

	As of
(in thousands)	July 1, 2023
Remaining fiscal 2023	$	2,453
Fiscal 2024	9,088
Fiscal 2025	8,817
Fiscal 2026	8,382
Fiscal 2027	6,462
Thereafter	26,168
Total minimum lease payments	$	61,370
Less: Interest	$	13,411
Present value of lease obligations	$	47,959
Less: Current portion	$	6,569
Long-term portion of lease obligations	$	41,390

XML

DEBT AND OTHER OBLIGATIONS DEBT AND OTHER OBLIGATIONS (Notes)

9 Months Ended

Jul. 01, 2023

Debt Disclosure [Abstract]

Debt and Other Obligations

10. DEBT AND OTHER OBLIGATIONS

Bank Guarantees

On November 22, 2013, the Company obtained a $5.0 million credit facility with Citibank in connection with the issuance of bank guarantees for operational purposes. As of July 1, 2023, the outstanding amount under this facility was $3.2 million.

Credit Facilities

On February 15, 2019, the Company entered into a Facility Letter and Overdraft Agreement (collectively, the “Facility Agreements”) with MUFG Bank, Ltd., Singapore Branch (the “Bank”). The Facility Agreements provide the Company and one of its subsidiaries with an overdraft facility of up to $150.0 million (the “Overdraft Facility”) for general corporate purposes. Amounts outstanding under the Overdraft Facility, including interest, are payable upon thirty days written demand by the Bank. Interest on the Overdraft Facility is calculated on a daily basis, and the applicable interest rate is calculated at the Secured Overnight Financing Rate (“SOFR”) plus a margin of 1.5% per annum. The Overdraft Facility is an unsecured facility per the terms of the Facility Agreements. The Facility Agreements contain customary non-financial covenants, including, without limitation, covenants that restrict the Company’s ability to sell or dispose of its assets, cease owning at least 51% of two of its subsidiaries (the “Subsidiaries”), or encumber its assets with material security interests (including any pledge of monies in the Subsidiaries' cash deposit account with the Bank). The Facility Agreements also contain typical events of default, including, without limitation, non-payment of financial obligations when due, cross defaults to other material indebtedness of the Company and any breach of a representation or warranty under the Facility Agreements. As of July 1, 2023, there were no outstanding amounts under the Overdraft Facility.

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS

9 Months Ended

Jul. 01, 2023

Share-Based Payment Arrangement [Abstract]

SHAREHOLDERS’ EQUITY AND EMPLOYEE BENEFIT PLANS

11. SHAREHOLDERS’ EQUITY AND EMPLOYEE BENEFIT PLANS

401(k) Retirement Income Plans

The Company has a 401(k) retirement plan (the “401(k) Plan”) for eligible U.S. employees. The 401(k) Plan allows for employee contributions and matching Company contributions from 4% to 6% based upon terms and conditions of the 401(k) Plan.

The following table reflects the Company’s contributions to the 401(k) Plan during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Cash	$	463	$	419	$	1,477	$	1,423

Share Repurchase Program

On August 15, 2017, the Company’s Board of Directors authorized a program (the “Program”) to repurchase up to $100 million of the Company’s common stock on or before August 1, 2020. In 2018, 2019 and 2020, the Board of Directors increased the share repurchase authorization under the Program to $200 million, $300 million, and $400 million, respectively. On March 3, 2022, the Board of Directors further increased the share repurchase authorization under the Program by an additional $400 million to $800 million, and extended its duration through August 1, 2025. On May 7, 2022, the Company entered into a written trading plan under Rule 10b5-1 of the Exchange Act to facilitate repurchases under the Program. This trading plan was most recently modified on May 29, 2023. The Program may be suspended or discontinued at any time and is funded using the Company’s available cash, cash equivalents and short-term investments. Under the Program, shares may be repurchased through open market and/or privately negotiated transactions at prices deemed appropriate by management. The timing and amount of repurchase transactions under the Program depend on market conditions as well as corporate and regulatory considerations.

During the three and nine months ended July 1, 2023, the Company repurchased a total of approximately 174.9 thousand and 1,331.1 thousand shares of common stock under the Program at a cost of approximately $8.5 million and $58.9 million, respectively. The stock repurchases were recorded in the periods they were delivered and accounted for as treasury stock in the Company’s Consolidated Condensed Balance Sheets. The Company records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon re-issuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital.

If the Company reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between acquisition cost and the reissue price, this difference is recorded against retained earnings.

As of July 1, 2023, our remaining stock repurchase authorization under the Program was approximately $190.2 million.

Dividends

On November 16, 2022, the Board of Directors declared a quarterly dividend of $0.19 per share of common stock. Dividends paid during the three and nine months ended July 1, 2023 totaled $10.8 million and $31.3 million, respectively. The declaration of any future cash dividend is at the discretion of the Board of Directors and will depend on the Company’s financial condition, results of operations, capital requirements, business conditions and other factors, as well as a determination that such dividends are in the best interests of the Company’s shareholders.

Accumulated Other Comprehensive Loss

The following table reflects accumulated other comprehensive loss reflected on the Consolidated Condensed Balance Sheets as of July 1, 2023 and October 1, 2022: 

	As of
(in thousands)	July 1, 2023		October 1, 2022
Loss from foreign currency translation adjustments	$	(16,341)	$	(29,854)
Unrecognized actuarial loss on pension plan, net of tax	(884)		(812)
Unrealized loss on hedging	(500)		(2,234)
Accumulated other comprehensive loss	$	(17,725)	$	(32,900)

Equity-Based Compensation

The Company has a stockholder-approved equity-based compensation plan, the 2021 Omnibus Incentive Plan (the “Plan”) from which employees and directors receive grants. As of July 1, 2023, 2.5 million shares of common stock are available for grant to the Company’s employees and directors under the Plan.

•Relative Total Shareholder Return Performance Share Units (“Relative TSR PSUs”) entitle the employee to receive common stock of the Company on the award vesting date, typically the third anniversary of the grant date (or as soon as administratively practicable if later), if market performance objectives which measure the relative TSR are attained. Relative TSR is calculated based upon the 90-calendar day average price at the end of the performance period of the Company’s stock as compared to specific peer companies that comprise the GICS (45301020) Semiconductor Index. TSR is measured for the Company and each peer company over a performance period, which is generally three years. Vesting percentages range from 0% to 200% of awards granted. The provisions of the Relative TSR PSUs are reflected in the grant date fair value of the award; therefore, compensation expense is recognized regardless of whether the market condition is ultimately satisfied. Compensation expense is reversed if the award is forfeited prior to the vesting date.

•Revenue Growth Performance Share Units (“Growth PSUs”) entitle the employee to receive common stock of the Company on the award vesting date, typically the third anniversary of the grant date (or as soon as administratively practicable if later), based on organic revenue growth objectives and relative growth performance against named competitors as set by the Management Development and Compensation Committee (“MDCC”) of the Company’s Board of Directors. Organic revenue growth is calculated by averaging revenue growth (net of revenues from acquisitions) over a performance period, which is generally three years. Revenues from acquisitions will be included in the calculation after four fiscal quarters after acquisition. Any portion of the grant that does not meet the revenue growth objectives and relative growth performance is forfeited. Vesting percentages range from 0% to 200% of awards granted.

•In general, Time-based Restricted Share Units (“Time-based RSUs”) awarded to employees vest ratably over a three-year period on the anniversary of the grant date provided the employee remains employed by the Company.

Equity-based compensation expense recognized in the Consolidated Condensed Statements of Operations for the three and nine months ended July 1, 2023 and July 2, 2022 was based upon awards ultimately expected to vest, with forfeiture accounted for when they occur.

The following table reflects Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock granted during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended		Nine months ended
(shares in thousands)	July 1, 2023	July 2, 2022	July 1, 2023	July 2, 2022
Time-based RSUs	—	1	512	303
Relative TSR PSUs	—	—	186	154
Growth PSUs	—	—	92	77
Common stock	5	4	17	12
Equity-based compensation in shares	5	5	807	546

The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Cost of sales	$	272	$	193	$	903	$	727
Selling, general and administrative	3,800		3,233		12,398		10,485
Research and development	1,331		1,039		4,002		3,261
Total equity-based compensation expense	$	5,403	$	4,465	$	17,303	$	14,473

The following table reflects equity-based compensation expense, by type of award, for the three and nine months ended July 1, 2023 and July 2, 2022:  

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Time-based RSUs	$	3,560	$	2,845	$	10,758	$	8,763
Relative TSR PSUs	1,252		1,073		3,697		3,060
Growth PSUs	354		310		2,137		1,938
Common stock	237		237		711		712
Total equity-based compensation expense	$	5,403	$	4,465	$	17,303	$	14,473

XML

REVENUE AND CONTRACT BALANCES

9 Months Ended

Jul. 01, 2023

Revenue from Contract with Customer [Abstract]

REVENUE AND CONTRACT BALANCES

12. REVENUE AND CONTRACT BALANCES

The Company recognizes revenue when we satisfy performance obligations as evidenced by the transfer of control of our products or services to customers. In general, the Company generates revenue from product sales, either directly to customers or to distributors. In determining whether a contract exists, we evaluate the terms of the agreement, the relationship with the customer or distributor and their ability to pay. Service revenue is generally recognized over time as the services are performed. For the three and nine months ended July 1, 2023, and July 2, 2022, the service revenue was not material.

The Company reports revenue based on its reportable segments. The Company believes that reporting revenue on this basis provides information about how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Please refer to Note 15: Segment Information, for disclosure of revenue by segment.

Contract Balances

Our contract assets relate to our rights to consideration for revenue with collection dependent on events other than the passage of time, such as the achievement of specified payment milestones. The contract assets will be transferred to net account receivables as our right to consideration for these contract assets become unconditional. Contracts assets are reported in the accompanying Consolidated Condensed Balance Sheets within prepaid expenses and other current assets.

Our contract liabilities are primarily related to payments received in advance of satisfying performance obligations, and are reported in the accompanying Consolidated Condensed Balance Sheets within accrued expenses and other current liabilities.

Contract liabilities increase as a result of receiving new advance payments from customers and decrease as revenue is recognized from product sales under advance payment arrangements upon satisfying the performance obligations.

The following table shows the changes in contract asset balances during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Contract assets, beginning of period	$	29,210	$	26,721	$	26,317	$	—
Additions	1,337		18,563		4,230		45,284
Transferred to accounts receivable or collected	(20,365)		—		(20,365)		—
Contract assets, end of period	$	10,182	$	45,284	$	10,182	$	45,284

The following table shows the changes in contract liability balances during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Contract liabilities, beginning of period	$	6,556	$	17,300	$	3,160	$	15,596
Revenue recognized	(12,404)		(29,612)		(28,950)		(104,796)
Additions	11,832		17,996		31,774		94,884
Contract liabilities, end of period	$	5,984	$	5,684	$	5,984	$	5,684

XML

EARNINGS PER SHARE

9 Months Ended

Jul. 01, 2023

Earnings Per Share [Abstract]

EARNINGS PER SHARE

13. EARNINGS PER SHARE

Basic income per share is calculated using the weighted average number of shares of common stock outstanding during the period. Restricted stock are included in the calculation of diluted earnings per share, except when their effect would be anti-dilutive.

The following table reflects a reconciliation of the shares used in the basic and diluted net income per share computation for the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended
(in thousands, except per share data)	July 1, 2023				July 2, 2022
	Basic		Diluted		Basic		Diluted
NUMERATOR:
Net income	$	4,161	$	4,161	$	119,034	$	119,034
DENOMINATOR:
Weighted average shares outstanding - Basic	56,553		56,553		58,985		58,985
Dilutive effect of Equity Plans			966				970
Weighted average shares outstanding - Diluted			57,519				59,955
EPS:
Net income per share - Basic	$	0.07	$	0.07	$	2.02	$	2.02
Effect of dilutive shares			—				(0.03)
Net income per share - Diluted			$	0.07			$	1.99
Anti-dilutive shares(1)			0				19

	Nine months ended
(in thousands, except per share data)	July 1, 2023				July 2, 2022
	Basic		Diluted		Basic		Diluted
NUMERATOR:
Net income	$	33,791	$	33,791	$	368,641	$	368,641
DENOMINATOR:
Weighted average shares outstanding - Basic	56,763		56,763		60,951		60,951
Dilutive effect of Equity Plans			921				989
Weighted average shares outstanding - Diluted			57,684				61,940
EPS:
Net income per share - Basic	$	0.60	$	0.60	$	6.05	$	6.05
Effect of dilutive shares			(0.01)				(0.10)
Net income per share - Diluted			$	0.59			$	5.95
Anti-dilutive shares(1)			1				1

(1) Represents the Relative TSR PSUs and Growth PSUs that are excluded from the calculation of diluted earnings per share for the three and nine months ended July 1, 2023 and July 2, 2022 as the effect would have been anti-dilutive.

XML

INCOME TAXES

9 Months Ended

Jul. 01, 2023

Income Tax Disclosure [Abstract]

INCOME TAXES

14. INCOME TAXES

The following table reflects the provision for income taxes and the effective tax rate for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended						Nine months ended
(dollar amounts in thousands)	July 1, 2023			July 2, 2022			July 1, 2023			July 2, 2022
Provision for income taxes	$	148		$	5,165		$	9,462		$	36,813
Effective tax rate	3.4		%	4.2		%	21.9		%	9.1		%

For the three months ended July 1, 2023, the decrease in provision for income taxes as compared to the prior year period was primarily due to a decrease in profitability and the decrease in effective tax rate was primarily related to tax benefits from the reversal of uncertain tax positions partially offset by the increase in global intangible low-taxed income (“GILTI”) resulting from the capitalization of research and development expenditures as mandated by the U.S. Tax Cuts and Jobs Act of 2017. For the three months ended July 1, 2023, the effective tax rate is lower than the U.S. federal statutory tax rate primarily due to foreign income earned in lower tax jurisdictions, tax incentives, tax credits, and tax benefits from the reversal of uncertain tax positions, partially offset by GILTI.

For the nine months ended July 1, 2023, the decrease in provision for income taxes as compared to the prior year period was primarily due to a decrease in profitability and the increase in effective tax rate was primarily related to the increase in GILTI resulting from the capitalization of research and development expenditures as mandated by the U.S. Tax Cuts and Jobs Act of 2017, partially offset by tax benefits from the reversal of uncertain tax positions. For the nine months ended July 1, 2023, the effective tax rate is higher than the U.S. federal statutory tax rate primarily due to GILTI, partially offset by foreign income earned in lower tax jurisdictions, tax incentives, tax credits, and tax benefits from the reversal of uncertain tax positions.

XML

SEGMENT INFORMATION

9 Months Ended

Jul. 01, 2023

Segment Reporting [Abstract]

SEGMENT INFORMATION

15. SEGMENT INFORMATION

Reportable segments are defined as components of an enterprise that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker (the “CODM”) in deciding how to allocate resources and assess performance. The Company’s Chief Executive Officer is the CODM. The CODM does not review discrete asset information.

As discussed in Note 1, during the third quarter of fiscal year 2023, the Company reconsidered the guidance under ASC 280, Segment Reporting, and determined that certain prior period conclusions about the Company’s operating and reportable segments were erroneous. As a result, the Company had incorrectly presented certain segment-related disclosures in the notes to our previously issued consolidated financial statements.

The Company has revised the prior period presentation to reflect its four reportable segments as follows: (1) Ball Bonding Equipment, (2) Wedge Bonding Equipment, (3) Advanced Solutions, and (4) Aftermarket Products and Services (“APS”). The four reportable segments are disclosed below:

Ball Bonding Equipment: Reflects the results of the Company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment.

Wedge Bonding Equipment: Reflects the results of the Company from the design, development, manufacture and sale of wedge bonding equipment.

Advanced Solutions: Reflects the results of the Company from the design, development, manufacture and sale of certain advanced display, die-attach and thermocompression systems and solutions.

APS: Reflects the results of the Company from the design, development, manufacture and sale of a variety of tools, spares and services for our equipment.

Any other operating segments that have not been aggregated within the reportable segments described above which do not meet the quantitative threshold to be disclosed as a separate reportable segment have been grouped within an “All Others” category. This group is reflective of the results of the Company from the design, development, manufacture and sale of certain advanced display, advanced dispense, electronics assembly, die-attach and lithography systems and solutions. Results for the “All Others” category and other corporate expenses are included as a reconciling item between the Company’s reportable segments and its consolidated results of operations.

The following table reflects operating information by segment for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Net revenue:
Ball Bonding Equipment	$	76,865	$	217,912	$	184,049	$	751,496
Wedge Bonding Equipment	42,563		50,800		145,805		142,284
Advanced Solutions	23,858		34,614		58,997		71,651
APS	39,672		50,191		119,822		152,924
All Others	7,959		18,620		31,498		98,952
Net revenue	190,917		372,137		540,171		1,217,307
Income/(loss) from operations:
Ball Bonding Equipment	18,534		93,863		49,337		323,884
Wedge Bonding Equipment	15,974		19,443		$	53,958	$	49,599
Advanced Solutions	(2,570)		3,134		$	(21,160)	$	(7,574)
APS	11,510		22,282		34,778		64,651
All Others	(23,857)		2,671		(35,025)		28,372
Corporate Expenses	(24,079)		(19,316)		(61,925)		(56,404)
(Loss)/Income from operations	$	(4,488)	$	122,077	$	19,963	$	402,528

We have considered: (1) information that is regularly reviewed by our CODM in evaluating financial performance and how to allocate resources; and (2) other financial data, including information that we include in our earnings releases but which is not included in our financial statements, to disaggregate revenues by end markets served. The principal category we use to disaggregate revenues is by the end markets served.

The following table reflects net revenue by end markets served for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
General Semiconductor	$	77,745	$	223,034	$	217,186	$	670,251
Automotive & Industrial	44,973		51,018		149,608		160,366
LED	17,678		20,203		32,765		128,394
Memory	10,849		27,691		20,790		105,372
APS	39,672		50,191		119,822		152,924
Total revenue	$	190,917	$	372,137	$	540,171	$	1,217,307

The following table reflects capital expenditures, depreciation expense and amortization expense for the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Capital expenditures:
Ball Bonding Equipment	$	316	$	179	$	805	$	855
Wedge Bonding Equipment	83		358		403		780
Advanced Solutions	6,439		1,049		29,425		2,423
APS	1,251		1,151		4,443		2,851
All Others	30		437		279		700
Corporate Expenses	2,332		1,779		8,130		3,604
	$	10,451	$	4,953	$	43,485	$	11,213
Depreciation expense:
Ball Bonding Equipment	$	388	$	346	$	1,173	$	1,012
Wedge Bonding Equipment	304		252		878		732
Advanced Solutions	2,989		519		4,821		1,494
APS	1,517		1,681		4,742		4,971
All Others	416		250		1,017		792
Corporate Expenses	1,191		1,053		3,372		3,229
	$	6,805	$	4,101	$	16,003	$	12,230
Amortization expense:
Ball Bonding Equipment	$	—	$	—	$	—	$	—
Wedge Bonding Equipment	—		—		—		—
Advanced Solutions	—		—		—		—
APS	380		208		1,116		684
All Others	1,314		809		3,352		2,584
Corporate Expenses	92		92		275		275
	$	1,786	$	1,109	$	4,743	$	3,543

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Notes)

9 Months Ended

Jul. 01, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS

16. COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS

Warranty Expense

The Company’s equipment is generally shipped with a one-year warranty against manufacturing defects. The Company establishes reserves for estimated warranty expense when revenue for the related equipment is recognized. The reserve for estimated warranty expense is based upon historical experience and management’s estimate of future warranty costs, including product part replacement, freight charges and related labor costs expected to be incurred in correcting manufacturing defects during the warranty period.

The following table reflects the reserve for warranty activity for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Reserve for warranty, beginning of period	$	10,468	$	15,518	$	13,443	$	16,961
Provision for warranty	4,007		2,842		8,989		9,001
Utilization of reserve	(3,908)		(4,118)		(11,865)		(11,720)
Reserve for warranty, end of period	$	10,567	$	14,242	$	10,567	$	14,242

Other Commitments and Contingencies

The following table reflects obligations not reflected on the Consolidated Condensed Balance Sheets as of July 1, 2023:

			Payments due by fiscal year
(in thousands)	Total		2023		2024		2025		2026		2027		thereafter
Inventory purchase obligation (1)	$	198,566	$	21,676	$	176,890	$	—	$	—	$	—	$	—

(1)The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancelable and a portion may have varying penalties and charges in the event of cancellation.

From time to time, the Company is party to or the target of lawsuits, claims, investigations and proceedings, including for personal injury, intellectual property, commercial, contract, and employment matters, which are handled and defended in the ordinary course of business. The Company accrues a contingent loss liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When a single amount cannot be reasonably estimated but the cost can be estimated within a range, the Company accrues the minimum amount. The Company expenses legal costs, including those expected to be incurred in connection with a loss contingency, as incurred.

Unfunded Capital Commitments

As of July 1, 2023, the Company also has an obligation to fund uncalled capital commitments of approximately $9.6 million, as and when required, in relation to its investment in a private equity fund.

Concentrations

The following table reflects significant customer concentrations as a percentage of net revenue for the nine months ended July 1, 2023 and July 2, 2022:

	Nine months ended
	July 1, 2023		July 2, 2022
First Technology China Ltd.(1)	10.0	%	*

* Represents less than 10% of total net revenue

(1) Distributor of the Company's products

The following table reflects significant customer concentrations as a percentage of total accounts receivable as of July 1, 2023 and July 2, 2022:

	As of
	July 1, 2023		July 2, 2022
Intel Corporation	12.2	%	*
Apple Inc.	10.3	%	*
Tianshui Huatian Technology Co., Ltd.	*		20.6	%

* Represents less than 10% of total accounts receivable

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Jul. 01, 2023	Jul. 02, 2022
Pay vs Performance Disclosure
Net income	$ 4,161	$ 15,041	$ 14,589	$ 119,034	$ 116,001	$ 133,606	$ 33,791	$ 368,641

XML

Insider Trading Arrangements	9 Months Ended
	Jul. 01, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

BASIS OF PRESENTATION (Policies)

9 Months Ended

Jul. 01, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Consolidation

These consolidated condensed financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (“we,” “us,” “our,” or the “Company”), with appropriate elimination of intercompany balances and transactions.

The interim consolidated condensed financial statements are unaudited and, in management’s opinion, include all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement of results for these interim periods. The interim consolidated condensed financial statements do not include all of the information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K/A for the fiscal year ended October 1, 2022 (the “2022 Annual Report”) filed with the Securities and Exchange Commission on August 8, 2023, which includes the Consolidated Balance Sheets as of October 1, 2022 and October 2, 2021, and the related Consolidated Statements of Operations, Statements of Comprehensive Income, Changes in Shareholders’ Equity and Cash Flows for each of the years in the three-year period ended October 1, 2022. The results of operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for a full year.

Fiscal Year

Fiscal Year    Each of the Company’s first three fiscal quarters end on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30. Fiscal 2023 quarters end on December 31, 2022, April 1, 2023, July 1, 2023 and September 30, 2023. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. Fiscal 2022 quarters ended on January 1, 2022, April 2, 2022, July 2, 2022 and October 1, 2022.

Nature of business

Nature of Business

The Company designs, develops, manufactures and sells capital equipment and tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company’s operating results depend upon the capital and operating expenditures of integrated device manufacturers (“IDMs”), outsourced semiconductor assembly and test providers (“OSATs”), foundry service providers, and other electronics manufacturers and automotive electronics suppliers worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry’s demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, tools, solutions and services, including those sold or provided by the Company. These downturns and slowdowns have in the past adversely affected the Company’s operating results. The Company believes such volatility will continue to characterize the industry and the Company’s operations in the future.

Use of Estimates

Use of Estimates

The preparation of consolidated condensed financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated condensed financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, the valuation estimates and assessment of impairment and observable price adjustments, income taxes, equity-based compensation expense, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of the Company’s assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.

Due to the persistent macroeconomic headwinds, there has been uncertainty and disruption in the global economy and financial markets. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of July 1, 2023. While there was no material impact to our consolidated condensed financial statements as of and for the quarter ended July 1, 2023, these estimates may change, as new events occur and additional information is obtained, including macroeconomic headwinds that could materially impact our consolidated condensed financial statements in future reporting periods.

Revision of Segment-Related Disclosures within the Previously Issued Consolidated Financial Statements

Revision of Segment-Related Disclosures within the Previously Issued Consolidated Financial Statements

During the third quarter of fiscal year 2023, in response to comment letters from and ongoing discussions with the staff of the SEC, the Company reconsidered the guidance under ASC 280, Segment Reporting, and determined that certain prior period conclusions about the Company’s operating and reportable segments were erroneous. As a result, the Company had incorrectly presented certain segment-related disclosures in the notes to our previously issued consolidated financial statements, included in our Annual Report on Form 10-K for the year ended October 1, 2022, originally filed with the SEC on November 17, 2022 (the “Original Form 10-K”).

The Company has evaluated the materiality of the incorrect presentation of its segment-related disclosures in the notes to its consolidated financial statements and has concluded that it did not result in a material misstatement of the Company’s previously issued consolidated financial statements.

In light of the changes to the Company’s operating and reportable segments, the Company has revised, in this Quarterly Report on Form 10-Q, the segment-related disclosures in Note 4: Goodwill and Intangible Assets and Note 15: Segment Information to update the prior period presentation. The effect of this revision has been reflected in all footnotes impacted by this revision.

Recent accounting pronouncements

Recent Accounting Pronouncements

Government Assistance

In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832): Disclosure by Business Entities about Government Assistance which aims at increasing the transparency of government assistance received by most business entities. The standard requires business entities to make annual disclosures about the nature of the transactions and the related accounting policy used to account for the transactions, the line items and applicable amounts on the balance sheet and income statement that are affected by the transactions, and significant terms and conditions of the transactions, including commitments and contingencies. If an entity omits any required disclosures because it is legally prohibited, it must describe the general nature of the information and indicate that the omitted disclosures are legally prohibited from being disclosed. This ASU is effective for fiscal years beginning after December 15, 2021, which for the Company is in fiscal 2023. The Company will include disclosures for material items with the filing of its Annual Report on Form 10-K for the year ending on September 30, 2023.

Business Combinations

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination in accordance with Topic 606: Revenue from Contracts with Customers. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments with early adoption permitted. We elected for an early adoption of this ASU in fiscal year 2023. The adoption of this ASU did not have a material impact on our consolidated condensed financial statements.

XML

BALANCE SHEET COMPONENTS (Tables)

9 Months Ended

Jul. 01, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Components of significant balance sheet accounts

The following tables reflect the components of significant balance sheet accounts as of July 1, 2023 and October 1, 2022:

	As of
(in thousands)	July 1, 2023		October 1, 2022
Short-term investments, available-for-sale (1)	$	310,000	$	220,000
Inventories, net:
Raw materials and supplies	$	127,216	$	118,833
Work in process	71,052		40,114
Finished goods	49,155		45,277
	247,423		204,224
Inventory reserves	(19,432)		(19,238)
	$	227,991	$	184,986
Property, plant and equipment, net:
Land	$	2,182	$	2,182
Buildings and building improvements	22,929		22,783
Leasehold improvements	83,785		32,400
Data processing equipment and software	37,483		38,223
Machinery, equipment, furniture and fixtures	93,192		90,151
Construction in progress	11,910		25,004
	251,481		210,743
Accumulated depreciation	(137,914)		(129,835)
	$	113,567	$	80,908
Accrued expenses and other current liabilities:
Accrued customer obligations (2)	$	52,268	$	58,916
Wages and benefits	31,735		50,279
Dividends payable	10,734		9,743
Commissions and professional fees	3,825		5,019
Accrued leasehold renovations	13,378		—
Severance	—		19
Other	8,566		10,565
	$	120,506	$	134,541

(1)All short-term investments were classified as available-for-sale and the fair value approximates cost basis. The Company did not recognize any realized gains or losses on the sale of investments during the three and nine months ended July 1, 2023 and July 2, 2022.

(2)Represents customer advance payments, customer credit program, accrued warranty expense and accrued retrofit obligations.

XML

BUSINESS COMBINATION (Tables)

9 Months Ended

Jul. 01, 2023

Business Combinations [Abstract]

Summary of assets acquired and liabilities assumed as of acquisition date

The following table summarizes the allocation of the assets acquired and liabilities assumed based on the fair values as of the Closing Date:

(in thousands)	February 22, 2023
Cash and cash equivalents	$	1,238
Account and other receivables, net	1,156
Inventory	1,581
Property, plant and equipment, net	1,462
Right-of-use assets	989
Other assets	127
Goodwill	27,975
Intangible assets	7,768
Accounts and other payables	(965)
Accrued expenses and other liabilities	(251)
Contract liabilities	(187)
Lease liability	(989)
Deferred tax liabilities	(1,785)
Total purchase price	$	38,119

The following table summarizes the fair value, useful life and valuation methodology of each identifiable intangible asset.

(in thousands)	Fair Value		Useful Lives
Developed technology(1)	$	4,261	8
Customer relationships(2)	2,131		8
In-process research and development (“IPR&D”)(3)	459		N.A.
Patents(3)	524		8
Order Backlog(4)	393		1
Total identifiable intangible assets	$	7,768

(1)The fair value of developed technology was determined using the Relief-from-Royalty Method under the income approach.

(2)Customer relationships represent the fair value of the existing relationships using the Multi-Period Excess Earnings Method under the income approach.

(3)The fair value of IPR&D and Patents were determined using the Replacement Cost Method, a form of the cost approach.

(4)Order backlog represents primarily the fair value of purchase arrangements with customers using the Multi-Period Excess Earnings Method under the income approach.

XML

GOODWILL AND INTANGIBLE ASSETS (Tables)

9 Months Ended

Jul. 01, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

The following table summarizes the Company’s recorded goodwill, where applicable, by reportable segments and the “All Others” category (refer to Note 15 for further information) as of July 1, 2023 and October 1, 2022:

(in thousands)	Wedge Bonding Equipment		APS		All Others	Total
Balance at October 1, 2022(1)	$	18,280	$	25,907	23,909	$	68,096
Acquired in business combination	—		—		27,975	$	27,975
Goodwill impairment	—		—		(9,794)	$	(9,794)
Other	—		294		2,720	$	3,014
Balance at July 1, 2023	$	18,280	$	26,201	44,810	$	89,291

(1) Cumulative goodwill impairment pertaining to the “All Others” category as of October 1, 2022 was $35.2 million.

During the quarter ended April 1, 2023, the Company recorded goodwill relating to the acquisition of AJA. For further information on the acquisition of AJA, please refer to Note 3.

Net intangible assets

The following table reflects net intangible assets as of July 1, 2023 and October 1, 2022: 

	As of				Average estimated
(dollar amounts in thousands)	July 1, 2023		October 1, 2022		useful lives (in years)
Developed technology	$	99,614	$	89,017	6.0 to 15.0
Accumulated amortization	(65,861)		(58,636)
Impairment charges	$	(6,900)	$	—
Net developed technology	$	26,853	$	30,381
Customer relationships	$	37,259	$	33,515	5.0 to 8.0
Accumulated amortization	(35,217)		(33,515)
Net customer relationships	$	2,042	$	—
In-process research and development	$	459	$	—	N.A
Net in-process research and development	$	459	$	—
Trade and brand name	$	7,212	$	6,945	7.0 to 8.0
Accumulated amortization	(7,212)		(6,945)
Net trade and brand name	—		—
Other intangible assets	$	5,634	$	4,700	1.0 to 8.0
Accumulated amortization	(3,570)		(3,142)
Net other intangible assets	$	2,064	$	1,558
	$	31,418	$	31,939

Estimated annual amortization expense related to intangible assets

The following table reflects estimated annual amortization expense related to intangible assets as of July 1, 2023:

	As of
(in thousands)	July 1, 2023
Remaining fiscal 2023	$	1,378
Fiscal 2024	5,274
Fiscal 2025	5,110
Fiscal 2026	5,110
Fiscal 2027	4,835
Thereafter	9,711
Total amortization expense	$	31,418

XML

CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS (Tables)

9 Months Ended

Jul. 01, 2023

Cash and Cash Equivalents [Abstract]

Cash, cash equivalents, restricted cash and short-term investments

Cash, cash equivalents, and short-term investments consisted of the following as of July 1, 2023:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	31,696	$	—	$	—	$	31,696
Cash equivalents:
Money market funds (1)	215,114		—		(13)		215,101
Time deposits (2)	155,009		—		—		155,009
Total cash and cash equivalents	$	401,819	$	—	$	(13)	$	401,806
Short-term investments:
Time deposits (2)	310,000		—		—		310,000
Total short-term investments	$	310,000	$	—	$	—	$	310,000
Total cash, cash equivalents and short-term investments	$	711,819	$	—	$	(13)	$	711,806

(1)The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2)Fair value approximates cost basis.

Cash, cash equivalents and short-term investments consisted of the following as of October 1, 2022:

(in thousands)	Amortized Cost		Unrealized Gains		Unrealized Losses		Estimated Fair Value
Current assets:
Cash	$	173,402	$	—	$	—	$	173,402
Cash equivalents:
Money market funds (1)	157,145		—		(20)		157,125
Time deposits (2)	225,010		—		—		225,010
Total cash and cash equivalents	$	555,557	$	—	$	(20)	$	555,537
Short-term investments:
Time deposits (2)	220,000		—		—		220,000
Total short-term investments	$	220,000	$	—	$	—	$	220,000
Total cash, cash equivalents and short-term investments	$	775,557	$	—	$	(20)	$	775,537

(1)The fair value was determined using unadjusted prices in active, accessible markets for identical assets, and as such they were classified as Level 1 assets in the fair value hierarchy.

(2)Fair value approximates cost basis.

XML

EQUITY INVESTMENTS (Tables)

9 Months Ended

Jul. 01, 2023

Equity Method Investments [Abstract]

Equity investments

Equity investments consisted of the following as of July 1, 2023 and October 1, 2022:

	As of
(in thousands)	July 1, 2023		October 1, 2022
Non-marketable equity securities	$	433	$	5,397

During the three and nine months ended July 1, 2023, the Company recorded an impairment of $5.0 million on a non-marketable equity security without a readily determinable fair value. The entire amount of the investment in the non-marketable equity security was impaired due to a significant deterioration in the earnings performance of the equity investee. The impairment amount is recorded in the Company’s Consolidated Condensed Statements of Operations.

XML

DERIVATIVES FINANCIAL INSTRUMENTS (Tables)

9 Months Ended

Jul. 01, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The fair value of derivative instruments on our Consolidated Condensed Balance Sheets as of July 1, 2023 and October 1, 2022 were as follows:

	As of
	July 1, 2023				October 1, 2022
(in thousands)	Notional Amount		Fair Value Liability Derivatives(1)		Notional Amount		Fair Value Liability Derivatives(1)
Derivatives designated as hedging instruments:
Foreign exchange forward contracts (2)	$	58,288	$	(500)	$	57,570	$	(2,234)
Total derivatives	$	58,288	$	(500)	$	57,570	$	(2,234)

(1)The fair value of derivative liabilities is measured using level 2 fair value inputs and is included in accrued expenses and other current liabilities on our Consolidated Condensed Balance Sheets.

(2)Hedged amounts expected to be recognized to income within the next twelve months.

Derivative Instruments, Gain (Loss)

The effects of derivative instruments designated as cash flow hedges in our Consolidated Condensed Statements of Comprehensive Income for the three and nine months ended July 1, 2023 and July 2, 2022 were as follows:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Foreign exchange forward contract in cash flow hedging relationships:
Net (loss)/gain recognized in OCI, net of tax (1)	$	(1,280)	$	(1,233)	$	2,550	$	(1,168)
Net gain/(loss) reclassified from accumulated OCI into income, net of tax (2)	$	518	$	(170)	$	816	$	(793)

(1)Net change in the fair value of the effective portion classified in OCI.

(2)Effective portion classified as selling, general and administrative expense.

XML

LEASES (Tables)

9 Months Ended

Jul. 01, 2023

Leases [Abstract]

Lease expense and components of lease expense

The following table shows the components of lease expense:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Operating lease expense (1)	$	2,846	$	2,173	$	8,119	$	6,217

(1)Operating lease expense includes short-term lease expense, which is immaterial for the three and nine months ended July 1, 2023 and July 2, 2022.

The following table shows the cash flows arising from lease transactions. Cash payments related to short-term leases are not included in the measurement of operating lease liabilities, and, as such, are excluded from the amounts below:

	Nine months ended
(in thousands)	July 1, 2023		July 2, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases	$	6,913	$	5,715

Weighted-average lease terms and discount rates

The following table shows the weighted-average lease terms and discount rates for operating leases:

	As of
	July 1, 2023		October 1, 2022
Operating leases:
Weighted-average remaining lease term (in years):	7.7		8.0
Weighted-average discount rate:	6.4	%	5.8	%

Future lease payments after ASC 842 adoption

Future lease payments, excluding short-term leases are detailed as follows:

	As of
(in thousands)	July 1, 2023
Remaining fiscal 2023	$	2,453
Fiscal 2024	9,088
Fiscal 2025	8,817
Fiscal 2026	8,382
Fiscal 2027	6,462
Thereafter	26,168
Total minimum lease payments	$	61,370
Less: Interest	$	13,411
Present value of lease obligations	$	47,959
Less: Current portion	$	6,569
Long-term portion of lease obligations	$	41,390

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Tables)

9 Months Ended

Jul. 01, 2023

Share-Based Payment Arrangement [Abstract]

Company’s matching contributions to the Plan

The following table reflects the Company’s contributions to the 401(k) Plan during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Cash	$	463	$	419	$	1,477	$	1,423

Accumulated other comprehensive income reflected on the Consolidated Balance Sheets

The following table reflects accumulated other comprehensive loss reflected on the Consolidated Condensed Balance Sheets as of July 1, 2023 and October 1, 2022: 

	As of
(in thousands)	July 1, 2023		October 1, 2022
Loss from foreign currency translation adjustments	$	(16,341)	$	(29,854)
Unrecognized actuarial loss on pension plan, net of tax	(884)		(812)
Unrealized loss on hedging	(500)		(2,234)
Accumulated other comprehensive loss	$	(17,725)	$	(32,900)

Restricted stock and common stock granted

The following table reflects Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock granted during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended		Nine months ended
(shares in thousands)	July 1, 2023	July 2, 2022	July 1, 2023	July 2, 2022
Time-based RSUs	—	1	512	303
Relative TSR PSUs	—	—	186	154
Growth PSUs	—	—	92	77
Common stock	5	4	17	12
Equity-based compensation in shares	5	5	807	546

Equity-based compensation expense

The following table reflects total equity-based compensation expense, which includes Time-based RSUs, Relative TSR PSUs, Growth PSUs and common stock, included in the Consolidated Condensed Statements of Operations during the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Cost of sales	$	272	$	193	$	903	$	727
Selling, general and administrative	3,800		3,233		12,398		10,485
Research and development	1,331		1,039		4,002		3,261
Total equity-based compensation expense	$	5,403	$	4,465	$	17,303	$	14,473

The following table reflects equity-based compensation expense, by type of award, for the three and nine months ended July 1, 2023 and July 2, 2022:  

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Time-based RSUs	$	3,560	$	2,845	$	10,758	$	8,763
Relative TSR PSUs	1,252		1,073		3,697		3,060
Growth PSUs	354		310		2,137		1,938
Common stock	237		237		711		712
Total equity-based compensation expense	$	5,403	$	4,465	$	17,303	$	14,473

XML

REVENUE AND CONTRACT BALANCES (Tables)

9 Months Ended

Jul. 01, 2023

Revenue from Contract with Customer [Abstract]

Contract Assets and Liabilities

The following table shows the changes in contract asset balances during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Contract assets, beginning of period	$	29,210	$	26,721	$	26,317	$	—
Additions	1,337		18,563		4,230		45,284
Transferred to accounts receivable or collected	(20,365)		—		(20,365)		—
Contract assets, end of period	$	10,182	$	45,284	$	10,182	$	45,284

The following table shows the changes in contract liability balances during the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Contract liabilities, beginning of period	$	6,556	$	17,300	$	3,160	$	15,596
Revenue recognized	(12,404)		(29,612)		(28,950)		(104,796)
Additions	11,832		17,996		31,774		94,884
Contract liabilities, end of period	$	5,984	$	5,684	$	5,984	$	5,684

XML

EARNINGS PER SHARE (Tables)

9 Months Ended

Jul. 01, 2023

Earnings Per Share [Abstract]

Reconciliation of shares used in the basic and diluted net income per share computation

The following table reflects a reconciliation of the shares used in the basic and diluted net income per share computation for the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended
(in thousands, except per share data)	July 1, 2023				July 2, 2022
	Basic		Diluted		Basic		Diluted
NUMERATOR:
Net income	$	4,161	$	4,161	$	119,034	$	119,034
DENOMINATOR:
Weighted average shares outstanding - Basic	56,553		56,553		58,985		58,985
Dilutive effect of Equity Plans			966				970
Weighted average shares outstanding - Diluted			57,519				59,955
EPS:
Net income per share - Basic	$	0.07	$	0.07	$	2.02	$	2.02
Effect of dilutive shares			—				(0.03)
Net income per share - Diluted			$	0.07			$	1.99
Anti-dilutive shares(1)			0				19

	Nine months ended
(in thousands, except per share data)	July 1, 2023				July 2, 2022
	Basic		Diluted		Basic		Diluted
NUMERATOR:
Net income	$	33,791	$	33,791	$	368,641	$	368,641
DENOMINATOR:
Weighted average shares outstanding - Basic	56,763		56,763		60,951		60,951
Dilutive effect of Equity Plans			921				989
Weighted average shares outstanding - Diluted			57,684				61,940
EPS:
Net income per share - Basic	$	0.60	$	0.60	$	6.05	$	6.05
Effect of dilutive shares			(0.01)				(0.10)
Net income per share - Diluted			$	0.59			$	5.95
Anti-dilutive shares(1)			1				1

(1) Represents the Relative TSR PSUs and Growth PSUs that are excluded from the calculation of diluted earnings per share for the three and nine months ended July 1, 2023 and July 2, 2022 as the effect would have been anti-dilutive.

XML

INCOME TAXES (Tables)

9 Months Ended

Jul. 01, 2023

Income Tax Disclosure [Abstract]

Provision for income taxes and the effective tax rate

The following table reflects the provision for income taxes and the effective tax rate for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended						Nine months ended
(dollar amounts in thousands)	July 1, 2023			July 2, 2022			July 1, 2023			July 2, 2022
Provision for income taxes	$	148		$	5,165		$	9,462		$	36,813
Effective tax rate	3.4		%	4.2		%	21.9		%	9.1		%

XML

SEGMENT INFORMATION (Tables)

9 Months Ended

Jul. 01, 2023

Segment Reporting [Abstract]

Operating information by segment

The following table reflects operating information by segment for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Net revenue:
Ball Bonding Equipment	$	76,865	$	217,912	$	184,049	$	751,496
Wedge Bonding Equipment	42,563		50,800		145,805		142,284
Advanced Solutions	23,858		34,614		58,997		71,651
APS	39,672		50,191		119,822		152,924
All Others	7,959		18,620		31,498		98,952
Net revenue	190,917		372,137		540,171		1,217,307
Income/(loss) from operations:
Ball Bonding Equipment	18,534		93,863		49,337		323,884
Wedge Bonding Equipment	15,974		19,443		$	53,958	$	49,599
Advanced Solutions	(2,570)		3,134		$	(21,160)	$	(7,574)
APS	11,510		22,282		34,778		64,651
All Others	(23,857)		2,671		(35,025)		28,372
Corporate Expenses	(24,079)		(19,316)		(61,925)		(56,404)
(Loss)/Income from operations	$	(4,488)	$	122,077	$	19,963	$	402,528

Schedule of net revenue by Capital Equipment end markets

The following table reflects net revenue by end markets served for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
General Semiconductor	$	77,745	$	223,034	$	217,186	$	670,251
Automotive & Industrial	44,973		51,018		149,608		160,366
LED	17,678		20,203		32,765		128,394
Memory	10,849		27,691		20,790		105,372
APS	39,672		50,191		119,822		152,924
Total revenue	$	190,917	$	372,137	$	540,171	$	1,217,307

Capital expenditures, depreciation and amortization expense

The following table reflects capital expenditures, depreciation expense and amortization expense for the three and nine months ended July 1, 2023 and July 2, 2022:

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Capital expenditures:
Ball Bonding Equipment	$	316	$	179	$	805	$	855
Wedge Bonding Equipment	83		358		403		780
Advanced Solutions	6,439		1,049		29,425		2,423
APS	1,251		1,151		4,443		2,851
All Others	30		437		279		700
Corporate Expenses	2,332		1,779		8,130		3,604
	$	10,451	$	4,953	$	43,485	$	11,213
Depreciation expense:
Ball Bonding Equipment	$	388	$	346	$	1,173	$	1,012
Wedge Bonding Equipment	304		252		878		732
Advanced Solutions	2,989		519		4,821		1,494
APS	1,517		1,681		4,742		4,971
All Others	416		250		1,017		792
Corporate Expenses	1,191		1,053		3,372		3,229
	$	6,805	$	4,101	$	16,003	$	12,230
Amortization expense:
Ball Bonding Equipment	$	—	$	—	$	—	$	—
Wedge Bonding Equipment	—		—		—		—
Advanced Solutions	—		—		—		—
APS	380		208		1,116		684
All Others	1,314		809		3,352		2,584
Corporate Expenses	92		92		275		275
	$	1,786	$	1,109	$	4,743	$	3,543

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Tables)

9 Months Ended

Jul. 01, 2023

Commitments and Contingencies Disclosure [Abstract]

Reserve for product warranty activity

The following table reflects the reserve for warranty activity for the three and nine months ended July 1, 2023 and July 2, 2022: 

	Three months ended				Nine months ended
(in thousands)	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
Reserve for warranty, beginning of period	$	10,468	$	15,518	$	13,443	$	16,961
Provision for warranty	4,007		2,842		8,989		9,001
Utilization of reserve	(3,908)		(4,118)		(11,865)		(11,720)
Reserve for warranty, end of period	$	10,567	$	14,242	$	10,567	$	14,242

Obligations not reflected on the Consolidated Balance Sheet

The following table reflects obligations not reflected on the Consolidated Condensed Balance Sheets as of July 1, 2023:

			Payments due by fiscal year
(in thousands)	Total		2023		2024		2025		2026		2027		thereafter
Inventory purchase obligation (1)	$	198,566	$	21,676	$	176,890	$	—	$	—	$	—	$	—

(1)The Company orders inventory components in the normal course of its business. A portion of these orders are non-cancelable and a portion may have varying penalties and charges in the event of cancellation.

Schedule of Revenue by Major Customers by Reporting Segments

The following table reflects significant customer concentrations as a percentage of net revenue for the nine months ended July 1, 2023 and July 2, 2022:

	Nine months ended
	July 1, 2023		July 2, 2022
First Technology China Ltd.(1)	10.0	%	*

* Represents less than 10% of total net revenue

(1) Distributor of the Company's products

Significant customer concentrations as a percentage of total accounts receivable

The following table reflects significant customer concentrations as a percentage of total accounts receivable as of July 1, 2023 and July 2, 2022:

	As of
	July 1, 2023		July 2, 2022
Intel Corporation	12.2	%	*
Apple Inc.	10.3	%	*
Tianshui Huatian Technology Co., Ltd.	*		20.6	%

* Represents less than 10% of total accounts receivable

XML

BALANCE SHEET COMPONENTS (Components of significant balance sheet accounts) (Details) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Short-term investments	$ 310,000	$ 220,000
Inventories, net:
Raw materials and supplies	127,216	118,833
Work in process	71,052	40,114
Finished goods	49,155	45,277
Inventory, gross	247,423	204,224
Inventory reserves	(19,432)	(19,238)
Inventories, net	227,991	184,986
Property, plant and equipment, net:
Land	2,182	2,182
Buildings and building improvements	22,929	22,783
Leasehold improvements	83,785	32,400
Data processing equipment and software	37,483	38,223
Machinery, equipment, furniture and fixtures	93,192	90,151
Construction in progress	11,910	25,004
Property, plant and equipment, gross	251,481	210,743
Accumulated depreciation	(137,914)	(129,835)
Property, plant and equipment, net	113,567	80,908
Accrued expenses and other current liabilities:
Accrued customer obligations	52,268	58,916
Wages and benefits	31,735	50,279
Dividends payable	10,734	9,743
Commissions and professional fees	3,825	5,019
Accrued leasehold renovations	13,378	0
Severance	0	19
Other	8,566	10,565
Accrued expenses and other current liabilities	$ 120,506	$ 134,541

XML

BUSINESS COMBINATION (Narrative) (Details) - Advanced Jet Automation Co. Ltd - USD ($) $ in Millions		3 Months Ended	9 Months Ended
	Feb. 23, 2023	Jul. 01, 2023	Jul. 01, 2023
Business Acquisition [Line Items]
Cash purchase price	$ 38.1
Amount held in escrow		$ 4.0	$ 4.0
Business acquisition, net income (loss)		(0.9)	(1.3)
Expenses incurred related to the acquisition		$ 0.1	$ 0.5
Amount held in escrow, period from acquisition date			24 months

XML

BUSINESS COMBINATION (Assets Acquired and Liabilities Assumed) (Details) - USD ($) $ in Thousands	Jul. 01, 2023	Feb. 22, 2023	Oct. 01, 2022
Business Acquisition [Line Items]
Goodwill	$ 89,291		$ 68,096
Advanced Jet Automation Co. Ltd
Business Acquisition [Line Items]
Cash and cash equivalents		$ 1,238
Account and other receivables, net		1,156
Inventory		1,581
Property, plant and equipment, net		1,462
Right-of-use assets		989
Other assets		127
Goodwill		27,975
Intangible assets		7,768
Accounts and other payables		(965)
Accrued expenses and other liabilities		(251)
Contract liabilities		(187)
Lease liability		(989)
Deferred tax liabilities		(1,785)
Total purchase price		$ 38,119

XML

BUSINESS COMBINATION (Intangible assets acquired) (Details) - Advanced Jet Automation Co. Ltd $ in Thousands	Feb. 22, 2023 USD ($)
Business Acquisition [Line Items]
Intangible assets	$ 7,768
Developed technology
Business Acquisition [Line Items]
Intangible assets	$ 4,261
Useful Lives	8 years
Customer relationships
Business Acquisition [Line Items]
Intangible assets	$ 2,131
Useful Lives	8 years
In-process research and development
Business Acquisition [Line Items]
Intangible assets	$ 459
Patents
Business Acquisition [Line Items]
Intangible assets	$ 524
Useful Lives	8 years
Order Backlog
Business Acquisition [Line Items]
Intangible assets	$ 393
Useful Lives	1 year

XML

GOODWILL AND INTANGIBLE ASSETS (Goodwill by Reportable Segment) (Details) - USD ($) $ in Thousands	9 Months Ended
	Jul. 01, 2023	Oct. 01, 2022
Goodwill [Roll Forward]
Balance at October 1, 2022	$ 68,096
Acquired in business combination	27,975
Goodwill impairment	9,794
Other	3,014
Balance at July 1, 2023	89,291
Goodwill, cumulative impairment		$ 35,200
Ball Bonding Equipment
Goodwill [Roll Forward]
Balance at October 1, 2022	18,280
Acquired in business combination	0
Goodwill impairment	0
Other	0
Balance at July 1, 2023	18,280
APS
Goodwill [Roll Forward]
Balance at October 1, 2022	25,907
Acquired in business combination	0
Goodwill impairment	0
Other	294
Balance at July 1, 2023	26,201
All Others
Goodwill [Roll Forward]
Balance at October 1, 2022	23,909
Acquired in business combination	27,975
Goodwill impairment	9,794
Other	2,720
Balance at July 1, 2023	$ 44,810

XML

GOODWILL AND INTANGIBLE ASSETS (Net intangible assets) (Details) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Schedule Of Intangible Assets [Line Items]
Net intangible assets	$ 31,418	$ 31,939
In-process research and development
Schedule Of Intangible Assets [Line Items]
Gross intangible assets	459	0
Net intangible assets	459	0
Developed technology
Schedule Of Intangible Assets [Line Items]
Gross intangible assets	99,614	89,017
Accumulated amortization	(65,861)	(58,636)
Impairment charges	(6,900)	0
Net intangible assets	$ 26,853	30,381
Developed technology | Minimum
Schedule Of Intangible Assets [Line Items]
Estimated useful life	6 years
Developed technology | Maximum
Schedule Of Intangible Assets [Line Items]
Estimated useful life	15 years
Customer relationships
Schedule Of Intangible Assets [Line Items]
Gross intangible assets	$ 37,259	33,515
Accumulated amortization	(35,217)	(33,515)
Net intangible assets	$ 2,042	0
Customer relationships | Minimum
Schedule Of Intangible Assets [Line Items]
Estimated useful life	5 years
Customer relationships | Maximum
Schedule Of Intangible Assets [Line Items]
Estimated useful life	8 years
Trade and brand name
Schedule Of Intangible Assets [Line Items]
Gross intangible assets	$ 7,212	6,945
Accumulated amortization	(7,212)	(6,945)
Net intangible assets	$ 0	0
Trade and brand name | Minimum
Schedule Of Intangible Assets [Line Items]
Estimated useful life	7 years
Trade and brand name | Maximum
Schedule Of Intangible Assets [Line Items]
Estimated useful life	8 years
Other intangible assets
Schedule Of Intangible Assets [Line Items]
Gross intangible assets	$ 5,634	4,700
Accumulated amortization	(3,570)	(3,142)
Net intangible assets	$ 2,064	$ 1,558
Other intangible assets | Minimum
Schedule Of Intangible Assets [Line Items]
Estimated useful life	1 year
Other intangible assets | Maximum
Schedule Of Intangible Assets [Line Items]
Estimated useful life	8 years

XML

GOODWILL AND INTANGIBLE ASSETS (Estimated annual amortization expense) (Details) $ in Thousands	Jul. 01, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remaining fiscal 2023	$ 1,378
Fiscal 2024	5,274
Fiscal 2025	5,110
Fiscal 2026	5,110
Fiscal 2027	4,835
Thereafter	9,711
Total amortization expense	$ 31,418

XML

GOODWILL AND INTANGIBLE ASSETS (Narrative) (Details) - USD ($) $ in Thousands	9 Months Ended
	Jul. 01, 2023	Oct. 01, 2022
Goodwill [Line Items]
Goodwill impairment	$ 9,794
Developed technology
Goodwill [Line Items]
Cumulative impairment	6,900	$ 0
All Others
Goodwill [Line Items]
Goodwill impairment	$ 9,794
Growth rate
Goodwill [Line Items]
Reporting unit, measurement input	2.50%
Discount rate
Goodwill [Line Items]
Reporting unit, measurement input	11.70%

XML

CASH, CASH EQUIVALENTS, RESTRICTED CASH AND SHORT-TERM INVESTMENTS (Details) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments [Line Items]
Cash, Amortized Cost	$ 31,696	$ 173,402
Cash, Unrealized Gains	0	0
Cash, Unrealized Losses	0	0
Cash, Estimated Fair Value	31,696	173,402
Cash and Cash Equivalents, Amortized Cost	401,819	555,557
Cash and Cash Equivalents, Unrealized Gain	0	0
Cash and Cash Equivalents, Unrealized Loss	(13)	(20)
Cash and Cash Equivalents, Estimated Fair Value	401,806	555,537
Short-term investments, Amortized Cost	310,000	220,000
Short-term Investments, Unrealized Gain	0	0
Short-term Investments, Unrealized Loss	0	0
Short-term Investments, Estimated Fair Value	310,000	220,000
Cash, Cash Equivalents, Restricted Cash, and Short-Term Investments, Amortized Cost	711,819	775,557
Cash, Cash Equivalents, Restricted Cash, and Short-Term Investments, Unrealized Gain	0	0
Cash, Cash Equivalents, Restricted Cash, and Short-Term Investments, Unrealized Loss	(13)	(20)
Cash, Cash Equivalents, Restricted Cash, and Short-Term Investments, Estimated Fair Value	711,806	775,537
Money market funds
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments [Line Items]
Cash Equivalents, Amortized Cost	215,114	157,145
Cash Equivalents, Unrealized Gain	0	0
Cash Equivalents, Unrealized Loss	(13)	(20)
Cash Equivalents, Estimated Fair Value	215,101	157,125
Time deposits
Cash, Cash Equivalents, Restricted Cash and Short-Term Investments [Line Items]
Cash Equivalents, Amortized Cost	155,009	225,010
Cash Equivalents, Unrealized Gain	0	0
Cash Equivalents, Unrealized Loss	0	0
Cash Equivalents, Estimated Fair Value	155,009	225,010
Short-term investments, Amortized Cost	310,000	220,000
Short-term Investments, Unrealized Gain	0	0
Short-term Investments, Unrealized Loss	0	0
Short-term Investments, Estimated Fair Value	$ 310,000	$ 220,000

XML

EQUITY INVESTMENTS (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jul. 01, 2023	Jul. 01, 2023	Oct. 01, 2022
Equity Method Investments [Abstract]
Non-marketable equity securities	$ 433	$ 433	$ 5,397
Impairment charges	$ 5,000	$ 5,000

XML

DERIVATIVES FINANCIAL INSTRUMENTS (Fair value of derivative instruments) (Details) - USD ($) $ in Thousands	9 Months Ended
	Jul. 01, 2023	Oct. 01, 2022
Derivatives, Fair Value [Line Items]
Notional Amount	$ 58,288	$ 57,570
Fair value liability, derivates	$ (500)	(2,234)
Gain (loss) reclassification, estimate of time to transfer	12 months
Derivatives designated as hedging instruments: | Foreign exchange forward contracts
Derivatives, Fair Value [Line Items]
Foreign exchange forward contract, term of contract	12 months
Notional Amount	$ 58,288	57,570
Accrued Expenses and Other Current Liabilities | Derivatives designated as hedging instruments: | Foreign exchange forward contracts
Derivatives, Fair Value [Line Items]
Fair value liability, derivates	$ (500)	$ (2,234)

XML

DERIVATIVES FINANCIAL INSTRUMENTS (Gain (loss) of derivative instruments) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized (loss)/gain on derivative instruments, net of tax	$ (1,280)	$ (1,233)	$ 2,550	$ (1,168)
Reclassification adjustment for (gain)/loss on derivative instruments recognized, net of tax	518	(170)	816	(793)
Unrealized loss on hedging
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized (loss)/gain on derivative instruments, net of tax	(1,280)	(1,233)	2,550	(1,168)
Reclassification adjustment for (gain)/loss on derivative instruments recognized, net of tax	$ 518	$ (170)	$ 816	$ (793)

XML

LEASES - Narrative (Details)	9 Months Ended
	Jul. 01, 2023 extend_options
Lessee, Lease, Description [Line Items]
Options to extend	4
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, term of contract	1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, term of contract	20 years

XML

LEASES - Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Lease, Cost [Abstract]
Operating lease expense	$ 2,846	$ 2,173	$ 8,119	$ 6,217
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash outflows from operating leases			$ 6,913	$ 5,715

XML

LEASES - Lease Terms and Discount Rates (Details)	Jul. 01, 2023	Oct. 01, 2022
Leases [Abstract]
Weighted-average remaining lease term (in years):	7 years 8 months 12 days	8 years
Weighted-average discount rate:	6.40%	5.80%

XML

LEASES - Future Lease Payments After Adoption ASC 842 (Details) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
Remaining fiscal 2023	$ 2,453
Fiscal 2024	9,088
Fiscal 2025	8,817
Fiscal 2026	8,382
Fiscal 2027	6,462
Thereafter	26,168
Total minimum lease payments	61,370
Less: Interest	13,411
Present value of lease obligations	47,959
Less: Current portion	6,569	$ 6,766
Long-term portion of lease obligations	$ 41,390	$ 34,927

XML

DEBT AND OTHER OBLIGATIONS DEBT AND OTHER OBLIGATIONS (Details) - USD ($)	3 Months Ended
	Jul. 01, 2023	Feb. 15, 2019	Nov. 22, 2013
Citibank
Capital Leased Assets [Line Items]
Capacity under credit facility			$ 5,000,000
Outstanding amounts under credit facility	$ 3,200,000
Facility agreements | MUFG Bank, Ltd., Singapore Branch
Capital Leased Assets [Line Items]
Capacity under credit facility		$ 150,000,000
Outstanding amounts under credit facility	$ 0
Secured Overnight Financing Rate (SOFR) | Facility agreements | MUFG Bank, Ltd., Singapore Branch
Capital Leased Assets [Line Items]
Debt instrument, basis spread on variable rate	1.50%

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended						9 Months Ended
	Oct. 18, 2021	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Jul. 01, 2023	Jul. 02, 2022	Mar. 03, 2022	Oct. 03, 2020	Jan. 31, 2019	Jul. 10, 2018	Aug. 15, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchase program, authorized amount										$ 800,000	$ 400,000	$ 300,000	$ 200,000	$ 100,000
Authorized amount, additional amount										$ 400,000
Value of shares acquired		$ 8,541	$ 4,990	$ 45,382	$ 31,098	$ 176,153	$ 15,380
Cash dividends declared (in dollars per share)	$ 0.19
Common stock cash dividends paid		$ (10,800)						$ (31,303)	$ (29,393)
Relative TSR calculation period								90 days
Relative TSR Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shareholder return award performance measurement period								3 years
Revenue Growth Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shareholder return award performance measurement period								3 years
Time-based Restricted Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shareholder return award performance measurement period								3 years
Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (in shares)		2,500,000						2,500,000
the Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares repurchased in period (shares)		174,900						1,331,100
Value of shares acquired		$ 8,500						$ 58,900
Remaining repurchase authorized amount		$ 190,200						$ 190,200
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Company contributions								4.00%
Minimum | Relative TSR Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		0.00%						0.00%
Minimum | Revenue Growth Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		0.00%						0.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Company contributions								6.00%
Maximum | Relative TSR Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		200.00%						200.00%
Maximum | Revenue Growth Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage		200.00%						200.00%

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Matching contributions to the Plan) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
401(k) Cash Contributions
Cash	$ 463	$ 419	$ 1,477	$ 1,423

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Accumulated other comprehensive income) (Details) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Loss from foreign currency translation adjustments
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity	$ (16,341)	$ (29,854)
Unrecognized actuarial loss on pension plan, net of tax
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity	(884)	(812)
Unrealized loss on hedging
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity	(500)	(2,234)
Accumulated Other Comprehensive (Loss)/Income
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity	$ (17,725)	$ (32,900)

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Restricted stock and common stock granted) (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation in shares	5	5	807	546
Time-based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation in shares	0	1	512	303
Relative TSR PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation in shares	0	0	186	154
Growth PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation in shares	0	0	92	77
Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation in shares	5	4	17	12

XML

SHAREHOLDERS' EQUITY AND EMPLOYEE BENEFIT PLANS (Total equity-based compensation expense) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	$ 5,403	$ 4,465	$ 17,303	$ 14,473
Time-based RSUs
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	3,560	2,845	10,758	8,763
Relative TSR PSUs
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	1,252	1,073	3,697	3,060
Growth PSUs
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	354	310	2,137	1,938
Common Stock
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	237	237	711	712
Cost of sales
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	272	193	903	727
Selling, general and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	3,800	3,233	12,398	10,485
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total equity-based compensation expense	$ 1,331	$ 1,039	$ 4,002	$ 3,261

XML

REVENUE AND CONTRACT BALANCES - Contract Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]
Contract assets, beginning of period	$ 29,210	$ 26,721	$ 26,317	$ 0
Additions	1,337	18,563	4,230	45,284
Transferred to accounts receivable or collected	(20,365)	0	(20,365)	0
Contract assets, end of period	$ 10,182	$ 45,284	$ 10,182	$ 45,284

XML

REVENUE AND CONTRACT BALANCES - Contract Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Change in Contract with Customer, Liability [Roll Forward]
Contract liabilities, beginning of period	$ 6,556	$ 17,300	$ 3,160	$ 15,596
Revenue recognized	(12,404)	(29,612)	(28,950)	(104,796)
Additions	11,832	17,996	31,774	94,884
Contract liabilities, end of period	$ 5,984	$ 5,684	$ 5,984	$ 5,684

XML

EARNINGS PER SHARE (Reconciliation of the shares used in the basic and diluted net income per share computation) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Jul. 02, 2022	Apr. 02, 2022	Jan. 01, 2022	Jul. 01, 2023	Jul. 02, 2022
NUMERATOR:
Net income	$ 4,161	$ 15,041	$ 14,589	$ 119,034	$ 116,001	$ 133,606	$ 33,791	$ 368,641
DENOMINATOR:
Weighted average shares outstanding - Basic (in shares)	56,553,000			58,985,000			56,763,000	60,951,000
Dilutive effect of Equity Plans (in shares)	966,000			970,000			921,000	989,000
Weighted average shares outstanding - Diluted (in shares)	57,519,000			59,955,000			57,684,000	61,940,000
EPS:
Net income per share - Basic (in dollars per share)	$ 0.07			$ 2.02			$ 0.60	$ 6.05
Effect of dilutive shares (in dollars per share)	0			0.03			0.01	0.10
Net income per share - Diluted (in dollars per share)	$ 0.07			$ 1.99			$ 0.59	$ 5.95
Anti-dilutive shares (in shares)	0			19,000			1,000	1,000

XML

INCOME TAXES (Provision for income taxes and the effective tax rate) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 148	$ 5,165	$ 9,462	$ 36,813
Effective tax rate	3.40%	4.20%	21.90%	9.10%

XML

SEGMENT INFORMATION (Narrative) (Details)	9 Months Ended
	Jul. 01, 2023 segment
Segment Reporting [Abstract]
Number of reportable segments	4

XML

SEGMENT INFORMATION (Operating information by segment) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Net revenue:
Net revenue	$ 190,917	$ 372,137	$ 540,171	$ 1,217,307
Income/(loss) from operations:
(Loss)/Income from operations	(4,488)	122,077	19,963	402,528
Ball Bonding Equipment
Net revenue:
Net revenue	76,865	217,912	184,049	751,496
Income/(loss) from operations:
(Loss)/Income from operations	18,534	93,863	49,337	323,884
Wedge Bonding Equipment
Net revenue:
Net revenue	42,563	50,800	145,805	142,284
Income/(loss) from operations:
(Loss)/Income from operations	15,974	19,443	53,958	49,599
Advanced Solutions
Net revenue:
Net revenue	23,858	34,614	58,997	71,651
Income/(loss) from operations:
(Loss)/Income from operations	(2,570)	3,134	(21,160)	(7,574)
APS
Net revenue:
Net revenue	39,672	50,191	119,822	152,924
Income/(loss) from operations:
(Loss)/Income from operations	11,510	22,282	34,778	64,651
All Others
Net revenue:
Net revenue	7,959	18,620	31,498	98,952
Income/(loss) from operations:
(Loss)/Income from operations	(23,857)	2,671	(35,025)	28,372
Corporate Expenses
Income/(loss) from operations:
(Loss)/Income from operations	$ (24,079)	$ (19,316)	$ (61,925)	$ (56,404)

XML

SEGMENT INFORMATION (Schedule of net revenue by Capital Equipment end markets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 190,917	$ 372,137	$ 540,171	$ 1,217,307
Ball Bonding Equipment | General Semiconductor
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	77,745	223,034	217,186	670,251
Ball Bonding Equipment | Automotive & Industrial
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	44,973	51,018	149,608	160,366
Ball Bonding Equipment | LED
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	17,678	20,203	32,765	128,394
Ball Bonding Equipment | Memory
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	10,849	27,691	20,790	105,372
APS
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 39,672	$ 50,191	$ 119,822	$ 152,924

XML

SEGMENT INFORMATION (Capital expenditures, depreciation and amortization expense by segment) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Segment Reporting, Other Significant Reconciling Item [Line Items]
Capital expenditures:	$ 10,451	$ 4,953	$ 43,485	$ 11,213
Depreciation and amortization expense:
Depreciation expense:	6,805	4,101	16,003	12,230
Amortization expense:	1,786	1,109	4,743	3,543
Ball Bonding Equipment
Segment Reporting, Other Significant Reconciling Item [Line Items]
Capital expenditures:	316	179	805	855
Depreciation and amortization expense:
Depreciation expense:	388	346	1,173	1,012
Amortization expense:	0	0	0	0
Wedge Bonding Equipment
Segment Reporting, Other Significant Reconciling Item [Line Items]
Capital expenditures:	83	358	403	780
Depreciation and amortization expense:
Depreciation expense:	304	252	878	732
Amortization expense:	0	0	0	0
Advanced Solutions
Segment Reporting, Other Significant Reconciling Item [Line Items]
Capital expenditures:	6,439	1,049	29,425	2,423
Depreciation and amortization expense:
Depreciation expense:	2,989	519	4,821	1,494
Amortization expense:	0	0	0	0
APS
Segment Reporting, Other Significant Reconciling Item [Line Items]
Capital expenditures:	1,251	1,151	4,443	2,851
Depreciation and amortization expense:
Depreciation expense:	1,517	1,681	4,742	4,971
Amortization expense:	380	208	1,116	684
All Others
Segment Reporting, Other Significant Reconciling Item [Line Items]
Capital expenditures:	30	437	279	700
Depreciation and amortization expense:
Depreciation expense:	416	250	1,017	792
Amortization expense:	1,314	809	3,352	2,584
Corporate Expenses
Segment Reporting, Other Significant Reconciling Item [Line Items]
Capital expenditures:	2,332	1,779	8,130	3,604
Depreciation and amortization expense:
Depreciation expense:	1,191	1,053	3,372	3,229
Amortization expense:	$ 92	$ 92	$ 275	$ 275

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Reserve for product warranty activity) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]
Reserve for warranty, beginning of period	$ 10,468	$ 15,518	$ 13,443	$ 16,961
Provision for warranty	4,007	2,842	8,989	9,001
Utilization of reserve	(3,908)	(4,118)	(11,865)	(11,720)
Reserve for warranty, end of period	$ 10,567	$ 14,242	$ 10,567	$ 14,242

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Obligations not reflected on the Consolidated Balance Sheet) (Details) $ in Thousands	Jul. 01, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Total	$ 198,566
2023	21,676
2024	176,890
2025	0
2026	0
2027	0
thereafter	$ 0

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Significant customer concentrations as a percentage of net revenue) (Details)	9 Months Ended
	Jul. 01, 2023
First Technology China Ltd.(1) | Revenue Benchmark | Customer Concentration Risk
Concentration Risk [Line Items]
Customer concentrations risk percentage	10.00%

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Significant customer concentrations as a percentage of total accounts receivable) (Details) - Accounts Receivable - Customer Concentration Risk	9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022
Intel Corporation
Concentration Risk [Line Items]
Customer concentrations risk percentage	12.20%
Tianshui Huatian Technology Co., Ltd.
Concentration Risk [Line Items]
Customer concentrations risk percentage		20.60%
Apple Inc.
Concentration Risk [Line Items]
Customer concentrations risk percentage	10.30%

XML

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS - Narrative (Details) $ in Thousands	9 Months Ended
	Jul. 01, 2023 USD ($)
Other Commitments [Line Items]
Period of warranty for manufacturing defects	1 year
Unfunded Capital Commitment
Other Commitments [Line Items]
Other Commitment	$ 9,600